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The work presented in this dissertation is the response to a series of technical and 
clinical challenges encountered during the first four years of operations in the 
Gamma Knife Centre at Queen Square. These challenges, which are common to 
most contemporary Gamma Knife centres, were prospectively addressed and 
practical solutions were developed for the questions they posed. 
The dosimetric differences between the new convolution algorithm and the 
standard TMR 10 algorithm traditionally used for prediction of dose distribution 
in Gamma Knife Radiosurgery (GKR) were explored. It was demonstrated that 
inhomogeneity correction with the convolution algorithm results in a considerable 
but consistent dose shift compared to TMR 10. No significant difference in 
relative dose distribution was noted and it was concluded that a reduction of the 
prescription dose is necessary to obtain the same absolute dosimetric effect with 
the convolution algorithm. 
The stability of the stereotactic Leksell frame G in GKR was demonstrated using 
a comprehensive study design that involved repeated measurements of landmarks 
by two observers. The study provided reliable and realistic evidence of 
submillimetre stability of the stereotactic frame throughout the treatment 
procedure which is important for evaluation and development of new frameless 
radiosurgery systems. 
The technical feasibility of using a combination of three magnetic resonance 
angiography sequences (triple-MRA), instead of digital subtraction angiography 
(DSA), for visualisation and delineation of brain Arteriovenous Malformations 
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(AVMs) for GKR targeting was demonstrated. Target volumes obtained using 
triple-MRA are on average 10% smaller than AVM targets obtained with the 
standard DSA planning method and this can potentially reduce the risk of adverse 
radiation effects (ARE). The treatment planning method described here has laid 
the way for a change in clinical practice that favours a less invasive treatment 
planning approach.  
The same principle of less invasive AVM imaging with triple-MRA was used at 
the post-GKR stage, when a DSA is performed to confirm AVM obliteration. 
Triple-MRA was found to consistently confirm or rule out residual AVMs in 
patients who had undergone GKR for brain AVMs, compared to DSA, and it can 
also be reliably used for characterisation of residual AVMs. The use of triple-
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The technical development of Gamma Knife Radiosurgery (GKR) started in the 
1950s and it flourished in the 1980s, with the introduction of Computed 
Tomography (CT) and Magnetic Resonance (MR) imaging (Leksell, 1951; 
Leksell & Jernberg, 1980). GKR has significantly contributed to the shift towards 
less invasive management of neurosurgical pathologies over the last few decades 
(Koga et al, 2010).  
The safety and efficacy of GKR has been steadily demonstrated by cumulative 
numbers of studies -mainly outcome reports- and a variety of intracranial 
conditions including brain tumours, vascular malformations and functional 
pathologies are now routinely treated using the Gamma Knife (Mansouri et al, 
2015a; Nagy et al, 2012). The indications for GKR continue to expand, with an 
increasing interest in functional and staged radiosurgery while the volume of 
patients receiving GKR also grows. More than a million patients have been 
treated with the Gamma Knife to date and there are over 300 Gamma Knife 
centres operating in 45 countries around the world (Leksell Gamma Knife 
Society, 2016). The Gamma Knife Centre at Queen Square started operations in 
October 2013 and since its opening a series of technical and clinical challenges 
have been encountered. These challenges, common to most contemporary Gamma 
Knife centres, are the main focus of this dissertation. 
GKR is, for radiation oncology standards, a relatively aggressive treatment with 
doses about ten times that of standard radiotherapy. At the same time, it is a less 
invasive treatment modality for intracranial pathologies that would otherwise be 
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managed surgically. For these reasons, it continues to be closely scrutinised by 
both the radiation oncology and neurosurgery communities. GKR has been 
compared to other treatment modalities and radiosurgical techniques and its 
limitations have been readily identified (Park et al, 2016). It has been criticised for 
failing to correct treatment dose for tissue heterogeneity and for using instead a 
simpler algorithm, Tissue Maximum Ratio 10 (TMR 10), to predict the 
distribution of ionizing radiation in the brain. TMR 10 assumes the patient’s head 
is of an even density, equivalent to water (Nakazawa et al, 2014b). This results in 
a significant approximation of the dose delivered by the Gamma Knife and for 
this reason a new dose calculation algorithm (convolution) capable of performing 
heterogeneity corrections has been developed and released by the manufacturer 
(Elekta, 2011b). The dosimetric differences between TMR 10 and convolution 
algorithms need to be better understood before the new method can be deployed 
in a clinical setting. However, both methods are available in GKR planning 
system and the choice of which algorithm to use, together with appropriate dose 
adjustments, are at the discretion of the radiosurgery practitioner. This issue is 
addressed in chapter 3 by investigating how GKR dose calculations vary when 
using the new convolution algorithm compared with the established TMR 10 
algorithm. 
Radiosurgery has recently seen an accelerated development of frameless 
radiosurgical techniques which are thought to deliver submillimetre accuracy 
without the discomfort of a solid frame fitting procedure (Schlesinger et al, 2012). 
In addition, the latest enhancement of the Gamma Knife itself, the Icon, 
incorporates a stereotactic cone beam CT and real-time motion management to 
enable frameless immobilization (Ruschin et al, 2013). However, most data on the 
safety and efficacy of stereotactic radiosurgery comes from GKR and probably 
around 99% of all GKR procedures have been performed using the stereotactic 
Leksell frame G (Lunsford et al, 2013). The Leksell frame is therefore considered 
to be the gold standard stereotactic immobilization method and its accuracy and 
stability will serve as a reference to assess performance of new frameless 
technologies. For this reason, we have investigated the stability of the Leksell 
frame by evaluating the possibility that the actual location of a target within the 
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stereotactic system at treatment differs from its calculated location, due to 
displacement of the reference frame between initial stereotactic imaging and the 
end of the stereotactic procedure. This data, presented in chapter 4, will be 
valuable for future evaluation and development of frameless radiosurgery 
systems.  
The publication of the ARUBA trial (A randomized trial for un-ruptured Brain 
arteriovenous malformations) in 2014 changed the clinical management of un-
ruptured arteriovenous malformations (AVM) and a less invasive approach is now 
favoured (Mohr et al, 2014). The ARUBA trial concluded that medical 
management alone is superior to medical management with interventional therapy 
(microsurgery, embolization and/or radiosurgery) for the prevention of death or 
stroke in patients with un-ruptured brain AVMs followed up for 33 months. The 
methodology and external validity of this trial has been extensively questioned 
and its applicability to our field is greatly undermined by the poor representation 
of radiosurgery -only 31 patients- and the lack of subgroup outcome data 
(Bambakidis et al, 2014). Nonetheless, the ARUBA trial has raised awareness of 
the invasiveness of treatments used for AVMs and has reinforced the imperative 
for these interventions to be made less invasive, where possible. In radiosurgery, 
this can be achieved by optimising the planning method which is currently based 
on digital subtraction angiography (DSA), an invasive procedure that carries a 
non-negligible risk of complication (Kaufmann et al, 2007). We proposed that a 
combination of three advanced MR angiography (MRA) sequences could be 
successfully used as an alternative to DSA for the planning of GKR (chapter 5). 
The MRA sequences selected and optimised for this study are 4D arterial spin 
labelling based MR angiography (ASL-MRA), time-resolved contrast-enhanced 
MRA (CE-MRA) and high definition time-of-flight angiography (HD-TOF), and 
they are collectively referred to as triple-MRA.  
A parallel study was also carried out to apply the same principle of less invasive 
AVM imaging with a combination of MRA sequences at the post-GKR stage, 
when a DSA is routinely performed to confirm AVM obliteration (chapter 6). 
This study aimed to evaluate whether triple-MRA can be used as an alternative to 
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DSA to confirm AVM obliteration following GKR and to characterise residual 
AVMs in case of incomplete response. This is clinically relevant because triple-
MRA can not only avoid unnecessary DSA examinations for patients with cured 
AVMs, but it can also help rationalize its use in patients with residual AVMs, 
who may need further treatments.  
The studies presented in this dissertation have been motivated by distinct 
challenges of radiosurgery practice at Queen Square. The evaluation of the 
convolution algorithm, for instance, was performed to inform our GKR 
practitioners on dosimetry algorithm selection. The use of triple-MRA for GKR 
planning has the potential to reduce the invasiveness of AVM radiosurgery 
treatment. The methodology used to address these challenges was purposefully 
planned and the research procedures prospectively conducted to ensure the 
external validity of the results, which are better understood within the context of a 






2. Literature review 
2.1 Gamma Knife Radiosurgery 
GKR is a well-established radiation based treatment for benign and malignant 
tumours, vascular malformations and functional disorders of the brain (Koga et al, 
2010). The Gamma Knife Stereotactic Radiosurgery (SRS) technique, as 
developed by Lars Leksell in the 1950’s and subsequently used in most Gamma 
Knife peer reviewed publications, involves the stereotactic delivery of a high dose 
of radiation to a well-defined intracranial target in a single session using a rigid 
skull immobilisation system (Leksell, 1968; Lipski et al, 2015). 
The energy delivered using the Gamma Knife is expected to inactivate all cells 
contained within the radiosurgical target while preserving the normal surrounding 
tissue (Lippitz et al, 2014). This makes GKR fundamentally different to standard 
radiotherapy in which the more radio-sensitive tumour cells are selectively 
inactivated while minimal or tolerable exposure and damage is caused to normal 
cells within the treatment volume (Patel & Mehta, 2007). This is achieved in 
standard radiotherapy by dose fractionation which exploits the increased repair 
capacity of normal cells and creates a therapeutic window which enables the use 
of standard radiotherapy (Bentzen, 2006). In GKR, however, the high dose 
delivered elicits a necrotizing effect and tissue preservation within the target is not 
expected. Preservation of the surrounding structures, in the other hand, is 
accomplished by a steep dose gradient outside the radiosurgical target and this is 
one of the key factors that make radiosurgery feasible (Paddick & Lippitz, 2006).  
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The principle of radiosurgery has been extended to treatment of extracranial 
conditions and it has been greatly diversified with the development of a variety of 
systems and techniques capable of safely delivering high doses of ionizing 
radiation to well defined targets. This is reflected by the most recent definition of 
SRS by the American Association of Neurological Surgeons (AANS), the 
Congress of Neurological Surgeons (CNS), and the American Society for 
Therapeutic Radiology and Oncology (ASTRO), which states: “SRS is a distinct 
discipline that utilizes externally generated ionizing radiation in certain cases to 
inactivate or eradicate defined target(s) in the head and spine without the need to 
make an incision. The target is defined by high-resolution stereotactic imaging. 
SRS is typically performed in a single session, using a rigidly attached stereotactic 
guiding device, other immobilization technology and/or a stereotactic image-
guidance system, but can be performed in a limited number of sessions, up to a 
maximum of five. Technologies that are used to perform SRS include linear 
accelerators, particle beam accelerators, and multisource Cobalt 60 units. In order 
to enhance precision, various devices may incorporate robotics and real time 
imaging” (Barnett et al, 2007). 
2.2 History of Gamma Knife Radiosurgery 
The term and concept of stereotactic radio-surgery were first described by Lars 
Leksell in 1951 (Leksell, 1951). This pioneering work, carried out in partnership 
with Börje Larsson, combined a stereotactic guiding device with a radio-
therapeutic modality, initially proton beams and linear accelerators which were 
soon abandoned in favour of the more practical and efficient cobalt-60 sources 
(Larsson et al, 1958). The first prototype of a Gamma Knife device using 179 
Co60 sources was developed by Leksell and Larsson at the Karolinska institute in 
Sweden and first used to treat a patient in 1967 (Leksell, 1968). 
The use of the Gamma Knife in the early days was limited to pathologies that 
could be targeted with the imaging methods available at the time; such as 
trigeminal neuralgia in which the Gasser ganglion can be located using plain X 
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rays (Leksell, 1971). Probably for this reason, the second Gamma Knife unit in 
Stockholm was specially re-designed to treat AVMs, which could be well 
depicted at the time using DSA (Steiner et al, 1972). Early work in functional 
radiosurgery in the 1970’s included thalamotomies for intractable pain and 
capsulotomies for psychiatric disorders (Leksell & Backlund, 1978; Leksell et al, 
1972) but it was only in the 1980’s when the introduction of CT and MR imaging 
enabled the safe and successful application of GKR to a prolific variety of 
intracranial conditions (Hounsfield, 1976; Leksell et al, 1985a; Leksell & 
Jernberg, 1980; Leksell et al, 1985b). The 1980’s also saw the installation of a 
third unit (first out of Sweden) in Buenos Aires, Argentina and the commissioning 
of the fourth GKR unit in Sheffield, United Kingdom in the summer of 1985 
(Walton et al, 1987). The fifth Gamma Knife in the world, and first in the United 
States, became operational in the University of Pittsburgh in 1987 (Lunsford et al, 
1989). More than one million GKR procedures have been performed around the 
world since then (Berkowitz et al, 2013). 
2.3 The Gamma Knife Perfexion 
The Perfexion Gamma Knife was released in 2006 as an entirely redesigned 
radiosurgery unit that differed fundamentally from previous models of the Leksell 
Gamma Knife. It did not only incorporate a new fully automated collimator 
arrangement and patient positioning system but also software developments were 
included to improve the ability to create complex shapes of isodose volumes. The 
Gamma Knife Perfexion was used for all research activities presented in this 
thesis. 
It incorporates 192 Co60 sources distributed in 8 sectors cylindrically arranged. 
Each sector comprises 24 sources distributed in five rows that when aligned with 
the adjacent sectors form five rings of beams as shown in Figure 2.1 (Lindquist & 
Paddick, 2007). The radiation beams are shaped using cylindrical 120 mm long 
tungsten tubes (collimators) built into a collimator body. Three collimator sizes 
are incorporated, 4, 8 and 16 mm and an automated drive system slides each 
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sector back and forth enabling selective exposure of the collimators of the 
selected size to the sources (Figure 2.1c). A sector can also be positioned between 
two rows of collimators and this enables blocking of individual sectors during 
treatment (Petti et al, 2008). The collimated beams are converged with high 
accuracy to a fixed isocentre where the target is positioned during treatment using 
a skull immobilisation system and a fully automated patient positioning system 
(Novotny et al, 2014). 
2.4 Leksell stereotactic frame G 
The safety and efficacy of GKR relies on the high precision of its image-guided 
targeting system. The use of a stereotactic frame tightly attached to the skull is 
still considered the most accurate technique for beam delivery inside the head 
(Rojas-Villabona et al, 2016b). The Leksell stereotactic coordinate frame is a 
dedicated stereotactic tool introduced by the Swedish Neurosurgeon Lars Leksell 
in the 1970s and further developed over the last few decades (Leksell & Jernberg, 
1980). It was extensively used as a stereotactic tool for brain biopsies before 
neuro-navigation systems were developed and it is still used for GKR and 







Figure 2.1. The Gamma Knife Perfexion. (A) The Gamma Knife perfexion 
incorporates 192 Co60 sources distributed in 8 sectors cylindrically arranged. Each sector 
comprises 24 sources distributed in five rows that when aligned with the adjacent sectors 
form five rings of beams (B). Three collimator sizes are incorporated (4, 8 and 16 mm) 
and an automated drive system slides each sector back and forth enabling selective 
positioning of that group of sources on the collimators of the desired size (C).  






The most recent version of the Leksell frame is the model G which is made of 
titanium-aluminium alloy. The dimensions of the rectangular frame base are 190 x 
210 mm, and a straight or curved front piece can be used anteriorly. Four vertical 
posts and titanium pins are used to secure the frame to the outer layer of the skull 
and a system of fiducial markers attached to the frame during imaging enables the 
accurate definition of scans into a computerised stereotactic coordinate system. 
The coordinates of the frame centre are 100, 100, 100, and a hypothetical frame 
origin, i.e., x, y and z = 0, is located in the right upper posterior corner of the 
frame. For GKR, virtually any target located above the upper border of the frame 
base (z =167) can be treated and long posts are available to enable coverage of 
lesions located as low as the upper cervical spine (C2). Figure 2.2 shows the 
assembled Leksell frame G as it is used for GKR at QSRC.  
 
 
Figure 2.2. Leksell stereotactic coordinate frame G. Left: Frame assembled with the 
curved front piece in the upwards position, angled anterior insulated posts and medium 
straight insulated posts posteriorly. Right: Lateral view of the Leksell G frame with the 






2.5 Gamma Knife dosimetry 
A typical radiosurgery treatment plan is made of a number of exposures, called 
isocenters or shots, directed to different areas of the target to conformaly cover a 
pre-defined target volume (TV). Once the location of the shots has been specified 
in the coordinate system, a treatment dose and prescription isodose (PI) are 
selected based on pathology (Table 3.7), target size, location, previous treatments 
and surrounding organs at risk (Lippitz et al, 2014). The final treatment plan is 
made of the stereotactic coordinates and length of exposure (Beam-on-time) of a 
number of shots with their specified collimator size arrangement.  
Shots can be planned with a combination of collimator sizes (hybrid) and this 
feature allows each individual isocentre of a treatment plan to have its own 
optimized shape, thereby, increasing the overall matching between the volume of 
the prescription isodose (PIV) and the TV. This concept of how well the PIV 
conforms to the TV is known as conformity and a number of parameters have 
been described to assess treatment plans in this regard (Lindquist & Paddick, 
2007). The most basic of these is coverage, which is the percentage of TV that is 
included or covered by the PIV. More complex indices have also been developed 
to describe agreement between the TV and PIV. They include the prescription 
isodose to target volume ratio (PITV), defined by Shaw et al and also known as 
conformity index, and the new conformity index described by Paddick et al 
(Paddick & Lippitz, 2006; Shaw et al, 1993). They are calculated using the 
following equations: 
!"#$	('()*(+,-./	-)012) = 56787 		                                 (2.1) 
!900-:;<=	)1>	:()*(+,-./	-)012 = 87?@AB87	×	567			                     (2.2) 
where TVPIV is the volume of the target encompassed by the PIV. An ideal PITV 
is 1, or slightly higher, and a score of less than unity suggests a lack of target 
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coverage. Paddick’s conformity index is between 0 and 1, with the highest score 
representing the most conformal plan (Paddick & Motti, 2013) 
As a consequence of the number, locations and respective weights of multiple 
isocenters used, a high degree of heterogeneity inside the target volume and a 
very steep dose falloff outside the target volume is created. The latter, enables 
maximal exposure within the target with minimal damage to surrounding 
structures and is one of the factors that makes radiosurgery possible (Massager et 
al, 2006). Therefore, dose distribution outside the target, is as important as 
conformity in the assessment of planning quality. The most basic metric 
describing dose fall-off outside the target is selectivity which is the percentage of 
PIV included in the TV. Ideally all PIV should be inside the TV which results in 
100% selectivity. The Gamma Knife planning software also enables the 
calculation of dose volume histograms that describe dose distribution inside and 
outside TV, PIV and defined organs at risk. A gradient Index has also been 
described to objectively measure dose falloff outside the target (Paddick & 
Lippitz, 2006). It is the ratio of the volume of half the prescription isodose volume 
(PIV1/2) to the volume of the prescription isodose (PIV): 
D+90-1).	")012 = 567E/B567 			                              (2.3) 
2.5 Clinical Applications of Gamma Knife Radiosurgery 
A variety of intracranial conditions including brain tumours, vascular 
malformations and functional pathologies are now routinely treated using the 
Gamma Knife (Mansouri et al, 2015a; Nagy et al, 2012). The worldwide estimates 
of treatment by indication, as reported by the International Leksell Gamma Knife 
Society (LGKS) between 1968 and 2016, shows malignant tumours as the most 
common indication (44.2%) followed by benign tumours (36.8%), vascular 
(11.3%) and functional disorders (7.3%) (Leksell Gamma Knife Society, 2016). 
This varies between countries and between GKR centres. At Queen Square, 
benign tumours (i.e., vestibular shwannoma and meningioma) are the most 
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frequent indication (48%) followed by vascular malformations, namely AVMs 
(19.5%). Malignant pathology (i.e., brain metastases) is our third most common 
indication (18%) followed by functional disorders, mainly trigeminal neuralgia in 
8% of the cases (unpublished data). This pathology distribution is reflected on the 
subjects recruited for our studies (Table 3.1) and for this reason the literature 
review focuses on the five most common pathologies treated at QSRC which 
comprises more than 93% of our practice.  
2.5.1 Vestibular schwannoma 
Vestibular schwannomas (VS), also called acoustic neuromas, are benign 
intracranial neoplasms arising from the Schwann cells that myelinate the 
vestibular portion of the eighth cranial nerve (Bari et al, 2002). Data from 
histopathological studies have demonstrated an overall VS incidence of 0.57 to 
2.7% but the clinical incidence is considered to be 10 per-million per-year 
(Yoshimoto, 2005). Hearing loss is the most common presenting complaint 
affecting 95% of patients and this is followed in frequency by tinnitus, vertigo, 
dizziness and less often hydrocephalus (Matthies & Samii, 1997).  
VS can be classified by size and neurotopographic features using the Koos 
grading system as shown in Table 1.1 (Koos et al, 1998). It describes a predictable 
growth process from small intra-canalicular lesions to larger tumours that occupy 
the cerebello-pontine cistern and eventually displace the brainstem. As part of 
their natural history, between 29 and 54% of these tumours continue to grow if 
left untreated and 37 – 46% loose functional hearing following diagnosis (Arthurs 
et al, 2011; Yoshimoto, 2005). However, only around 20% of them do require 
active treatment and for this reason, conservative management with regular 
imaging surveillance has traditionally been advocated as the appropriate first line 
treatment for newly diagnosed -small to moderate size- vestibular schwannomas.  
Microsurgery, using either a translabyrinthine or retrosigmoid approach, is the 
traditional treatment with approximately 1% of the cases requiring additional 
treatment. It has, however, a poorer hearing preservation rate and between 14 and 
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29% of patients experience permanent facial neuropathy. For this reason it is 
reserved for larger tumours, i.e., > 30 mm in diameter (Arthurs et al, 2011). 
SRS is an increasingly popular intervention for VS which results in arrest of 
tumour growth in 91 – 95% of treated cases with 1.6% to 4.2% of the cases 
needing additional treatment after SRS (Myrseth et al, 2007). Comparative studies 
have repeatedly demonstrated that GKR provides the best outcome in terms of 
tumour control and functional preservation for enlarging intra-canalicular VS 
(Koos I) and those protruding into the cerebellopontine angle (Koos II), compared 
to conservative management and surgical excision (Lipski et al, 2015). Several 
reports also demonstrate the successful application of GKR to larger VS with 
satisfactory control rates and minimal complications (Chung et al, 2010).  
Most evidence on safety and efficacy of SRS for VS comes from GKR with a 
treatment dose between 11 and 13 Gy delivered to the tumour margin in a single 
session (Figure 2.3). Hearing preservation with this method ranges from 44 to 
63%. Permanent facial and trigeminal neuropathy occur in less than 10% and 11 - 
16% of the cases, respectively (Yamakami et al, 2003).  
 
Table 1.1. Koos neuro-topographic grading system.  
Grade Description 
I      Small intra-canalicular tumour 
II      Small tumour (<2 cm diameter) protruding into the CP angle  
III      Tumour occupying CP cistern with no brainstem displacement 
IV      Any tumour displacing the brainstem 
 







Meningiomas are a heterogeneous group of tumours arising from the arachnoid 
villi in the meninges and they account for more than one third of all central 
nervous system tumours (Kohler et al, 2011). The vast majority of them are 
benign, with only 2% classified as anaplastic or malignant (Harrison et al, 2016). 
There is great heterogeneity in diagnosis, histological type and aggressiveness 
which warrants individualised treatment selection. Tumour size and location, 
along with tumour behaviour, are the main factors determining treatment choice. 
Complete surgical resection, including dural base and underlying bone, is the first 
line treatment for benign intracranial meningiomas when achievable (Santacroce 
et al, 2012). Conservative management with regular imaging surveillance is 
frequently used for incidental, non-growing or inoperable tumours and the use of 
radiation based treatments as primary or secondary management has become 
increasingly important in the multimodality care of patients with meningiomas 
(Mansouri et al, 2015a). 
SRS was initially used for the management of skull base meningiomas which are 
difficult to resect (Figure 2.3). It has, however, gained acceptance as a first line 
modality in the management of meningiomas in other locations, due to good 
tumour control rates in the long term and low side-effects (Sheehan et al, 2010). 
Tumour control rates with GKR vary between 86% to 97% for small to medium 
size meningiomas (< 3.5 cm diameter) in case series with long-term follow-up 
(Mansouri et al, 2015b; Santacroce et al, 2012; Sheehan et al, 2010). Adjuvant 
SRS after subtotal excision of intracranial meningiomas has also been 
demonstrated to improve progression-free survival at 15 years compared to 







Figure 2.3. Gamma Knife Radiosurgery for brain tumours. Left: Representative GKR treatment plan of a right sided vestibular schwannoma 
compressing the brainstem. This T2 weighted MR sequence enables identification of the adjacent cochlea (blue arrow) which is considered the critical 
structure to protect for hearing preservation. Middle: GKR is the treatment of choice for this residual skull base meningioma due to its proximity to the 
optic pathways (delineated in red) and several critical vascular structures. Right: GKR treatment plan of three metastatic lesions in the posterior fossa in 
a patient who has undergone surgical resection of a larger lesion in the close proximity. 
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 2.5.4 Brain metastases 
Brain metastases (BM) are the most common brain tumours in adults and their 
estimated incidence is between 4 and 15 cases per 100.000 persons/year (Counsell 
et al, 1996; Eichler & Loeffler, 2007). The number of cancer patients who 
develop BM varies across groups from 8 - 40% (Linskey et al, 2010; Schouten et 
al, 2002). The most common primary tumours in patients with BM are lung 
cancer (40% – 50%), breast cancer (15% – 25%), and melanoma (5% – 20%) 
(Karlsson et al, 2009).  
The presence of BM denotes high morbidity and extremely poor prognosis with 
median survival of around 51 days when the lesions are considered inoperable and 
left untreated (Langley et al, 2013). Management depends on several factors 
including primary tumour, number of lesions, tumours’ location and size, patient´s 
performance status and the extent, prognosis and treatability of extra cranial 
disease (Banfill et al, 2012). Patient age and primary tumour control are the most 
important factors to predict survival of patients with BM (Karlsson et al, 2009). 
The cornerstones of treatment are surgery, whole brain radiotherapy (WBRT), 
chemotherapy and SRS (Figure 2.3). A multidisciplinary approach is favoured 
with frequently a combination of treatments to prolong survival, preserve 
neurologic and neurocognitive function, and maximize quality of life (Eichler & 
Loeffler, 2007). 
Surgical resection of BM may benefit selected patients, particularly those with a 
solitary metastasis causing raised intracranial pressure, where decompression 
produces rapid symptom relief (Eichler & Loeffler, 2007). WBRT has been used 
for several decades to treat patients with BM based on non-randomized studies 
suggesting that WBRT increases the median survival time to 3 – 4 months 
compared with no treatment (1 month) and corticosteroids alone (2 months) 
(Zimm et al, 1981). The benefit of WBRT compared to supportive care alone has 
not been studied in RCT. The Medical Research Council QUARTZ trial, indicated 
no evidence of benefit on quality of life or overall survival for patients with 
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inoperable BM from non-small cell lung cancer treated with WBRT and Optimal 
Supportive Care (OSC) as compared to patients receiving OSC alone (Langley et 
al, 2013). The most recent Cochrane systematic review on WBRT for treatment of 
newly diagnosed multiple BM also concluded that WBRT does not provide a 
significant benefit in terms of OS, neurological function, or symptoms control 
(Tsao et al, 2012). The long-term neurotoxic effects of WBRT have become a 
deterrent to its use, particularly on patients with good performance status who are 
expected to survive significantly longer than the onset time of prominent WBRT-
induced neurocognitive decline (Khalsa et al, 2013; Langley et al, 2013). In 
current clinical practice, WBRT is reserved for patients with multiple BM not 
amenable to surgery or SRS, poor functional status, or active/disseminated 
systemic disease for palliation of neurological symptoms. Nevertheless, it has 
been demonstrated that the number of distant recurrences is higher when WBRT 
is omitted and this has been used as an argument to use WBRT as an adjuvant to 
surgery or SRS (Aoyama et al, 2006; Tsao et al, 2012).  
SRS is a widely accepted treatment modality for newly diagnosed patients, alone 
or in combination with WBRT, and as a salvage therapy for progressive 
intracranial disease after WBRT (Karlsson et al, 2009). Large multicentre series 
have reported a consistently high local tumour control rate of 80% - 90% 
following GKR for single and multiple BM which is the most common indication 
for GKR in the US (Chang et al, 2000; Da Silva et al, 2009; Karlsson et al, 2009; 
Salvetti et al, 2013). Prospective randomised studies have shown prolonged 
survival for patients with single brain metastasis treated with SRS plus WBRT 
compared to WBRT alone (Andrews et al, 2004). SRS offers several advantages 
over craniotomy and WBRT, such as the treatment of surgically inaccessible 
lesions in deep-seated or eloquent areas, shorter admissions, and feasibility for 
physically ill patients with multiple lesions (Figure 2.3). The ARE that occur after 
GKR are usually mild and include treatment induced oedema (4% – 6%), seizures 
(2% – 6%) and delayed radiation necrosis (2% – 17%) (Banfill et al, 2012; 
Breneman et al, 1997). Cognitive dysfunction is rare following SRS (Aoyama et 
al, 2007); however, SRS does not address distant failure in the brain which occurs 
in around 30% of the patients following SRS (Hanssens et al, 2011). 
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2.5.3 Trigeminal Neuralgia  
Trigeminal neuralgia (TN) is defined by the International Association for the 
Study of Pain (IASP) as “sudden, usually unilateral, severe, brief, stabbing, 
recurrent pain in the distribution of one or more branches of the fifth cranial 
nerve” (IASP, 1986). In patients with tumours, multiple sclerosis, AVMs or other 
lesions that affect the trigeminal pathway the condition is considered secondary 
whereas it is termed idiopathic if no structural abnormalities of this kind are found 
(Zakrzewska, 2002). In the majority of patients with idiopathic TN, a 
neurovascular conflict involving the trigeminal nerve is observed in the Root 
Entry Zone (REZ) as the nerve enters the brain in the skull base, and mounting 
evidence supports this as a major causative or contributing factor (Nurmikko & 
Eldridge, 2001; Zakrzewska & Coakham, 2012). 
The first line treatment for TN is medical management with antiepileptic and 
antidepressant agents and this results in adequate pain control in the majority of 
newly diagnosed cases (Zakrzewska, 2002). For those patients whose pain is not 
controlled medically, or the side effects of medication are unacceptable, surgical 
options are available. These can be divided into ablative and non-ablative 
procedures. The only non-ablative procedure available involves surgical 
microvascular decompression. It is the most invasive procedure of all but also the 
most effective in terms of long-term pain relief. Percutaneous ablative procedures 
such as thermo-coagulation or glycerol injection are also routinely used 
(Nurmikko & Eldridge, 2001). GKR is an ablative treatment and the National 
Institute for Health and Clinical Excellence (NICE) has issued guidelines on SRS 
for TN using the Gamma Knife in the UK (Allsop et al, 2015). 
Modern GKR of TN involves the delivery of 80 - 90 Gy to the cisternal portion of 
the trigeminal nerve using a single 4 mm shot positioned 7 - 8 mm anterior to the 
REZ as shown in Figure 2.4. The Barrow Neurological Institute (BNI) pain 
intensity score (Rogers et al, 2000) is extensively used in radiosurgery to assess 
treatment response (Table 1.2). Several groups have consistently reported 
adequate pain control (BNI I - III) in 65 - 75% of the patients at 1 year, 60 - 65% 
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at two years and 40 - 60% at 5 years post GKR (Baschnagel et al, 2014; Dhople et 
al, 2009; Regis et al, 2006; Rogers et al, 2000; Verheul et al, 2010). Usual time to 
response is between 2 and 12 weeks and non-bothersome facial numbness, which 
is reported in up to 25% of the cases, is the commonest side effect (Dhople et al, 
2009; Kondziolka et al, 2010). 
 
Table 1.2. Barrow Neurological Institute (BNI) pain intensity score for 
trigeminal neuralgia.  
Score Description 
I      No trigeminal pain, no medication 
II      Occasional pain, not requiring medication 
IIIa      No pain, pain medication used 
IIIb      Some pain adequately controlled with medication 
IV      Some pain not adequately controlled with medication 
V      Severe pain no relieved with medication 
 
 
Figure 2.4. GKR treatment plan for trigeminal neuralgia. Single 4 mm shot in the 




2.5.5 Arteriovenous Malformations 
AVMs are congenital vascular abnormalities characterized by anomalous 
connections between arteries and veins leading to arteriovenous shunting through 
a network of coiled and tortuous vessels, the so-called nidus, without a normal 
intervening capillary bed (Hernesniemi et al, 2008). Brain AVMs prevalence 
varies between 15 and 18 per 100 000 adults (Al-Shahi et al, 2002a). The overall 
AVM detection rate is 1 per 100 000 adults/ year and they are incidental findings 
on brain MRI scans in approximately 0.05% of the population (Morris et al, 2009; 
Stapf et al, 2002). Around half of patients with brain AVMs present with 
intracranial haemorrhage and this is a potential source of substantial neurological 
morbidity and mortality (van Beijnum et al, 2011). The annual haemorrhage risk 
of patients with brain AVMs may be as low as 0.9% per year in cases with un-
ruptured, superficially located AVMs with superficial drainage, but may be as 
high as 34% per year in patients with previously ruptured, deeply seated brain 
AVMs with deep venous drainage (da Costa et al, 2009; Stapf et al, 2006). Less 
often patients present with seizures, headaches, bruit or tinnitus and an increasing 
number of patients are incidentally diagnosed (Hernesniemi et al, 2008)  
Currently available treatment options for cerebral AVMs include microsurgery, 
endovascular embolization and SRS, alone or in combination, and in some cases 
conservative management with regular imaging surveillance (Rubin et al, 2014). 
Microsurgery (i.e., craniotomy and excision) has been reported to have a low risk 
of complications in small AVMs located in non-eloquent and accessible areas and 
it results in immediate cure when complete resection is achieved (Mohr et al, 
2013). Embolization is a less invasive approach used to obliterate small 
malformations, to make larger AVMs amenable for surgery/radiosurgery, or to 
eliminate a possible cause of active haemorrhage (e.g. associated aneurysms) (van 
Beijnum et al, 2011). 
Radiosurgery is a well-established non-invasive option for small to medium size 
compact AVMs. It produces a detectable decrease in blood flow through the 
AVM a few months after treatment, which gradually progresses so that by two to 
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three years, approximately 75% of the AVMs are completely obliterated, Figure 
2.5 (Koltz et al, 2013).  
Large AVMs generally require staged or multimodality treatments and the 
treatment outcome is dependent on both patient characteristics and AVM 
location/morphology (van Beijnum et al, 2011). The latter can be systematically 
assessed using the Spetzler-Martin grade scale (Table 1.3), which is a composite 
score of nidus size (3cm, 3 - 6cm, > 6cm; 1 - 3 points), eloquence of adjacent 
brain (1 point if located in brainstem, thalamus, hypothalamus, cerebellar 
peduncles, or sensorimotor, language, and primary visual cortex), and the 
presence of deep venous drainage (1 point if any or all drainage is through deep 
veins, such as internal cerebral veins, basal veins, or pre-central cerebellar veins) 
(Spetzler & Martin, 1986). GKR has been extensively used for brain AVMs and, 
except for timing of obliteration, the outcome for patients with AVMs Spetzler-
Martin grade I to III appears to be comparable to surgical outcomes reported on 
similar grade cohorts (Koltz et al, 2013). GKR is the treatment of choice when 
surgical risks are thought to be excessive and complete obliteration is not 
expected or achievable with endovascular treatment (Koltz et al, 2013). 
 
Table 1.3. Spetzler-Martin grading scale. 
Parameter Score 
Size 
< 3 cm 1 
3 - 6 cm 2 
> 6 cm 3 
Eloquence Non-eloquent 0 Eloquent 1 
Drainage Superficial only 0 Deep 1 








Figure 2.5. Right cerebellar AVM treated with GKR. Left: DSA and MRI (bottom) 
performed on the day of GKR showed a sizeable right side cerebellar AVM which was 
treated with GKR. Right: MRI scan (bottom) of the same patient 30 months after GKR 
shows reduction of size of the treated vascular abnormality and DSA (top) confirmed 
treatment response.   
Day of GKR 30 months post-GKR 
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Interventional treatment of ruptured AVMs is advisable and the aim of treatment 
is to completely resect/obliterate the lesion to minimize the risk of new bleeding 
(van Beijnum et al, 2011). The recently published ARUBA trial suggested that 
medical management alone is superior to medical management with interventional 
therapy  (either surgery, embolization or radiosurgery) for the prevention of death 
or stroke in patients with un-ruptured brain AVMs followed up for 33 months. 
However, the methodology and external validity of the trial has been extensively 
questioned and a consensus on the best management option for un-ruptured 
AVMs has not been reached (Bambakidis et al, 2014). 
2.6 Imaging of brain AVMs 
Stereotactic catheter-based DSA has historically been the main imaging modality 
used for delineation of AVM for GKR planning (Figure 2.6), and it is still 
considered the reference standard technique for AVM visualization and targeting 
(Pollock et al, 2016). DSA, which is performed on the day of treatment together 
with volumetric MRI, enables very high resolution, dynamic and vessel selective, 
2D imaging of the cerebral vasculature (Seymour et al, 2016).  
Although widely used in most Gamma Knife centres around the world, DSA 
conveys a small risk of severe peri-procedural complications, it exposes both 
patients and medical staff to ionizing radiation and carries the risk associated with 
injection of iodinated contrast agents. Kaufmann et al retrospectively reviewed the 
complication data of 19826 consecutive patients undergoing diagnostic cerebral 
angiography at one institution from 1981 to 2003 and reported neurologic 
complications in 522 examinations (2.63%). Twenty-seven of these (0.14%) were 
strokes with permanent disability, twelve deaths occurred (0.06%) and access site 






Figure 2.6. Catheter-based cerebral angiography using Digital Subtraction 
Angiography (DSA). This interventional diagnostic procedure involves insertion of an 
endovascular catheter into the femoral artery which is then advanced to the intracranial 
blood vessels. An iodinated contrast agent is injected and a series of 2D X-ray images 
depicting the architecture of cerebral vessels obtained. After catheter removal, the patient 
is kept lying flat and under observation for several hours to prevent/early detect potential 
complications.  
 
Higher obliteration rates and less complications are achieved with GKR when 
inclusion of the entire AVM nidus is accomplished and the venous drainage 
excluded from the treatment volume. It is well accepted that, despite its 
invasiveness, DSA is the best technique currently available for this purpose 
(Safain et al, 2014). The ideal angiography technique for planning of GKR for 
AVMs, however, should not only have sufficient space resolution to depict the 
structural anatomy of the lesion and enough temporal resolution to characterise 
the vascular dynamics of the abnormality, allowing for heterogeneity in the 
structure of the blood vessels and flow. It should also involve no radiation or 
contrast exposure and should be presented in a format compatible with the GKR 
planning method and software. Table 2.1 summarises the characteristics of the 
cerebral angiography techniques which could potentially be used for AVM 
targeting. This list is by no means exhaustive but most currently available 
angiography techniques can be grouped into one of the listed categories. The 
papers quoted in Table 2.1 describe the advantages and disadvantages of these 
techniques compared to DSA.  
Cone-Beam CT Angiography (CB-CTA) has been shown to be feasible and useful 
for planning of GKR of AVMs. Safain et al reported consistent visualization of 
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the AVM nidus, feeding arteries and draining veins on CB-CTA imaging of a 
series of 22 patients undergoing GKR (Safain et al, 2014). Nonetheless, CTA is a 
relatively invasive technique that exposes the patient to ionizing radiation and 
iodinated contrast agent and is heavily affected by metal or embolic materials 
causing a starburst like artefact (Figure 3.2). Therefore, the focus of this literature 
review is on MRA sequences and their individual characteristics that define their 
suitability for planning of GKR. 
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Femoral	artery	catheter	 Iodinated	contrast	 Yes	 142	-	333	ms	(3-7	f/s)	 0.3	mm	1024	×	1024	matrix	 NA	 (Teksam	et	al,	2004)	
CT	Angiography	 CB-CTA	 IV	access	 Iodinated	contrast	 Yes	 Single	time	point	 Submillimetre	1	mm	slices	 NA	 (Safain	et	al,	2014)	
MR	
angiography	
TOF	 TOF	 IV	access	 Gad	based	 no	 Single	time	point	 0.57x0.57x0.57	mm	 NA	 (Yu	et	al,	2012)	
CE-MRA	
TR-CE-MRA	 IV	access	 Gad	based	 no	 1.4	s	 1.02	x	1.13	x	2	mm	 	 (Machet	et	al,	2012)	
4D-CE-MRA	 IV	access	 Gad	based	 no	 572	ms	 1.1	x	1.1	x	1.1	mm	 Keyhole	 (Kukuk	et	al,	2010)	
ASL-MRA	
pCASL-VIPR	 no	 no	 no	 Single	time	point	 0.68	x	0.68	x	0.68	mm	 Radial	acquisition	 (Wu	et	al,	2013)	
4D	MRA	 no	 no	 no	 83	ms	(50	-	100	ms)	 1	x	1	x	1	mm	 True	FISP	Cardiac	gated	 (Yu	et	al,	2012)	
te-pCASL	 no	 no	 no	 200	ms	 1.3	x	1.3	x	0.75	mm	 T1-TFE-EPI	LL	readout	 (Suzuki	et	al,	2014)	
CINEMA-
STAR	 no	 no	 no	 212	ms	 1.1	x	1.1	x	0.9	mm	 STAR	LL	readout	 (Suzuki	et	al,	2017)	
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5.2.1 Time-Of-Flight MR Angiography 
TOF imaging is probably the oldest and most popular MRA technique. It relies on 
the signal difference between stationary background tissues and flowing blood to 
collect images of the blood vessels (Bednarz et al, 2000). During a TOF 
acquisition, the static tissue is repeatedly excited with RF pulses reducing the 
steady-state magnetization signal (signal saturation). Unsaturated blood flowing 
into the excited volume gives considerably more MR signal than the background 
tissue creating the blood-to-background contrast known as TOF, Figure 2.7 
(Bosmans et al, 1995). The TOF effect is known to improve with increased 
magnetic field strength and with the addition of gadolinium based contrast agents 
to the blood (MacDonald & Frayne, 2015). This is because stronger magnetic 
fields increase the T1 of static tissue -improving its saturation as well as bulk 
magnetization- while gadolinium based contrast agents reduce the T1 of blood 
which enhances blood magnetisation recovery and improves the contrast between 
flowing blood and background tissues in this inherently T1 weighted acquisition 
(Yang et al, 2002). With the introduction of acceleration techniques and stronger 
magnetic fields TOF continues to improve and super high resolution images can 
be obtained with enhanced depiction of smaller vessels (Kang et al, 2009). 
 
 
Figure 2.7. Time-Of-Flight effect. TOF imaging relies on the contrast between the 
repeatedly excited static tissue (saturated) and the unsaturated blood flowing into the 
acquisition volume. (MacDonald & Frayne, 2015) 
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5.2.2 Contrast Enhanced MR Angiography 
Time-resolved CE-MRA, also referred to as TRICKS, TWIST or TRAK, has been 
compared to DSA regarding the diagnosis of brain AVMs (Machet et al, 2012). 
Good sensitivity for brain AVM detection and a good agreement with DSA on 
nidus size and type of venous drainage was reported. Nonetheless, it still suffers 
from low temporal and spatial resolution and vessels superposition, making 
differentiation of the arterial feeders of the nidus difficult at times. CE-MRA 
using sensitivity encoding (SENSE) in combination with Keyhole acquisition and 
segmented central k-space ordering, i.e., contrast-enhanced robust-timing 
angiography (CENTRA), has been reported to provide sub-second temporal 
resolution and 100% agreement with DSA with regard to Spetzler-Martin grade of 
cerebral AVMs (Hadizadeh et al, 2008).  
CE-MRA is performed by tracking an intravenous injection of gadolinium based 
contrast agents. The MR acquisition sequence uses the T1 shortening produced by 
gadolinium to collect positive vascular contrast which is also potentiated by the 
TOF effect of the flowing blood (Bosmans et al, 1995). A 3D T1 weighted image 
must be collected before contrast injection, usually with a fast gradient recovery 
echo (GRE) technique such as spoiled gradient recovery (SPGR), and a second 
image - or a series of images- is acquired when the contrast agent is in the blood 
vessels of interest. The pre- and post-contrast images are then subtracted leaving 
only the enhanced signal from the blood vessels (MacDonald & Frayne, 2015).  
The acquisition of the second image can be timed to obtain selective images of the 
arteries or veins if a single time point CE-MRA technique is used. More advanced 
CE-MRA acquisitions allow time-resolved imaging in order to dynamically 
visualize the first passage of contrast agent (Lindner et al, 2015). One of these is 
the keyhole technique in which only one complete reference image, including all 
the k-space, is acquired during the scan and the dynamic images collect only the 
central k-space - or portions of it - which contain the image contrast information, 
Figure 2.8 (Willinek et al, 2008). The central k-space obtained with the dynamic 
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images is then merged with the profiles of the reference scan to achieve edge 
definition and sharpness at image reconstruction.  
CE MRA has an inherently high signal-to-noise ratio (SNR) compared to other 
MRA methods, and this allows significant acceleration of the imaging speed with 
methods such as constrained reconstruction (Chang et al, 2015; Lustig et al, 2007; 
Swan et al, 2002) and parallel imaging, i.e., SENSE (Haider et al, 2010; Johnson 
et al, 2010; Taschner et al, 2008). Acceleration rates of up to 60 times have been 
reported without compromising the overall visual quality (Willinek et al, 2008).  
 
 
Figure 2.8. Diagram of the accelerated CENTRA Keyhole acquisition method for 
time resolved CE-MRA mechanism. In this acquisition only a sampled portion of the 
central k-space cylinder is collected in each phase of the fast dynamic acquisition 








5.2.3 Arterial Spin Labelling MR Angiography 
ASL is an innovative MR technique in which arterial blood water is magnetically 
labelled with a radiofrequency (RF) pulse proximal to the brain and used as an 
intrinsic contrast agent and flow tracer (Le et al, 2012). This is achieved by 
inverting the longitudinal magnetization of arterial water spins which changes the 
contrast properties of inflowing blood with respect to the surrounding tissue 
(Alsop & Detre, 1998). The subtraction of an image with inverted blood spins 
(label) and without inversion (control) results in images of the inflowing blood 
only (Lindner et al, 2015). Under normal conditions, most labelled water is 
extracted at the capillary level into the tissue, giving rise to the parenchymal 
perfusion signal intensity for which ASL is better known (Petersen et al, 2006; Xu 
et al, 2010). The same principle, with an early acquisition -before the tagged 
water leaves the vasculature- can be applied to obtain angiographic images with 
near zero background and inflow dynamics similar to DSA, as seen in Figure 2.9 
(Suzuki et al, 2014). The T1 recovery of the labelled spins is shorter than capillary 
transit time and for this reason signal intensity is not normally seen within 
intracranial veins in ASL angiography (Kukuk et al, 2010). However, because 
AVMs lack a capillary bed for water extraction to take place, and the labelled 
spins are shunted into the venous circulation with minimal transit time, venous 
signal intensity can be obtained from the AVM draining veins using ASL (Jang et 
al, 2014).  
Depending on the labelling strategy and the image acquisition technique, static 
(Wu et al, 2013) or time-resolved images (Jang et al, 2014; Kopeinigg & 
Bammer, 2014) of the whole vascular tree (Wu et al, 2013) or only individually 
selected branches can be generated (Dai et al, 2010; Robson et al, 2010). 
Continuous or pulsed labelling strategies can be used with ASL. Pulsed methods 
are preferred for time resolved angiography because the inversion of a defined 
blood volume at once enables the leading portion of the bolus to be scanned as it 
reaches the imaging slab (Yan et al, 2010). In continuous ASL, flowing blood is 
continuously labelled and as a consequence tagged blood spins may have already 
reached the imaging slab by the time of acquisition and this makes it difficult to 
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visualize the arrival of the labelled bolus. Nonetheless, continuous ASL can have 
higher labelling efficiency and vessel selectivity (Helle et al, 2013; Wu et al, 
2007). 
Regarding the acquisition methods, a 3D technique is preferred for visualization 
of the whole cerebral vasculature because signal at all locations is sampled 
simultaneously and it allows image reformatting in arbitrary views (Lindner et al, 
2015). Single thick slab acquisitions can be used to reduce scanning time but their 
image resolution and geometrical coverage are poorer (Robson et al, 2010). 3D 
balanced steady state free precession (bSSFP) also allows shorter acquisition with 
good signal-to- noise ratio (SNR) but it is rather susceptible to artefacts and poor 
image quality (Bieri & Scheffler, 2005). Radiofrequency spoiled gradient echo 
imaging (T1-TFE) is a commonly used method with high SNR which is favoured 
by its less tendency to artefacts (Nakamura et al, 2013).  
Feasibility studies with non-contrast enhanced 3D intracranial MR angiography 
using pseudo-continuous arterial spin labelling (pCASL) and an accelerated radial 
acquisition known as vastly under-sampled isotropic projection (VIPR) achieved 
very good spatial resolution (0.68 x 0.68 x 0.68 mm, Table 2.1). It demonstrated 
reduced saturation artefacts compared with a standard TOF protocol in five 
healthy and five diseased subjects and showed great promise for static intracranial 
angiography (Wu et al, 2013). Furthermore, the combination of pCASL with 3D 
T1 Turbo-Field Echo (TFE) readout and a keyhole acceleration has enabled the 
acquisition of time-resolved (4D) MRA with high spatial and temporal resolution 
(Helle et al, 2010). Similar sequences using different combinations of labelling 
strategy, acquisition technique and acceleration methods have been recently 
described and successfully applied to several cerebrovascular diseases (Jensen-











Figure 2.9. 4DASL angiography labelling and sequence diagram. The labelling plane 
is positioned proximal to the imaging slab and two sets of interleaved tagging states, 
control and label, are acquired and subtracted to yield an angiographic image. Courtesy of 







3. Investigation of dosimetric differences 
between the TMR 10 and convolution 
algorithm for Gamma Knife Stereotactic 
Radiosurgery 
Rojas-Villabona, A., Kitchen, N. & Paddick, I.  
 J Appl Clin Med Phys (2016), 17(6), 217-29. 
3.1 Abstract 
Introduction: Since its inception, doses applied using GKR have been calculated 
using a simple TMR algorithm, which assumes the patient’s head is of even 
density, the same as water. This results in a significant approximation of the dose 
delivered by the Gamma Knife. We investigated how GKR dose calculations 
varied when using a new convolution algorithm clinically available for GKR 
planning that takes into account density variations in the head compared with the 
established calculation algorithm.  
Methods: Fifty-five patients undergoing GKR and harbouring 85 lesions were 
voluntarily and prospectively enrolled into the study. Their clinical treatment 
plans were created and delivered using TMR 10, but were then recalculated using 
the density correction algorithm. Dosimetric differences between the planning 
algorithms were noted. Beam-on-time, which is directly proportional to dose, was 
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the main value investigated. Changes of mean and maximum dose to organs at 
risk (OAR) were also assessed. Phantom studies were performed to investigate the 
effect of frame and pin materials on dose calculation using the convolution 
algorithm.  
Results: Convolution yielded a mean increase in beam-on-time of 7.4% (3.6% – 
11.6%). However, approximately 1.5% of this amount was due to the head 
contour being derived from the CT scans, as opposed to measurements using the 
Skull Scaling Instrument with TMR. Dose to the cochlea calculated with the 
convolution algorithm was approximately 7% lower than with the TMR 10 
algorithm. No significant difference in relative dose distribution was noted and 
CT artefact typically caused by the stereotactic frame, glue embolization material 
or different fixation pin materials did not systematically affect convolution 
isodoses. Nonetheless, substantial error was introduced to the convolution 
calculation in one target located exactly in the area of major CT artefact caused by 
a fixation pin.  
Conclusions: Inhomogeneity correction using the convolution algorithm results 
in a considerable, but consistent, dose shift compared to the TMR 10 algorithm 
traditionally used for GKR. A reduction of the prescription dose may be necessary 
to obtain the same clinical effect with the convolution algorithm. Head shape 










GKR relies on mathematical algorithms to predict the distribution of ionizing 
radiation in the brain (Wu et al, 1996). The dose distribution is affected by 
electron density heterogeneities of the tissues and this is a well-established 
concept that is compensated for in conventional radiotherapy and other forms of 
radiosurgery (Lu et al, 2005). However, for a number of reasons heterogeneity 
corrections have been unavailable for GKR. Doses applied with GKR have been 
traditionally calculated using a simpler water-based algorithm (Elekta, 2011a). 
The TMR 10 is the most recent enhancement of the water-based dose calculation 
algorithm used for GKR and it relies on a number of approximations to enable 
fast isodose computation during treatment planning. One of the most significant 
of these is the approximation of the head to water-equivalent density and this 
could introduce important uncertainty to isodose and beam-on-time calculations 
due to the increased electron density of brain and bone (relative to water) and the 
near-zero density of air cavities in the skull (Nakazawa et al, 2014b). 
The TMR 10 algorithm requires input data of off-axis ratios (dose profiles) and 
other parameters, such as, output factors, attenuation/virtual attenuation 
coefficients, virtual source-to-focus distances and scaling distances. The data used 
as input for the simulation has been extracted by analysing Monte Carlo 
simulations and subsequently adapting the calculation model to the results 
(Sempau et al, 2001). This simple algorithm was a practical method to overcome 
the relatively slow processing capabilities of older workstations, but with the 
advent of faster processors, the effect of tissue inhomogeneities can finally be 
calculated in reasonable time during the treatment planning process (Mack et al, 
2006). 
The ability to account for tissue heterogeneity in GKR has become available in 
the form of a convolution algorithm (Elekta, 2011b). It calculates dose by 
convolving a field describing the total amount of energy released by primary 
photons per unit mass (TERMA) with kernels describing how the energy is 
distributed by secondary particles (Lu et al, 2005). To account for tissue 
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heterogeneities in the head, the TERMA and the kernels are scaled by material 
densities obtained from CT Hounsfield units (HU), which are directly 
proportional to the electron density of the tissues (Wu et al, 1996). 
The Convolution algorithm is known to more accurately predict dose distributions 
across the brain (Xu et al, 2014; Xu et al, 2015). However, doses used for GKR 
were tested and optimized using water-based algorithms over the last few decades 
and the dosimetric differences between the water-based and convolution 
algorithms need to be better understood before this method can be confidently 
employed in a clinical setting. This study is aimed to understand the dosimetric 
implications of using convolution algorithm for GKR. 
3.3 Methods 
Treatment plans of a representative group of patients were created using the TMR 
10 algorithm and re-planned using the convolution algorithm. Beam-on-time, 
which is proportional to treatment dose, and a number of metrics commonly used 
to evaluate dose distribution, such as the Paddick Conformity Index (PCI), 
Gradient Index (GI) and coverage were estimated with both algorithms. Changes 
of mean and maximum dose to OAR were also assessed. Phantom studies were 
performed to investigate the effect of frame and pin materials on dose calculation 
using the convolution algorithm. 
3.3.1 Patients 
Fifty-five patients undergoing GKR for a variety of intracranial diseases between 
September 2013 and June 2014 were recruited for the study. Table 3.1 shows the 
demographic and diagnosis details of these subjects. The study was approved by 
the Queen Square Research Ethics Committee (Appendix 1). Written consent was 
received from all participants for an additional stereotactic CT scan of the head 
which is not part of the standard imaging procedure for planning of GKR in our 
centre. Please see appendix 2 for ethical considerations. 
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Table 3.1. Demographic and diagnosis details of the study subjects.  
 
Age mean (range): 53.4 (26 - 76) 
Female: 32 (58.2%) 
Diagnosis Patients Targets (%) 
Meningioma 16 24 (28.2) 
Acoustic neuroma 17 17 (20.0) 
AVM 11 12 (14.2) 
Trigeminal neuralgia 4 4 (4.7) 
Multiple metastases 3 24 (28.2) 
Single metastases 2 2 (2.4) 
Paraganglioma 2 2 (2.4) 
Total 55 85 (100%) 
 
3.3.2 Radiosurgery planning procedure with TMR 10 
A Leksell stereotactic coordinate frame G (Elekta Instruments AB, Stockholm, 
Sweden) was applied to the head of the patients using titanium pins. Twenty-four 
manual measurements of the patient’s head were manually taken for head shape 
approximation using the skull scaling instrument or “bubble” method shown in 
Figure 3.1. 
Stereotactic imaging for planning included three dimensional (3D) post-contrast 
T1 and T2 weighted sequences acquired with a Magnetom Avanto 1.5 T MRI 
system (Siemens AG, Erlangen, Germany) as follows: T1 weighted: fast low 
angle shot (FLASH); T2 weighted: constructive interference in steady state 
(CISS); acquisition matrix: 448 x 448; Slice thickness: 1.5 mm, no overlap; Field 
of view (FOV): 210 x 210 mm; voxel size: 0.47 x 0.47 x 1.5 mm. GKR treatment 
plans were created using Leksell GammaPlan 10.1 and the water-based TMR 10 
algorithm (Elekta Instruments AB). Targets and OAR were delineated and a 
treatment plan produced using several radiation isocenters to conformaly cover 
the target volume. Dose and prescription isodose were chosen based on 
recognized standards for each pathology (Lippitz et al, 2014). Treatments were 
delivered using a Leksell Gamma Knife Perfexion (Elekta AB).  
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The quality of head shape approximation with the scaling instrument and target 
position were thought to influence potential differences of beam-on-time between 
the dose calculation algorithms and they were therefore further assessed for each 
target. Discrepancies between the head outline obtained from manual 
measurements (red line, Figure 3.1d) and the head contour as observed in the CT 
scan (Figure 3.1e) were manually assessed by a single observer (ARV) at the axial 
level of the target initially. Multiplane evaluations were subsequently performed, 
looking for discrepancies above or at the level of the target, which is the expected 
trajectory of the beams. The maximum distance between the actual head contour 
and the line of the head shape from manual measurements were recorded using 
arbitrary ranges as follows: less than 0.5 cm, 0.5 to 1 cm and more than 1 cm. The 
position of the target in the head was evaluated with reference to the skull base, 
the head surface and the apex, manually measuring the minimum distance 
between these structures and the margin of the target. The targets were then 
classified using arbitrary thresholds - that is to say, skull base lesion if less than 
2.5 cm from any bony structure on the base of the skull (n: 35), apex target if less 
than 2.5 cm from the highest point of the head in the stereotactic system (n: 10), 
and superficial if less than 2.5 cm from the head surface at any point (n: 28). 













Figure 3.1. Head shape approximation methods. Skull scaling instrument (A) and the 
3D model (B) generated with twenty-four manual measurements of the patient’s head. 
Segmentation of the head surface using CT outlining produces a more accurate head 
shape model (C) and visual assessment of the CT scans can easily reveal discrepancies 
between the manual method (D) and CT outlining (E) in a subject with a right 










3.3.3 CT imaging and electron density calibration 
Stereotactic non-contrast CT scanning of the whole head was performed in all 
subjects using a Siemens Somatom Definition AS multislice helical CT scanner 
(Siemens AG, Forchheim, Germany). Acquisition matrix: 512 x 512; Slice 
thickness: 1.5 mm, no overlap; FOV: 240 x 240 mm; voxel size: 0.47 x 0.47 x 1.5 
mm. A frame-CT adapter was used to position the patient on the CT scanner.  
A Gammex 467 Tissue Characterization Phantom (Gammex. Middelton, WI, 
USA) together with the CT scanner and parameters above were used to establish 
the relationship between electron density (ρe) of various tissues and their 
corresponding CT number in HU for that specific scanner (Constantinou et al, 
1992). The CT number and electron density relative to water of the rod materials 
for the phantom used were entered in the treatment planning system and used as a 
reference for inhomogeneity corrections using the convolution algorithm. 
3.3.4 Treatment re-planning with convolution algorithm 
The original treatment plans calculated with the TMR 10 algorithm were 
transferred to an independent Leksell GammaPlan 10.1 workstation, calibrated 
with the same reference dose (3.484 Gy/min to 20/10/2012), for re-planning. The 
head segmenting tool in Leksell GammaPlan 10.1 was used to generate a 3D 
model of the patient’s head from CT images (Figure 3.1c and 3.1e). Minor 
modifications were performed manually to correct errors in irregular areas such as 
nose and ears and to completely exclude the stereotactic frame which can be 
mistakenly included in the model. The treatment plan was initially recalculated 
with the same TMR 10 algorithm, but using the new head shape obtained from CT 
outlining. All other treatment parameters including prescription dose, percentage 
isodose, number and location of isocenters and collimator size remained locked. 
Under these conditions it can be safely assumed that beam-on-time is directly 
proportional to delivered dose. 
Electron density was subsequently calculated for each case using the CT scans 
and parameters from the calibration procedure above. The CT fiducial indicator 
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box was excluded from the electron density calculations in GammaPlan and the 
treatment plans re-calculated using the convolution algorithm. Dose calculations 
in Leksell GammaPlan 10.1 can be made independently for each individual target 
or summed to account for scatter from other targets in the case of multiple lesions. 
The latter method better represents the dose delivered to the patient and this was 
used to obtain the study figures. 
3.3.5 Statistical analysis 
The non-parametric Wilcoxon signed-rank test was primarily used to assess the 
significance of differences in beam-on-time between the treatment plans. The 
actual difference, in minutes, between treatment plans does not fully describe the 
effect of heterogeneity correction for GKR planning. Therefore, percentage 
difference in beam-on-time was calculated for each target and used for further 
statistical analysis. Beam-on-time percentage difference was normally distributed 
and the independent samples t-test was used to compare target groups (e.g., skull 
base vs. non-skull base targets). Analysis of variance (ANOVA) was used to 
compare percentage difference in beam-on-time between diagnoses and 
Spearman’s rank correlation coefficient (ρ) was used to assess the relationship 
between percentage difference in beam-on-time and other numerical variables 
(i.e., TV, number of isocenters, beam-on-time) with the convolution algorithm. 
Each target was considered an independent study element for statistical purposes 
and data analysis was performed using the Statistical Package for the Social 
Sciences (SPSS Statistics, Version 22, IBM Corp). 
3.3.6 Effect of frame and pin materials on convolution calculation 
The effect of CT artefact from the frame materials on inhomogeneity correction 
with the convolution algorithm was evaluated using a Leksell Gamma Knife Solid 
Water dosimetry phantom (Elekta Instruments AB). The phantom was initially 
scanned without the Leksell G frame fixation posts and pins using the same CT 
scanner and parameters above. Subsequently, the frame fixation posts and 
titanium pins were added to the phantom setup and scanned under the same 
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conditions. The angled long insulated posts (155 mm) were used anteriorly and 
the medium straight posts (110 mm) posteriorly, to mimic a typical clinical setup. 
Posts were positioned in the z (sup-inf) direction to maximise the chance that 
some beams passing through the calibration point (100,100,100) would pass 
through the pins. Typical clinical pin lengths of 35 mm anteriorly and 45 mm 
posteriorly were used. 
The CT fiducial indicator box was then added to the phantom arrangement which 
was re-scanned using different pin materials (i.e., titanium, aluminium and older 
style aluminium/tungsten carbide tip pins). An experimental GKR plan was 
generated using the convolution algorithm and a single 4 mm shot located in the 
centre of the coordinate system (100, 100, 100). The maximum dose was set to 
100 Gy and the dose rate was 2.704 Gy on the day of the experiment. Convolution 
plans were then calculated using the CT scans from each of the scenarios 
described above. The planning procedure was also performed with single 
isocenters of the 8 and 16 mm collimators.  
3.4 Results 
In total 85 targets were treated in 55 subjects recruited for the study. These were 
adequately distributed across the head with 41% of the targets located less than 
2.5 cm from a bony structure in the skull base and 12% of the targets located less 
than 2.5 cm from the apex. Meningiomas (24 targets in 16 patients) and brain 
metastases (26 lesions in 5 patients) were the most common lesions comprising 
around two thirds of the study targets (Table 3.1). Four AVM patients had 
undergone partial embolization of their vascular lesion with 25 - 50% Glubran (N-
butyl-cyanoacrylate and metacrylossisulfolane; GEM, Viareggio, Italy) suspended 
in ethiodized oil. Table 3.2 summarizes the estimates of beam-on-time, coverage, 
PCI and GI for the three treatment plans produced per target, i.e., 1. TMR 10 
algorithm and head definition from manual measurements, 2. TMR 10 algorithm 
and head definition from CT scans, 3. Convolution algorithm and head definition 




Table 3.2. GKR plans calculated with different dose calculation algorithms and 
head shape approximation method. Parameters of treatment plans created using the 
TMR 10 algorithm and head approximation with the skull scaling instrument (1) and 
recalculated using head definition from CT scan outlining (2) and the convolution 
algorithm (3).  
 
Parameter 
1. TMR 10 +            
manual measurements 
mean (min - max) 
median; SD 
2. TMR 10 +           
CT head definition 
mean (min - max) 
median; SD 
3. Convolution +          
CT head definition 




31.12 (6.5 – 83.9) 31.59 (6.6 – 85.5) 33.39 (6.8 – 89.3) 
30.2; 18.6 30.7; 18.9 32.7; 19.9 
Coverage (%) 
n: 80a,b 
97.5 (94.3 – 100) 97.4 (94.3 – 100) 97.0 (91– 100) 
97.0; 1.58 97.0; 1.6 96.6; 0.83 
PCI 
n: 52a,b,c 
0.82 (0.48 – 0.93) 0.82 (0.48 – 0.93) 0.82 (0.51 – 0.93) 
0.84; 0.08 0.84; 0.08 0.84; 0.08 
GI 
n: 45a,c,d 
2.776 (2.48 – 3.52) 2.776 (2.48 – 3.52) 2.749 (2.46 – 3.53) 
2.730; 0.244 2.730; 0.245 2.660; 0.253 
 
a 1 target excluded due to its location in the area of pin distortion in the CT scan.  
b No treatment volume calculated for trigeminal neuralgia cases 
c PCI and GI were ignored for 28 small lesions with TV < 0.5 cc (Paddick, 2000; Paddick 
& Lippitz, 2006) 












Beam-on-time calculated with the convolution algorithm was longer for all the 
study targets except a very small metastatic lesion which was located precisely 
under the frame fixation pin as shown in Figure 3.2. The CT artefact generated by 
the titanium pin introduced significant error to the convolution calculation 
through an abnormally low-density artefact in the CT scan (HU: -664.4, SD: 
65.84; ρe: 0.291, < water). This resulted in a shorter beam-on-time if the 
convolution algorithm was used compared to TMR 10 (6.08 vs. 6.10 min, 
respectively). This lesion was excluded from further analysis. The percentage 
difference in beam-on-time between treatment plans, for the 84 targets included in 
the analysis, are summarised in Table 3.3. No significant difference in coverage, 




Figure 3.2. CT artefact from titanium fixation pin introducing significant error to 
the convolution calculation. Small brain metastasis (TV: 0.057 ml) located precisely 
under the Leksell G frame pin causes significant CT scan distortion and shorter beam-





Table 3.3. Change in beam-on-time between treatment plans calculated with 
different head shape approximation methods and dose calculation algorithms.  
 
 
1. Manual measurements 
vs CT head definition 
mean (min - max) 
SD; (p) b 
 
2. TMR 10 vs convolution 
mean (min - max) 
SD; (p) b 
3. Overall difference 
mean (min - max) 




1.45% (0.0 – 3.4) 5.86% (2.1 – 8.8) 7.39% (3.6 – 11.6) 
0.76; < 0.001 1.21; < 0.001 1.42; < 0.001 
 
a 1 target excluded. Very small lesion in the area of the pin artefact.  
b Wilcoxon signed-rank test 
 
3.4.1 Dosimetric effect of head approximation 
Head shape definition using CT outlining resulted in an average increase of 1.45% 
(95%CI: 1.3 - 1.6; p < 0.001) in beam-on-time compared to treatment plans using 
manual measurements with the skull scaling instrument. Beam-on-time with CT 
outlining was the same (n: 8) or longer in all cases and the maximum difference 
observed was 3.4%. The latter was a skull base target with significant 
discrepancies between the head approximation methods (Figures 3.1d and 3.1e). 
Visual evaluation of the head shape generated from manual measurements 
showed a discrepancy of more than 0.5 cm at the axial level of 70% of the targets 
and a multiplane discrepancy of more than 1 cm was observed above or at the 
level of 31% of the targets. The change in beam-on-time for lesions with a 
discrepancy of more than 0.5 cm at the axial level of the target (1.7%; 95%CI: 1.5 
- 1.9%) was significantly higher than the rest of the lesions (0.9%; 95%CI: 0.6 - 
1.2%); p < 0.001. Similarly, lesions with more than 1 cm discrepancy above or at 
the level of the target (1.6%; 95%CI: 1.4 - 1.7%) had significantly higher changes 
in beam-on-time compared to targets with less than 0.5 cm multiplane 
discrepancy (0.6%; 95%CI: 0.3 - 0.9%); p < 0.001. 
Table 3.4 shows the relative difference in beam-on-time between the planning 
methods per diagnosis. Convolution seems to reveal a fairly consistent shift from 
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TMR 10 for indications where the target location is the same (e.g., vestibular 
schwannoma). For indications where the location varies widely (e.g., 
meningiomas or metastases) convolution seems to demonstrate greater dosimetric 
inconsistencies. The ANOVA, however, failed to demonstrate a significant 
difference in beam-on-time percentage between diagnosis groups (p = 0.115). 
Location of the target in the head, specifically the depth, appears to negatively 
correlate with change in beam-on-time between the TMR 10 and convolution 
algorithm. Tumours located less than 2.5 cm from the surface at any point in the 
head showed greater changes in beam-on-time compared to deeper lesions, 6.5% 
(95%CI: 6.1 - 6.9; SD: 1.03) vs. 5.5% (95%CI: 5.2 - 5.8; SD: 1.17), p < 0.001, 
respectively. Similarly, distance from the edge of the target to the head surface 
negatively correlated with percentage change in beam-on-time between the 
algorithms (ρ: -0.36, p = 0.001). 
Change in beam-on-time for targets located in the skull base was not significantly 
different from those distant to that bony structure (5.6% vs. 6.0%; p = 0.1). 
Similarly, no relative difference was noted between targets located in the apex and 
the rest of the lesions distributed across the head anatomy (6.2% vs. 5.8%; p = 
0.27). Beam-on-time percentage difference between the planning algorithms did 
not correlate with target volume (ρ: 0.12; p = 0.2), number of shots (ρ: -0.005; p = 
0.96), beam-on-time with TMR 10 algorithm (ρ: -0.14, p = 0.19) or difference in 
beam-on-time between the head shape definition methods (ρ: 0.08; p = 0.47). 
Beam-on-time difference in AVM patients who had undergone partial glue 
embolization (5.2%; 95%CI: 4.3 – 6.1; SD: 0.56) was comparable to patients 
without previous endovascular treatment (5.0%; 95%CI: 4.2 – 5.7; SD: 0.8), and 







Table 3.4. Relative difference in beam-on-time between the TMR 10 and 
convolution algorithm per diagnosis.  
 
 
TMR 10 vs convolution 
mean (min - max) 
SD; (p) b 
Overall difference  
Convolution + head 
definition from CT scans  
mean (min - max) 
SD; (p) b 
AVM 
n: 12 
5.1% (3.7 – 6.3) 
0.76; 0.002 




5.8% (2.0 – 7.9) 
1.42; < 0.001 
7.1% (3.6 – 10.1) 
1.63; < 0.001 
Meningioma 
n: 24 
6.2% (4.4 – 8.6) 
1.03; < 0.001 
7.8% (6.0 – 11.6) 




5.4% (4.7 – 6.8) 
0.95; 0.068 





5.9% (4.5 – 7.6) 
0.94; < 0.001 
7.9% (6.6 – 9.8) 
0.85; < 0.001 
Paraganglioma 
n: 2 
6.2% (3.5 – 8.8) 
3.75; 0.18 
8.7% (7.0 – 10.4) 
2.35; 0.18 
 
a 1 target excluded due to its location in the area of pin distortion in the CT scan 
b Wilcoxon signed-rank test 
 
3.4.3 Dose to organs at risk 
Clinically relevant OAR were defined in 28 subjects and differences in mean and 
maximum dose between the TMR 10 and convolution plans were calculated. The 
ipsilateral cochlea was the OAR in twenty-four cases with vestibular 
schwannoma, cerebellopontine angle meningioma, paraganglioma and trigeminal 
neuralgia. The mean and maximum calculated dose to the cochlea with the 
convolution algorithm was approximately 7% lower than equivalent estimates 
obtained with the TMR 10 algorithm, as shown in Table 3.5. The optic apparatus 
was in close proximity to the target in four subjects and a lesser effect on mean 
and maximum dose to this OAR (2.0 and 2.4%, respectively) was noted between 
the planning algorithms. 
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Table 3.5. Difference in dose to organs at risk between the TMR 10 and 
convolution algorithm.  
Organs at risk 
 
TMR 10 
mean (95%CI); SD 
Convolution 
mean (95%CI); SD 
% Difference 




(Gy) 2.7 (2.2–3.2); 1.1 2.5 (2.1–3.0); 1.0 - 7.3% (3.6–11.1); 2.12 
max dose 





(Gy) 3.5 (2.3–4.7); 0.8 3.4 (2.2–4.5); 0.7 -2.0% (0.0–3.1); 1.4 
max dose 
(Gy) 6.5 (4.9–8.2); 1.05 6.4 (4.6–8.2); 1.1 - 2.4% (1.3–5.3); 1.89 
 
3.4.4 The effect of frame and pin materials on convolution 
calculation 
The effect of CT distortion from the stereotactic frame on the convolution 
algorithm was assessed by means of change in beam-on-time if an identical 
treatment plan was calculated using CT scans acquired with and without the 
Leksell frame G. The experiment demonstrated a maximum 4% longer beam-on-
time using the CT acquired with the posts and pins for the plan composed of a 
single shot of the 4 mm collimator. This effect was smaller for a similar plan with 
the 8 mm collimator and no effect at all was seen for the 16 mm collimator, Table 
3.6.  
No significant difference in beam-on-time was seen if the titanium or aluminium 
pins were used for single shot plans of the 4, 8 and 16 mm collimators. Only a 
small change of the order of 0.8% was seen for the 4 mm collimator plan if the 









Table 3.6. Effect of the stereotactic frame on the convolution algorithm.  
 Phantom only beam-on-time 
Frame and pins  




4 mm 73.23 min 76.21 min 4.0 % 
8 mm 43.79 min 44.56 min 1.7 % 
16 mm 37.34 min 37.26 min - 0.2 % 
 
3.5 Discussion 
This study aimed to evaluate the dosimetric implications of using inhomogeneity 
corrections with the convolution algorithm for GKR. The novel algorithm, 
available in the GKR planning system, was compared to TMR 10 which is the 
standard water-based algorithm traditionally used in GKR. Fifty-five actual GKR 
treatment plans were re-calculated with the convolution algorithm keeping all 
other treatment parameters unchanged and the study provided clinically relevant 
information on the magnitude of dose approximations traditionally accepted with 
TMR 10 algorithm. The overall dose difference if convolution algorithm is used 
along with head definition from CT outlining, is 7.4% on average and the 
maximum observed was 11.6%. However, 1.5% of this amount is due to the 
increased accuracy of the head contour from the CT scans, as opposed to manual 
measurements from the skull scaling instrument. 
3.5.1 Dose implications of convolution algorithm for GKR 
Doses currently used for GKR are the result of several decades of empirical 
optimisation using water-based algorithms. This titration process has resulted in a 
set of dosage recommendations shown to provide maximum clinical efficacy with 
the lowest morbidity (Lippitz et al, 2014). These doses have incorporated the 
uncertainty inherent to water-based algorithms and treatment plans calculated 
3.	Dosimetric	differences	between	the	TMR	10	and	convolution	algorithm	_________________________________________________________________________________________________________	
81	
with the new calculation algorithm should therefore be adequately understood and 
adjusted to ensure the dose delivered is comparable. 
The increment in dose to the target, attributable to inhomogeneity corrections, if 
exactly the same TMR 10 treatment plan is recalculated with the convolution 
algorithm was found to be 5.9% in our study. Similar results have been reported 
with phantom and clinical experiments (Xu et al, 2015). Xu et al reported an 
average dose difference of 6.5% between the convolution and the TMR classic 
algorithm using a single shot placed in different positions along the x, y and z axes 
on the stereotactic system with varying collimator sizes in a polystyrene phantom 
and a human head CT scan (Xu et al, 2014). Their study compared the dose 
calculation algorithms with a fixed geometry and established the baseline 
performance of the convolution algorithm. Similarly, Nakazawa et al found a 1 - 
7% change of absolute dose to the target in 29 cases of vestibular schwannomas 
which were re-planned with the convolution algorithm (Nakazawa et al, 2014b). 
Our study does not only quantify the uncertainty of the water-based algorithm in a 
larger group of patients with different intracranial conditions but it also informs 
radiosurgery prescribers on dose adjustments that may be required if the 
convolution algorithm is to be used clinically. For example, in a typical trigeminal 
neuralgia case a maximum dose of 80 Gy is planned with the TMR 10 algorithm. 
Re-planning this treatment with the convolution algorithm (assuming that 
homogeneity correction better simulates dose distribution) reveals that this target 
would actually receive a lower dose of around 76 Gy when treated with TMR 10. 
Table 3.7 shows similar estimates for other pathologies and demonstrates the 
rather conservative approach of the water-based algorithm where the uncertainty 
always results in “under-treating” the target. However, if the trigeminal neuralgia 
patient above was to be treated with the convolution algorithm and the same 
prescription isodose, 80 Gy would actually be delivered to the target which 





Table 3.7. Dosimetric differences between the TMR 10 and convolution 





Beam-on-time % difference 
TMR 10 vs convolution 
mean (min - max) 
Dosimetric change 
with convolution (Gy) 
AVM 
n:12 
25 Gy 5.1% (3.7 – 6.3) 1.27 Gy (0.9 – 1.6) 
Metastases 
n:25 
25 Gy 5.8% (2.0 – 7.9) 1.45 Gy (0.5 – 1.9) 
Meningioma 
n:24 
15 Gy 6.2% (4.4 – 8.6) 0.93 Gy (0.7 – 1.3) 
Trigeminal neuralgia 
n:4 
80 Gy 5.4% (4.7 – 6.8) 4.32 Gy (3.7 – 5.4 
Acoustic neuroma 
n:17 
13 Gy 5.9% (4.5 – 7.6) 0.76 Gy (0.5 – 1.0) 
Paraganglioma 
n:2 
15 Gy 6.2% (3.5 – 8.8) 0.93 Gy (0.5 – 1.3) 
 
The clinical significance of dose differences between the TMR 10 and 
convolution algorithm is debatable. No clinical studies have been published 
reporting outcomes of patients treated with the convolution algorithm but 
evidence from standard radiotherapy suggests that doses should be adjusted to 
obtain the same clinical effect if a homogeneity correction is to be used (Aarup et 
al, 2009; Vanderstraeten et al, 2006). The dose shift in our study seems to be 
consistent, particularly for tumours with the same location, and a simple dose 
reduction could potentially be sufficient to compensate for the differences 
between the planning algorithms (Table 3.7). Phantom-based studies initially 
demonstrated substantial changes in dose distribution in bone tissue and tissue 
interfaces (Moskvin et al, 2004). However, no substantial difference in dose 
distribution surrogates such as gradient index, PCI and coverage was noted in our 
study. Nakasawa et al also reported no change of relative dose distribution by 
visual assessment of the plans and suggested that the setting of multiple beams 
from all directions would offset the discrepancy of the dose distribution around 
the target. The latter could also explain our finding of lower difference in beam-
on-time for targets deeply located in the brain where a higher degree of 
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uncertainty compensation takes place as the beams travel longer distances through 
different tissue densities. 
The dosimetric differences between the planning algorithms in our study were 
relatively consistent particularly for targets located in the same area (i.e., 
trigeminal neuralgia and vestibular schwannomas). Therefore, keeping the same 
absolute dose by simply reducing the prescription isodose if the convolution 
algorithm is used may be appropriate for these pathologies. The dose uncertainty 
with TMR 10, however, seems to be less predictable for pathologies with variable 
location in the brain, such as metastases or meningiomas, and the convolution 
algorithm could better simulate the true dose delivered to these individual targets. 
Further clinical studies and close monitoring of outcomes for patients treated with 
the convolution algorithm must also be prospectively conducted to investigate 
potential differences on efficacy and side effects profile. A further implication of 
using a new dose calculation algorithm for GKR is the potentially poor 
comparability between clinical studies performed using the TMR 10 and the 
convolution algorithm in the future. 
The study also investigated differences in dose to OAR with the convolution 
algorithm, particularly the cochlear apparatus. Our findings demonstrate that 
doses delivered to the cochlea with the TMR 10 algorithm are actually 7.0% 
lower than initially thought. This difference is well explained by the high density 
of the temporal bone where the cochlea is embedded and reflects the fact that 
TMR 10 does not take into account attenuation of the beams as they travel 
through different tissue densities. A further degree of reduction in dose to the 
cochlea could take place if the prescription dose with the convolution algorithm 
were to be adjusted to deliver the same dose traditionally delivered to the targets 
with the TMR 10 algorithm. 
3.5.2 Potential dose calculation inaccuracies with convolution 
The convolution algorithm is by definition a better method to predict dose 
distribution in the brain and most modern therapeutic radiation techniques now 
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rely on inhomogeneity corrected dose calculations (Vanderstraeten et al, 2006). 
Convolution is, however, based on the physical densities of tissues obtained from 
tomographic studies and errors can be introduced to the calculation if artefacts are 
present. Potential inaccuracies arise mainly from external elements that change 
the apparent density of the tissues in the CT scan, i.e., contrast agent, intracranial 
clips, titanium cranioplasties, embolization materials and the stereotactic frame 
itself. In our study, one of the targets (out of 85) was considerably affected by 
imaging artefact from the frame pins and in this specific case the uncertainty of 
the convolution algorithm was significantly high. A method of overriding the 
electron density in areas of artefact would significantly reduce this uncertainty. 
A visual evaluation of the whole head CT scan should be sufficient to detect CT 
artefacts that potentially affect the convolution calculations. Adequate electron 
density calibration needs to be performed for each individual CT scan and 
scanning protocol and special attention must be given to the consistency of the 
scanning procedure to reduce technical variability. 
In our study, the imaging procedure was done with the stereotactic frame and this 
can produce CT artefact itself, as seen in Figure 3.2. Distortion from the frame 
ring occurs mainly in the lowest aspect of the scan and this is very unlikely to be 
part of a beam’s incoming trajectory. However, areas of artefact caused by the 
fixation posts and pins are certainly likely to be crossed by the collimated beams. 
Apart from our incidental finding of a lesion located precisely under the fixation 
pin, it was not possible to investigate the effect of the frame artefact in the 
patients and their more complex radiosurgery plans. Nonetheless, the phantom 
studies demonstrated no change on treatment plans with the 8 and 16 mm 
collimators and only a minor change (4%, worst-case scenario) if a single shot of 
the 4 mm collimator is used. This difference is probably undetectable for more 
complex multi-isocenter treatment plans and the significance of this finding as a 
weakness of the convolution algorithm is debatable because the frame will also be 
in place at the time of treatment. No significant difference was noted between 
different pin materials. 
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Potential dosimetric inaccuracies have been suggested with onyx embolization 
material and the effect of other embolization agents has not been fully understood 
(Shtraus et al, 2010). In our study four AVM patients had undergone partial glue 
embolization and the dose shift with the convolution algorithm in these cases was 
comparable to subjects who had not had endovascular treatment before GKR. 
These findings are consistent with the study by Mamalui-Hunter et al who 
concluded that dose inaccuracy due to attenuation of the 60Co beam by the AVM 
embolization material was very small for glue (n- butyl 2 cyanoacrytate) and also 
for Onyx (ethylene vinyl alcohol) because of the high-energy of the 60Co beam 
(Mamalui-Hunter et al, 2011). No patient in our study had undergone 
embolization with Onyx and our findings of no increased uncertainty due to 
previous embolizations apply only to glue. 
3.5.3 Head definition with CT 
Implementation of the convolution algorithm also involves using CT outlining to 
define the shape of the head and this results in dosimetric differences of 
approximately 1.5%. The maximum dose discrepancy due to head shape 
approximation in our study was 3.4% and comparable results have been reported 
by other groups (Nakazawa et al, 2014a; Wright et al, 2011). Nakazawa et al 
reported an average difference of -0.16% between measured and CT-based 
contours with a maximum difference of 3.4% and concluded it was an acceptable 
range. The manual method is certainly a practical and convenient approach and 
the justification of a head CT scan for head definition only is debateable. 
However, the head is a complex irregular structure and CT outlining can generate 
a better 3D model. It should be used if a CT scan of the head is available for other 
clinical reasons or the convolution algorithm is to be used. The uncertainty from 
head approximation tends to be greater in deep-seated targets and can be foreseen 






Inhomogeneity correction with the convolution algorithm results in a considerable 
but consistent dose shift compared to the TMR 10 algorithm traditionally used for 
GKR. No significant difference in relative spatial dose distribution was noted and 
a reduction of the prescription dose may be necessary to obtain the same absolute 
dosimetric effect with the convolution algorithm. This study has revealed that 
dose to the cochlea during GKR is approximately 7% lower than initially 
predicted with the TMR 10 algorithm and further reduction may be achieved if 
prescription doses with the convolution algorithm are adjusted. Head shape 
definition using CT outlining can be used to reduce uncertainty from head shape 
approximations and CT artefact typically caused by the stereotactic frame, glue 
embolization material or different fixation pin materials do not systematically 
affect convolution calculations. Nonetheless, special attention must be given to 
cases with major CT artefacts around the target where the convolution algorithm 






4. Evaluation of the stability of the 
stereotactic Leksell G frame in Gamma Knife 
Radiosurgery 
Rojas-Villabona, A., Miszkiel, K., Kitchen, N., Jäger, R. & Paddick, I. 
J Appl Clin Med Phys (2016), 17(3), 75-89. 
4.1 Abstract 
Introduction: The purpose of this study was to evaluate the stability of the 
Leksell Frame G in GKR.  
Methods: Forty patients undergoing GKR underwent pre-treatment stereotactic 
MRI for GKR planning and stereotactic CT immediately after GKR. The 
stereotactic coordinates of four anatomical landmarks (cochlear apertures and the 
summits of the anterior post of the superior semicircular canals, bilaterally) were 
measured by two evaluators on two separate occasions in the pre-treatment MRI 
and post-treatment CT scans and the absolute distance between the observations is 
reported. The measurement method was validated with an independent group of 
patients who underwent both stereotactic MRI and CT imaging before treatment 
(negative controls; n: 5). Patients undergoing GKR for AVM also underwent 
DSA, which could result in extra stresses on the frame. The distance between 
landmark localization in the scans for the negative control group (0.63 mm; 
95%CI: 0.57 – 0.70; SD: 0.29) represents the overall consistency of the evaluation 
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method and provides an estimate of the minimum displacement that could be 
detected by the study. Two patients in the study group had the fiducial indicator 
box accidentally misplaced at post-treatment CT scanning. This simulated the 
scenario of a frame displacement, and these cases were used as positive controls 
to demonstrate that the evaluation method is capable of detecting a discrepancy 
between the MRI and CT scans, if there was one.  
Results: The mean distance between the location of the landmarks in the pre-
treatment MRI and post-treatment CT scans for the study group was 0.71 mm 
(95%CI: 0.68 – 0.74; SD: 0.32), which was not statistically different from the 
overall uncertainty of the evaluation method observed in the negative control 
group (p = 0.06). The subgroup of patients with AVM (n: 9), who also underwent 
DSA, showed a statistically significant difference between the location of the 
landmarks compared to subjects with no additional imaging: 0.78 mm (95%CI: 
0.72 – 0.84) vs. 0.69 mm (95%CI: 0.66 – 0.72), p = 0.016. This is however a 
minimal difference (0.1 mm) and the mean difference in landmark location for 
each AVM patient remained submillimetre.  
Conclusions: This study demonstrates submillimetre stability of the Leksell 





GKR has traditionally relied on a rigid immobilization system to stereotactically 
converge multiple beams of ionizing radiation at a defined intracranial target. The 
procedure is aimed to eradicate or inactivate the target and the biological effect of 
the energy delivered is expected to affect all the structures within the volume of 
the prescribed dose, while minimizing exposure to the surrounding tissue 
(Sheehan et al, 2014). Therefore, the accuracy of the stereotactic system which 
encompasses localization of the targets with minimal spatial error and a high 
degree of reproducibility, is of paramount importance for safe delivery of GKR 
(Maciunas et al, 1994). 
The overall application accuracy of GKR, also referred to as the total clinically 
relevant error (Maciunas et al, 1994), is the result of individual inaccuracies 
associated with each step in the procedure and they can be grouped into three 
categories. First, is the difference between the radiation delivered to the patient 
and that defined in the treatment plan in terms of magnitude, location or 
distribution. This can result from errors or approximations in dose calculation or 
due to mechanical inaccuracy of the treatment delivery itself, which is the 
estimate of accuracy usually provided by the manufacturers. The second category 
refers to inaccurate definition of the target which results from erroneous imaging 
technique selection, inappropriate interpretation of the images or geometrical 
inaccuracies of the scans due to distortion or other technical factors (Sandstrom et 
al, 2014). This latter error has been well described and is usually assessed in 
standard QA procedures (Mack et al, 2002). The third source of error, which is the 
main scope of this study, is the possibility that the actual location of a target 
within the stereotactic system at treatment differs from its calculated location due 
to displacement of the reference frame between the imaging procedure and the 
treatment. Such displacement could occur from instability due to inadequate 
frame placement or from stresses induced in the frame between imaging and 
treatment. This source of error may be more likely to be significant in the case of 
multiple image studies (e.g., MRI, CT and DSA) and it tends to be overlooked by 
studies evaluating the accuracy of stereotactic systems by assuming that the frame 
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is rigid and therefore stable without actively testing it for potential displacements. 
Also, most studies investigating the stability of fixation systems are laboratory- 
and phantom-based and standard QA procedures are not capable of detecting 
potential frame displacement throughout the clinical procedure (Heck et al, 2007). 
The most commonly used immobilization and localization method for GKR is the 
Leksell stereotactic coordinate frame which is a dedicated stereotactic 
radiosurgery tool introduced by the Swedish Neurosurgeon Lars Leksell in the 
1970s and has been further developed over the last few decades (Leksell & 
Jernberg, 1980). The Leksell G frame was extensively used as a stereotactic tool 
for brain biopsies before neuro-navigation systems were developed and it is 
widely used for GKR and insertion of Deep Brain Stimulation (DBS) electrodes 
(Simon et al, 2005). The later procedure involves localization of very small 
targets such as the subthalamic nucleus and ventral intermediate nucleus of the 
thalamus and the level of precision required for such task is comparable to the 
accuracy required for targeting of the trigeminal nerve in GKR where a few 
millimetres of error could result in completely missing the target (Massager et al, 
2007). This reinforces the importance of actively evaluating the stability of the 
Leksell frame during GKR, which is the main aim of this study.  
4.3 Methods 
4.3.1 Patients 
Forty consecutive patients undergoing GKR for a variety of intracranial diseases 
between September 2013 and June 2014 underwent stereotactic MR imaging for 
GKR planning and stereotactic CT imaging after GKR for research purposes, i.e., 
evaluation of the convolution algorithm for GKR planning. The study was 
approved by the research ethics committee (Appendix1) and written consent was 
received from all participants. The demographic details and diagnosis of the 




Table 4.1. Demographic details and diagnoses of the study subjects. 
Age mean (min - max) 53.4 y (26 - 76) 
Female, n (%) 23 (57.5%) 
Diagnosis, n (%) 
Acoustic neuroma 16 (40%) 
Meningioma 10 (25%) 
AVM 9 (22.5%) 
TN 4 (10%) 
Brain metastases 1 (2.5%) 
Total 40 
AVM: Arteriovenous Malformation; TN: Trigeminal Neuralgia 
4.3.2 Stereotactic frame and pre-treatment imaging 
A Leksell stereotactic coordinate frame G (Elekta AB, Stockholm, Sweden), 
assembled as shown in Figure 2.2, was used for GKR. The curved front piece was 
in the upwards position, along with the angled anterior insulated posts (155 mm) 
and medium straight posts posteriorly (110 mm), which were used in most cases. 
Three patients had the frame applied with the front piece downwards to avoid 
nose compression and longer straight posts (137 mm) were used posteriorly on 
one patient to obtain a lower frame position. Application of the stereotactic frame 
was performed in a sitting position under local anaesthesia and the frame was 
manually checked for rigidity before fitting. An injection of 5 ml of lidocaine 
hydrochloride 1% was given in the planned site of each of the four titanium pins, 
which were advanced to the outer skull table and adjusted to a consistent pin 
pressure of 45 cNm using a torque driver. 
Stereotactic MRI for GKR planning was performed after frame application and 
using a Magnetom Avanto 1.5 T MRI system (Siemens AG, Erlangen, Germany). 
A frame MRI adapter (Elekta AB) was used to support and immobilise the 
patient’s head and stereotactic frame on the MRI table. Post-contrast 3D T1 and 
T2 weighted volumetric imaging was performed: T1 weighted: FLASH; T2 
weighted: CISS; acquisition matrix: 448 x 448; Slice thickness: 1.5 mm, no 
overlap; FOV: 210 x 210 mm; voxel size: 0.47 x 0.47 x 1.5 mm. The MRI scans 
were defined in stereotactic space using Leksell GammaPlan 10.1 (Elekta AB) 
based on fiducial markers obtained from the indicator box (Figure 2.2). An 
appropriate radiosurgical treatment plan was developed using the aforementioned 
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planning system and delivered using the Leksell Gamma Knife Perfexion (Elekta 
AB). Patients undergoing GKR for AVM (n: 9) also underwent DSA for lesion 
targeting and radiosurgery planning. This invasive procedure involves longer 
frame-on times and increased patient handling, which could result in extra stresses 
on the stereotactic frame and a potentially higher risk of frame displacement.  
4.3.3 Post-treatment imaging and landmarks measurement 
A post-GKR stereotactic non-contrast CT of the head was performed immediately 
after treatment and prior to frame removal using a Siemens Somatom Definition 
AS multislice helical CT scanner (Siemens AG, Forchheim, Germany). 
Acquisition matrix: 512 x 512; Slice thickness: 1.5 mm, no overlap; FOV: 240 x 
240 mm; pixel size: 0.47 x 0.47 mm. A frame CT adapter (Elekta AB) was used to 
secure the patient in the correct position and the scans were independently defined 
in stereotactic space using fiducial markers from the CT indicator box.  
The stereotactic coordinates of four landmarks were measured in the pre-
treatment MRI and again in the post-treatment CT scans by two different 
evaluators on two separate occasions with at least one week’s difference between 
repeated measures. Figure 4.1 shows the landmarks used for evaluation; bilateral 
cochlear apertures, at the base of the modiolus, and the summits of the anterior 
post of the superior semicircular canals (SSC). The landmark coordinates in the 
pre-treatment MRI scan were taken from the T2 weighted images and from the 
bone reconstruction on the post-treatment CT scan as shown in Figure 4.1. The 
stereotactic coordinates of the cochlear apertures were measured in the axial 
plane. In two study cases, one of the cochlear apertures was bisected by two slices 
and this resulted in discrepancies in the z coordinate reflecting the slice thickness 
rather than the apparent location of the landmark. A consensus was reached 
between the observers for these two cases and measurements were obtained from 
the same slice. To minimize the effect of slice thickness on the results, the 
stereotactic location of the SSC was taken from the reconstructed coronal plane. 
The distance between the stereotactic location of the landmarks observed in the 






Figure 4.1. Landmarks used for frame stability evaluation. The landmarks as seen in 
the T2 weighted sequence of the pre-GKR MRI scan are showed in the left panel. The 
right panel shows the same landmarks in the bone window of the post-treatment CT scan. 
A-B: Right cochlear apertures are identified by the intersection of the lines. C-D: A detail 
shows the red cross on the landmark as measured for the study. E-F: Initial identification 
of the anterior post of the left superior semicircular canal in the axial plane (line 




4.3.4 Data analysis 
The mean distance between the first and second session measurements by the 
same observer was used to evaluate intra-observer agreement. Inter-observer 
agreement was assessed comparing measurements between the observers for each 
landmark localization attempt. 
The distance between two points in the Euclidian space was calculated using the 
equation below:  
! ", $ = ("' − $')* + (", − $,)* + ("- − $-)*		                  (1) 
Validation of the measurement method was performed with an independent group 
of subjects (n: 5) who had undergone both stereotactic MRI and CT imaging 
before GKR. CT scanning is not routinely used for radiosurgery planning in our 
centre but it is used selectively for targets near bone structures where target 
definition can be aided by CT imaging. This was the reason for the clinical 
stereotactic CT scan before GKR in these subjects and it provided an estimate of 
the overall variability of the evaluation method in terms of uncertainty of 
landmark localization between two different imaging techniques (negative 
controls). The mean time interval between the beginning of the MRI scan and the 
CT scan in this group was 37.8 min (14 - 73 min). As there were no treatment-
related stresses applied to the frame between MRI and CT scanning in this group, 
it was assumed that no frame displacement had occurred in these patients. 
The mean distance between the location of the landmarks in the MRI and CT scan 
was calculated and reported for each patient to combine multiple observations of 
the landmarks. The individual localization attempts were used for evaluation of 
differences between the groups and logarithmic transformation of the distance 
data was done to enable comparison between the groups using independent 
sample’s t-test. Data analysis was performed using the Statistical Package for the 





The mean frame-on time defined as time difference between the beginning of the 
pre-GKR MRI and post-GKR CT scan in the study subjects was 157.8 minutes 
(89 - 298). Two patients in the study group, one of them undergoing GKR for 
AVM, had the CT fiducial indicator box accidentally misplaced at post-GKR CT 
scanning and this resulted in a considerable mismatch between the location of the 
landmarks in the MRI and CT scans in these two subjects (cases 13 and 17). As 
shown in Figure 4.2, the right posterior locating pin of the fiducial indicator box 
was not seated in the corresponding hole in the frame ring but it was displaced 
towards the midline allowing the box to rest on the frame, and the lateral clips to 
be secured, in an apparently normal position. The centre of the locating pin was 
misaligned by 7.5 mm from its normal position in both cases. This error was 
detected during definition of the CT scans in stereotactic space which yielded 
mean and maximum fiducial errors of 1.6 and 4.6 mm respectively. As expected, 
the discrepancy in the location of the landmarks between the scans was more 
evident on the right side and mainly affected the x axis. The mean distance 
between the location of the landmarks in the pre-treatment MRI and post-
treatment CT in these two patients was 1.46 mm and the maximum difference 
noted was 2.24 mm. These two cases accidentally simulated the scenario of a 
frame displacement and they were used as a positive control group for 
comparison. They were therefore excluded from the main study group, which was 
composed of 38 patients. 
The fiducial error estimates of definition of T2 weighted MRI and CT scans in the 
stereotactic space for the main study group are shown in Table 4.2. As expected, 
the mean fiducial error of MRI scans (0.44 mm) was slightly larger than for CT 
scans (0.26 mm).  Measurement of the position of the four landmarks was 
successfully accomplished in all but two patients. These were a subject with an 
AVM whose left cochlea was not included in the scan and a patient with a left 
sided vestibular schwannoma who had undergone previous trans-labyrinthine 
excision of the tumour and the SSC was not visible.  
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Table 4.2. Fiducial error in stereotactic definition of MRI and CT scans for the 
main study group. The pre-treatment T2 weighted MRI scan and post-treatment CT 
scan (bone window) were independently defined in the stereotactic space using 
GammaPlan. Fiducial errors in the definition process for 38 patients included in the study 
group are summarized.  
Study group  
(n:38) 
Pre-GKR MRI scan 
T2 weighted 





(0.42 - 0.46) 0.06 
0.26 mm 




(1.05 - 1.13) 0.13 
0.71mm 




Figure 4.2. Fiducial indicator box accidentally misplaced at post-GKR CT scan. A. 
Lateral view of the stereotactic frame with the CT fiducial indicator box in an apparently 
normal position with the lateral clip adequately secured (red arrow). B. An inferior view 
of the frame shows the right posterior locating pin of the indicator box displaced towards 
the midline (red circle) that resulted in an erroneous position of the fiducials in the CT 
scan (C, arrowhead). 
4.	Stability	of	the	stereotactic	Leksell	G	frame	_________________________________________________________________________________________________________	
97	
The total number of coordinate measurements was 4272 as follows: 45 (subjects) 
x 4 (landmarks) x 2 (observers) x 2 (repeated measurements) x 2 (MRI and CT 
scans) x 3 (x, y, z) - 48 coordinate measurements for the two missing landmarks as 
mentioned above. These measurements were obtained from three groups of 
patients, i.e., five subjects with both scans done before GKR and no plausible 
frame displacement (negative controls), two cases with misplaced indicator boxes 
at post-GKR CT simulating a frame displacement (positive controls) and the main 
group of patients under investigation who underwent MRI scan before and CT 
scan after GKR (study group: 38). Table 4.3 shows the estimates of variability 
between repeated measurements by the same observer on the same scans (intra-
observer variability) and between the observers (inter-observer variability) in the 
three groups. Repeated measurements by the same observer on the same scans 
were consistent across the groups with a mean distance between the first and 
second measurement of 0.25 mm. These estimates were similar for measurements 
obtained from CT (0.25 mm; 95%CI: 0.23 - 0.27) and MRI scans (0.24 mm; 
95%CI: 0.22 - 0.26), p = 0.3. The mean distance between measurements of the 
same landmark by different observers in the study group was higher at 0.59 mm 
(95%CI: 0.57 - 0.61).  
 
Table 4.3. Intra-observer and inter-observer variability of the measurements. 
Negative controls: patients who underwent both MRI and CT scans before GKR; Positive 
controls: two patients with an accidentally misplaced fiducial indicator box at post-GKR 
CT scanning (simulating a frame displacement); Study group: main group of subjects 
under investigation who underwent MRI scanning before and CT imaging after GKR (n: 
38); n: number of subjects; obs: number of observations. 
  
Intra-observer variability 
mean distance, mm (95%CI) 
SD; max 
Inter-observer variability 
mean distance, mm (95%CI) 
SD; max 
Negative controls 
n: 5; obs: 80 
0.25 mm (0.22 - 0.29) 
0.16; 0.70 
0.41mm (0.34 - 0.47) 
0.26; 1.14 
Positive controls 
n: 2; obs: 32 
0.21 mm (0.17 - 0.25) 
0.12; 0.45 
0.57 mm (0.47 - 0.67) 
0.26; 1.14 
Study group 
n:38; obs: 600 
0.25 mm (0.23 - 0.26) 
0.17; 1.14 





The difference between the location of the landmarks in the MRI and CT scans 
for the three groups is shown in Table 4.4. The distance observed in the negative 
control group (0.63 mm; 95%CI: 0.57 - 0.70; SD: 0.29) represents the overall 
consistency of the evaluation method and provides an estimate of the minimum 
displacement that could possibly be detected by the study. The positive control 
group with a mean distance between the location of the landmarks in the MRI and 
CT scans of 1.46 mm (maximum difference of 2.24 mm), demonstrates that the 
evaluation method is capable of detecting a discrepancy between the MRI and CT 
scans if there was one.   
The mean distance between the location of the landmarks in the pre-GKR MRI 
and post-GKR CT scans for the study group was 0.71 mm (95%CI: 0.68 - 0.74; 
SD: 0.32). The mean difference for each individual patient was below 1 mm. The 
estimates of difference between the MRI and CT coordinate measurements in the 
study group were consistent across the landmarks, i.e., cochleae: 0.71 mm 
(95%CI: 0.67 - 0.75) vs. 0.70 mm (95%CI: 0.67 - 0.74) for the SSC 
measurements, p = 0.99. 
There was no correlation between frame-on time and the difference between the 
MRI and CT coordinate measurements in the study group (Spearman's correlation 
coefficient: -0.03; p = 0.4) and this is shown in Figure 4.3 for each of the 
landmarks analysed.  
The group of patients with AVM, who also underwent DSA and so were subject 
to longer frame-on times and additional frame stress events, showed slightly 
larger estimates of difference between the location of the landmarks compared to 
subjects with no additional imaging in the study group, 0.78 mm (95%CI: 0.72 - 
0.84) vs. 0.69 mm (95%CI: 0.66 - 0.72), p = 0.016. This is however a minimal 
difference (0.1 mm) and the mean difference in landmark location for all AVM 





Table 4.4. Distance (mm) between the location of the landmarks in the MRI and 
CT scans. The negative control group had both MRI and CT scans before GKR. The 
fiducial indicator box was accidentally misplaced at post-GKR CT scanning in two cases 
(positive controls), simulating a frame displacement. The study group underwent MRI 
scanning before and CT imaging after GKR (n: 38). Subjects in the AVM group also had 
DSA for radiosurgery planning which involves longer frame-on times and additional 
frame stress events. 
Group 
Distance in landmark location MRI – CT  
mean distance, mm (95%CI) 
SD; max 
Negative controls 
n:5; obs: 80 
0.63 (0.57 - 0.70) 
0.29; 1.36 
Positive controls 
n:2; obs: 32 
1.46 (1.36 - 1.56) 
0.28; 2.24 
Study group 
n:38; obs: 600 
0.71(0.68 - 0.74) 
0.32; 1.76 
Study group excluding AVM  
n: 30; obs: 476 
0.69 (0.66 - 0.72) 
0.31; 1.76 
AVM only 
n:8; obs: 124 
0.78 (0.72 - 0.84) 
0.34; 1.75 
 







Figure 4.3. Difference between the MRI and CT coordinate measurements versus 
frame-on time in the study group for each of the landmarks analysed. No correlation 
is seen between the frame-on time and the estimated difference between the MRI and CT 






As shown in Figure 4.4 the distribution of the distance between the location of the 
landmarks in the MRI and CT scans for the negative control and the study groups 
are similar and no statistical difference was noted between these groups (p = 
0.06). The maximum difference observed between the location of the landmarks 
in the MRI and CT scans for the negative control group was 1.36 mm. Outlier 
values in the study group above 1.5 mm were considered beyond the maximum 
uncertainty justifiable by the slice thickness and underwent further review.  
Ten pairs of MRI-CT measurements in the study group, out of a total of six 
hundred, differed by more than 1.5 mm. Four of these outliers were observed in 
the left cochlea of a single patient by both observers on both occasions (case 33). 
This patient presented the maximum difference noted in the study group (1.76 
mm) but no similar difference was noted in the measurements of the ipsilateral 
SSC or the contralateral landmarks. Similarly, three outliers were observed in the 
right cochlea of a second subject by both observers, in two occasions by one of 
them, but again no large difference was noted in the ipsilateral SSC or the 
contralateral landmarks (case 20). A thorough review of these datasets 
demonstrated a discrepancy between the MRI and CT imaging planes which 
resulted in an overestimation of the difference in the z axis, comparable to the 1.5 
mm slice thickness. As shown in Figure 4.5, the CT slices bisected the cochlea at 
two levels, one closer to the top and the second closer to the bottom, rather than at 
the middle where the cochlear aperture would have been better visualized. This 
resulted in the landmark being measured at two different levels in the MRI and 
CT scans. The three remaining outliers were isolated inconsistencies measured by 
a single observer, in a single landmark and in three different patients (cases 22, 23 
and 46). These were also detected in only one of the two measurements made by 







Figure 4.4. Distribution of the distance (mm) between the location of the landmarks 
in the MRI and CT scans for the negative controls and the main study group. 
Negative controls (left) underwent both MRI and CT scans before GKR. Study group 
(right) were main group of subjects under investigation who underwent pre-treatment 
MRI scanning and CT imaging after GKR. 
 
4.5 Discussion 
This study aimed to evaluate a commonly overlooked factor contributing to the 
global accuracy of GKR.  It is the assumption that the stereotactic frame stays still 
during the treatment procedure and does not move. The location of four defined 
landmarks were measured in the planning MRI scan and compared to their 
observed position in a CT scan acquired immediately after treatment. If the 
stereotactic frame was completely stable and it was possible to measure the 
position of the landmarks in the two scans without any uncertainty, the difference 
between the first and second observations would have been zero. This was not the 
outcome of the study. A quantifiable difference of 0.71 mm (95%CI: 0.68 - 0.74; 
SD: 0.32) between the position of the landmarks in the pre-GKR MRI and the 
post-GKR CT scan was observed. This difference reflects the effect of three 
elements of the evaluation process i.e., the variability of the measurements within 
and between the observers, the uncertainty of the imaging techniques used for the 
study and a potential degree of frame displacement. These factors were quantified 
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in an independent group of subjects (negative controls) who underwent both scans 
before GKR with minimal time and frame stress events between them.  The mean 
difference between the location of the landmarks in the MRI and CT scans in this 
group was 0.63 mm (95%CI: 0.57 - 0.70; SD: 0.29). This is considered to be the 
best estimate of values with no frame displacement under the research conditions 
and provides a threshold of minimum displacement that could have possibly been 
detected by our study.  
The difference observed in the study group (0.71 mm; 95%CI: 0.68 - 0.74; SD: 
0.32) was not statistically different to the overall uncertainty of the evaluation 
method as observed in the negative control group (0.63 mm; 95%CI: 0.57 - 0.70; 
SD: 0.29). It is not possible to assert that frame displacement was zero because 
the difference found in the study group is equivalent to the uncertainty of the 
measurement method. It is also not possible to estimate from the study how much 
of the submillimetre difference observed in the study group is potentially 
explained by frame displacement. It can, however, be confidently concluded that 
no systematic frame displacement larger than 0.71 mm occurred in the study 
group. 
4.5.1 Intra and Inter-observer variability  
The variability of the measurements in our study is one of the factors contributing 
to the overall uncertainty of the results. The mean distance between repeated 
measurements by the same observer was 0.25 mm and as expected a larger mean 
distance was noted between measurements by different observers (0.59 mm). 
These estimates reflect not only the individual skills of the observers but also the 
size and nature of the landmarks which should be sensitive to potential frame 
displacement but also reliably identifiable in the scans. The cochlear apertures and 
the summit of the anterior post of the SSC were thought to be good landmarks for 
the study because they are non-midline structures sensitive to potential rotational 
displacement of the frame, they are clearly visible in both CT and T2 weighted 
MRI scans and small enough in size for their location to be acceptably 
summarized by a single set of x, y and z coordinates. There is however a degree of 
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imprecision in using a single point to define the location of a three-dimensional 
structure.  
The uncertainty of the coordinate measurements also derives from the fact that a 
landmark could be bisected by the scan slices at two different levels. The resultant 
discrepancy reflects the arbitrary quantization of the imaging planes rather than 
the exact position of the landmarks in the stereotactic system. The location of the 
SSC was measured in the coronal plane to minimise this source of error and also a 
consensus was reached between the observers in two cases where one of the 
cochlear apertures was bisected by two different slices. This however, applied 
only to measurements obtained from the same scan and it was not possible to 
adjust for slice misalignment when comparing the position of the cochlea (as 
measured in the axial plane) between two different scans. This error was 
particularly obvious in two of our study group patients where one of the cochleae 
was bisected at two levels by the post-GKR CT scans (Figure 4.5). This resulted 
in coordinate values being obtained from different anatomical structures due to 
suboptimal visualization of the landmark in the scans. The distance noted between 
these outlier observations was between 1.5 and 1.76 mm and this clearly reflects 
the slice thickness. No such difference was noted in the ipsilateral SSC of the 
same patients, which was measured in the coronal plane or the landmarks in the 
contralateral side. This reinforces the evidence that the outliers in our study are 
caused by the arbitrary slice misalignment between the scans rather than a 
displacement of the stereotactic frame. This would have been reduced if thinner 
slices were used for the imaging procedure. The coronal MRI and CT planes, 
reformatted from the axial images have an effective slice thickness of 0.47 mm 
(voxel dimensions: 0.47 x 0.47 x 1.5 mm) and this has a lesser effect for 
localisation of the SSC in the coronal plane. The cochleae, however, were not 
considered less suitable landmarks for comparison and their difference in apparent 
location between the MRI and CT scans was found to be comparable to the same 
estimates with the SCC (cochleae: 0.71 mm, 95%CI: 0.67 - 0.75 mm; SCC: 0.70 







Figure 4.5. Discrepancy between MRI and CT imaging planes causing 
overestimation of the difference seen in the outliers (case 33). A. The red cross shows 
an acceptable coordinate measure of the location of the cochlea in the pre-GKR MRI scan 
(x, y, z: 127.1, 99.5, 135.9). The next MRI slice does not show the cochlear aperture (C). 
The images in the right show the cochlea bisected at two levels by the CT scan, one 
closer to the top (D) and the second closer to the bottom of the cochlea (B). The CT 
measurements for the study (x, y, z: 127.6, 99.5, 134.2) were taken from the superior slice 






4.5.2 Localization uncertainty due to imaging techniques  
The validity of the conclusions reached by this study rest on the assumption that it 
is possible to reliably identify the same landmarks in two different imaging 
techniques i.e., MRI and CT. Figure 4.1 demonstrates the high-quality 
visualization of the landmarks in both images. Nonetheless, technical factors 
inherent to the imaging technique will introduce some uncertainty to the 
localization coordinates. MRI distortion is the most significant of these factors 
and was recently characterised by Nakasawa et al. They demonstrated that the 
maximum absolute error of coordinates in each dimension using 1.5 T MRI and 
the Leksell G frame with titanium fixation screws is between 1 and 2 mm 
(Nakazawa et al, 2014d). This is considerably higher than the estimate of 
distortion of the MRI unit used in our study which was found to be a mean of 0.46 
mm and a maximum of 0.88 mm using a GRID3D known target phantom (Modus 
Medical Devices Inc. London, Canada). For our CT scanner, a mean of 0.41 mm 
and a maximum of 0.70 mm was measured with the same phantom. Combining 
the errors for these two modalities in quadrature yields mean and maximum errors 
of 0.62 mm and 1.12 mm respectively. This mean error is remarkably close to the 
mean difference in the negative controls group, adding weight to our assumption 
that the negative controls group is a valid estimate of our uncertainties. 
The uncertainty caused by imaging distortion contributes to the apparent 
differences in landmark positions seen between the MRI and CT scans in some 
cases where the same stereotactic point seems to show a slightly different 
anatomical position in the scans (Figure 4.6).  This phenomenon has been 
described by Karlsson et al who reported a mismatch above 1.5 mm between two 
stereotactic MRI scans of the same subject and concluded it was the result of MRI 
distortion artefact (Karlsson et al, 2011). Pollock et al has also reported the 
importance of MRI distortion in stereotactic radiosurgery planning and sugested 
that imaging distortion could have partly caused some of their recurrent vestibular 
schwannomas to receive less than the prescribed dose to the entire tumour volume 
(Pollock et al, 2009). This is also relevant to our outlier measurements observed in 
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the cochlea where CT imaging is likely to better characterise the anatomy of the 
bony structure compared to MRI.  
Further testing of the measurement method was possible in our study due to 
unintentional misplacement of the CT indicator box in two cases (positive 
controls). The simulated displacement was evidenced in the coordinate 
measurements as a mean difference between the position of the landmarks in the 
MRI and CT scans of 1.46 mm (95%CI: 1.36 - 1.56). The maximum discrepancy 
observed was 2.24 mm, which is considerably larger than the maximum observed 
difference in the study group. This error was effectively detected by GammaPlan 
(Elekta AB) and the planner was made aware of this through unusually high 
fiducial errors during the stereotactic definition of the CT scans. This would not 
have been the case if a real frame shift occurred because there is currently no 
mechanism in place to detect such a displacement throughout the treatment 
procedure. The development of the Leksell Gamma Knife and its integration with 
movement tracking and live image guidance systems in the recently launched 
Gamma Knife Icon is expected to address potential geometric inaccuracies 
throughout the treatment procedure (Ruschin et al, 2013). 
The scenario of a misplaced indicator box is clearly geometrically simpler than a 
multiplane or rotational frame displacement but it can provide some 
understanding of the degree of error that would be added to a treatment if the 
stereotactic frame displaced. In the two cases with a misplaced indicator box in 
our study the right posterior locating pin of the fiducial indicator box was 
displaced 7.5 mm towards the midline and the maximum error of the scan 
definition process was 4.6 mm. However, the maximum discrepancy observed 
between the location of the landmarks in the MRI and CT scans was only 2.5 mm, 
considerably lower than the potential error in the system. This reduction of error 
is caused by a redistribution of the inaccuracies across the scans when they are 
defined in stereotactic space (Jones, 1993). Similar benign error redistribution 
effects could occur if the frame displaced under specific conditions such as axial 
rotation with a centrally located target and this study did not specifically address 
the issue of potential rotational displacement of the frame. Further understanding 
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of the effect of random geometrical uncertainties in the treatment procedure is 
needed to fully comprehend the clinical effect of potential frame displacement and 
also for evaluation and development of frameless radiosurgery systems 
(Schlesinger et al, 2012; Walton et al, 2002). 
 
 
Figure 4.6. Submillimetre discrepancies between the location of the landmarks in 
the MRI and CT scans attributed to imaging distortion. The red lines cross in the 
centre of the cochlear canal at the most medial spiral turn in the pre-GKR MRI scan (A) 
but slightly off-centre in the post-GKR CT scan (B). Similar discrepancies between 0.5 




4.5.3 Frame stability  
Karlsson et al evaluated the stability of the Leksell frame in a group of 18 patients 
who underwent high-definition MRI scans before and after GKR. The reported 
mean distance between the average of repeated readings of the location of defined 
landmarks before and after GKR was 0.47 mm and it was concluded that the 
position of the stereotactic frame is stable throughout the treatment procedure 
(Karlsson et al, 2011). The difference reported by Karlsson et al is considerably 
lower than that observed in our study and this is explained by the methodological 
differences. The comparison between the pre and post-GKR scans in their study 
was done using the calculated mean of repeated observations (mean position of 
localization), rather than each individual localization attempt, and this could result 
in erroneously favourable outcomes (Maciunas et al, 1994). Also, we used a 
different imaging technique before and after GKR and the imaging slices were 
also thicker in our study (1.5 vs. 0.7 mm), which explains the increased 
uncertainty of our measurements.  
The application accuracy of four commonly used stereotactic devices, including 
the Leksell frame, was challenged by Maciunas et al in an attempt to evaluate the 
total accuracy conveyed by the entire visualization, calculation and surgical 
systems working together (Maciunas et al, 1994). The study suggested a 
significant degree of error in the application accuracy of all the stereotactic 
instruments tested but failed to specifically address the question of stability of the 
frame itself. Their experiment compared the true location of a target in a phantom 
with the position reached by a needle tip if the target coordinates were set in the 
stereotactic arc system. This comparison was performed several times using 
different CT slice thickness and the mean error was found to be within 1 – 2 mm 
when 1 mm slices were used and within 2 – 3 mm with 4 mm slices. These 
estimates of inaccuracy are considerably larger than the observed mean difference 
in our study and only our outliers are somewhere near the best results by this 
group. This is probably due to the fact that the findings of the Maciunas study 
relied on the poor geometric accuracy of earlier generation CT scanners, which 
are now known to yield errors of a few mm (Yu et al, 2001). The experiment 
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designed by Maciunas et al cannot be used as evidence against the stability or 
accuracy of the Leksell G frame; however, it provides awareness of how slice 
thickness can influence the overall accuracy of stereotactic systems.  
4.5.4. Effect of frame weight bearing on the stereotactic frame 
The paper by Maciunas et al also claimed to evaluate the effect of frame weight-
bearing on the accuracy of the stereotactic systems and concluded that a mean 
displacement of 1.62 mm occurs if a weighting of 25 Kg is added to the Leksell G 
frame. This is a significant weight unlikely to represent any clinical scenario and 
it is not possible to determine from the study report how the Leksell frame was 
fixed to the phantom’s acrylic plastic base. Their results are more likely to reflect 
a technical fault on the specific experimental design rather than any clinically 
relevant instability of the frame. Nevertheless, the issue of frame weight bearing 
has not been fully addressed in the literature and our study provided the 
opportunity to compare a group of AVM patients, with additional frame stress 
events incurred in the process of DSA, and a group of subjects who were not 
exposed to these factors. The results demonstrated that the difference between the 
location of the landmarks in the pre- and post-treatment scans is slightly higher in 
the AVM patients, who were subject to longer frame-on times and additional 
frame stress events, compared to other subjects in the study group who underwent 
no additional imaging (0.78 mm vs. 0.69 mm; p = 0.016). The difference between 
these two groups, although very small in magnitude (0.1 mm), is statistically 
significant and it may be beneficial to reduce the number of frame stress events 
during the treatment procedure. This may also have implications for patients who 
are treated using trunnion fixation on Gamma Knife model B and C where patient 
frames are repeatedly stressed during docking for each isocenter.  
4.6 Conclusions 
A comprehensive study design involving repeated measurements of the landmarks 
in forty patients by two observers, along with validation of the evaluation method 
in an independent negative control group with no plausible frame displacement, 
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demonstrated that the observed difference in the study subjects is equivalent to the 
overall uncertainty of the evaluation method. This provides reliable and realistic 
evidence of submillimetre stability of the stereotactic frame throughout the 





5. Can Gamma Knife Radiosurgery for brain 
arteriovenous malformations be planned on 
triple Magnetic Resonance Angiography? 
Rojas-Villabona, A., Sokolska, M., Solbach, T., Grieve, J., Rega, M., Torrealdea, 
F., Benedetta Pizzini, F., Suzuki, Y., Van Osch, M., De Vita, E., Biondetti, E., 
Shmueli, K., Atkinson, D., Murphy, M., Paddick, I., Golay, X., Kitchen, N. & 
Jager, R.  
Under peer review for publication 
5.1 Abstract 
Introduction: GKR is a well-established minimally invasive treatment for 
selected cases of intracranial AVMs. State-of-the-art planning strategy involves 
intra-arterial Digital Subtraction Angiography (DSA) on the day of treatment for 
delineation of the radiosurgical target, as well as standard volumetric MRI scans. 
However, DSA is invasive and it carries a potential risk of peri-procedural 
complications. This study aims to evaluate whether a combination of three 
Magnetic Resonance Angiography sequences (triple-MRA), could be used as an 
alternative to DSA for delineation of brain AVMs for GKR targeting. 
Methods: Fifteen patients undergoing DSA for targeting of GKR for brain AVMs 
also underwent triple-MRA including: 4D arterial spin labelling based 
angiography (ASL-MRA), high definition time-of-flight angiography (HD-TOF) 
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and contrast-enhanced time-resolved MRA (CE-MRA). ASL-MRA acquisition 
was individualised in each case based on the filling velocity of the AVM and for 
this reason, triple-MRA scanning time varied among patients between 19:05 and 
25:33 minutes. 
The arterial phase of the AVM nidus, excluding draining veins, was delineated on 
triple-MRA and volumetric post-contrast T1 and T2 weighted MRI by an 
interventional neuroradiologist and a consultant neurosurgeon (triple-MRA 
volume). This was achieved by including the areas shown to be part of the AVM 
nidus in all three MRA techniques as well as standard volumetric MR imaging. 
Triple-MRA volumes were compared to the AVM target delineated by the GKR 
clinical team for delivery of radiosurgery using the current planning paradigm, i.e. 
stereotactic DSA and volumetric MRI (DSA volume). Difference in size, degree 
of inclusion (DI) and concordance index (CcI) between DSA and triple-MRA 
volumes were calculated.  
Results: The mean DSA volume was 3.89 ml (95%CI: 1.95 - 5.82 ml; median: 
3.35 ml; range: 0.1 - 10.77 ml). AVM volumes delineated on triple-MRA were 
significantly smaller at 3.49 ml (95%CI: 1.77 - 5.2 ml; median: 2.88 ml; range: 
0.09 - 9.89 ml), (p = 0.003), and were smaller than the DSA volume in all but 
once case (93%). The relative difference between DSA and triple-MRA volumes 
was on average 9.8% (95%CI: 5.6 - 13.9%; SD:7.14%; median: 10.5%; range: -
7.3 - 18.7%).  
DI of DSA volume in triple-MRA volume was on average 73.5% (95%CI: 71.2 - 
76; median: 73%; range: 65 - 80%). The mean percentage of triple-MRA volume 
not included on DSA was 18% (95%CI: 14.7 - 21.3; median: 18.4%; range: 7 - 
30%). The mean CcI was 0.63 (95%CI: 60.4 - 66.2; median: 0.63; range: 0.51 - 
0.72).  
Conclusion: The technical feasibility of using triple-MRA, instead of DSA, for 
delineation of brain AVMs for GKR targeting has been demonstrated. Target 
volumes obtained using triple-MRA are on average 10% smaller than AVM 
targets obtained with the standard DSA planning method and this can potentially 
5.	Triple-MRA	for	planning	of	GKR	for	brain	AVMs	_________________________________________________________________________________________________________	
114	
reduce the risk of ARE. The discrepancies observed between triple-MRA and 
DSA volumes are less than the inter-observer variability observed when an AVM 





GKR is a well-recognized non-invasive treatment option for selected cases of 
brain AVMs (Pollock et al, 2016; Starke et al, 2017). The treatment is aimed at 
eliminating the risk of intracranial haemorrhage by obliterating the AVM, with 
minimal injury to surrounding normal brain tissue (van Beijnum et al, 2011).  This 
is achieved by stereotactically delivering a high and greatly localized radiation 
dose to the AVM nidus, which is the network of coiled and tortuous blood vessels 
that abnormally connect arteries and veins and cause arteriovenous shunting in 
AVMs (Leksell, 1983; Seymour et al, 2016). Obliteration after radiosurgery 
occurs gradually over a two to three years period and success rates between 65 
and 85% have been reported (Hamm et al, 2008; Kano et al, 2012b; Koltz et al, 
2013). GKR, like other forms of radiosurgery, relies on the quality and accuracy 
of imaging used for treatment planning and delivery. It is well accepted that 
higher obliteration rates and less complications are achieved when inclusion of the 
entire AVM nidus is accomplished and draining veins are excluded from the 
treatment volume (Safain et al, 2014).  
Intra-arterial cerebral DSA has historically been the main imaging modality used 
for radiosurgery target delineation in AVM radiosurgery, and it is still considered 
the reference standard technique for AVM identification and characterisation 
(Pollock et al, 2017; Starke et al, 2017). Stereotactic DSA, which is performed on 
the day of treatment, alongside volumetric MR and/or CT imaging, enables high 
resolution, dynamic and vessel selective imaging of the cerebral vasculature 
(Seymour et al, 2016). However, DSA data integrated into the GKR planning 
system consist of two-dimensional (2D) projections in the coronal and sagittal 
planes and do not contain 3D information (Taschner et al, 2007). DSA also has a 
small but definite risk of neurological complications related to thromboembolic 
events. This lies between 0.3% and 2.63% per examination and is known to 
increase when multiple DSA procedures are performed, which is often the case in 
the AVM population (Dawkins et al, 2007; Fifi et al, 2009; Kaufmann et al, 2007; 
Leffers & Wagner, 2000). Silent embolic events are also found on diffusion 
weighted MRI in up to 23% of the patients after DSA (Bendszus et al, 1999) and 
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severe complications such as stroke with permanent disability (0.14%) and death 
(0.06%) have been reported (Kaufmann et al, 2007). In addition, DSA exposes 
both patients and medical staff to ionizing radiation, it carries the risk associated 
with injection of iodinated contrast agents and it is an unpleasant experience for 
patients due to pain, invasiveness and prolonged bed rest after the procedure (Fifi 
et al, 2009).  
Several studies have previously attempted to use alternative techniques for AVM 
radiosurgery targeting with varying degrees of success (Amponsah et al, 2012; 
Bednarz et al, 2000; Buis et al, 2007; Hamm et al, 2008; Kang et al, 2014; 
Nagaraja et al, 2005; St George et al, 2002; Taschner et al, 2007). Time-of-flight 
angiography (TOF) has been shown to increase the accuracy of AVM 
radiosurgery targeting (Bednarz et al, 2000) and as a result some GKR units have 
added TOF to their planning algorithms as a complementary imaging modality to 
DSA. CT angiography has also been shown to aid DSA based radiosurgery 
planning; however, it potentiates the limitations of DSA by increasing exposure to 
ionising radiation and iodinated contrast agent and it is also heavily affected by 
metal or embolic material artefacts (Kang et al, 2014). A feasibility study was 
conducted to integrate 4D imaging, such as time resolved contrast-enhanced MR 
angiography (CE-MRA), into the GKR planning process but the quality of CE-
MRA was thought to need further improvement to enable optimal planning of 
GKR without DSA (Taschner et al, 2007).  None of the angiography techniques 
mentioned above has been shown to provide accurate delineation of AVM 
radiosurgical targets when used individually on their own. Thus, the potential 
improvement of GKR planning procedure by replacing DSA with less-invasive 
imaging is still to be accomplished.  
The combination of multiple MRA sequences is an innovative strategy which has 
already shown promising results in AVM radiosurgery planning. Nagaraja et al 
found that in a group of 60 AVM patients, the maximum linear dimension and 
nidus volume delineated using a combination of static (post-contrast TOF) and 
dynamic (CE-MRA) magnetic resonance angiography techniques, correlated well 
with radiosurgical targets defined using the conventional DSA method (Nagaraja 
5.	Triple-MRA	for	planning	of	GKR	for	brain	AVMs	_________________________________________________________________________________________________________	
117	
et al, 2005). CE-MRA in this study, however, was used through visual inspection 
only and measurements of nidus volume were based solely on TOF angiography, 
due to the technical difficulties of integrating 4D data into radiosurgery planning 
algorithms. An MR angiography fusion technique with acceptable spatial 
accuracy has also been described to generate hybrid images of high-resolution 
contrast enhanced MRA and TOF (McGee et al, 2006). However, the contrast 
enhanced MRA sequence used in that study was not time-resolved and therefore 
DSA was still required for AVM characterisation and targeting.  
More recently, we described triple-MRA which is the combined use of three 
MRA sequences including HD-TOF, time resolved CE-MRA and 4D ASL-MRA 
(Rojas Villabona et al, 2017). Triple-MRA was shown to consistently 
demonstrate/rule out residual AVMs in patients treated with GKR for brain 
AVMs compared to DSA and it can also be reliably used for characterisation of 
residual AVMs. The major accomplishment of using multiple MRA investigations 
is the combination of high temporal and spatial resolution, which are both 
necessary to appreciate the unpredictable blood flow dynamics of AVMs 
(Nagaraja et al, 2005; Taschner et al, 2007). The distinctive element of triple-
MRA, in terms of sequences, is ASL-MRA which enables acquisition of dynamic 
cerebral angiography with temporal resolution comparable to that of DSA (100 - 
200 ms) without the administration of contrast agents (Lindner et al, 2015; Suzuki 
et al, 2017; Wu et al, 2013). ASL-MRA has already been shown to be useful for 
non-invasive assessment of cerebral AVMs and it can provide dynamic 
information on flow and angio-architecture of AVMs which had not been 
previously possible using MRA (Fujima et al, 2016; Iryo et al, 2016). 
This study aims to evaluate whether the combination of three MRA techniques, 
referred to as triple-MRA, could be used as an alternative to DSA for visualisation 







Fifteen consecutive adult patients undergoing DSA for targeting of GKR for brain 
AVMs at the National Hospital for Neurology and Neurosurgery between June 
2015 and October 2016 were prospectively recruited. All participants gave written 
consent for a triple-MRA to be performed before GKR and the study was 
approved by the Queen Square research ethics committee (Appendix 3). The 
research pathway and image analysis framework used for radiosurgery target 
delineation with DSA and triple-MRA, are shown in the flow diagram in Figure 
5.1. 
 
Figure 5.1. Research pathway and image analysis framework used for target 
delineation with DSA and triple-MRA. DSA volume is the radiosurgical target 
drawn for delivery of GKR using 2D projections of DSA together with post-
contrast T1, TOF and T2 weighted MRI. Triple-MRA volume includes the areas 




Exclusion criteria included inability to tolerate MR imaging without 
sedation/anaesthesia, impaired renal function (eGFR < 30ml/min), inability to 
consent, pregnancy, allergy to gadolinium, contraindication to MRI (i.e., 
pacemakers, metallic implants, etc.) and history of endovascular coiling of 
cerebral aneurysms. 
Table 5.1 shows the demographic details and AVM characteristics of the study 
subjects. Mean age was 38 years (range: 18 - 62) and 10 patients (66%) were 
female. Ten patients presented with intracranial bleeds, two with seizures and the 
AVM was incidentally found in three subjects. The lesions were Spetzler-Martin 
grade 1 and 2 in 43% of the cases, grade 3 in 42% of the patients and high-grade 
AVMs (4 and 5) were observed in 15% of them. Three patients had undergone 
partial glue embolization before GKR, one of them on two occasions, and none of 
them had undergone previous microsurgical excision.  
 
Table 5.1. Demographic details and AVM characteristics of the study subjects. 
Age mean (min - max) 38 y (18 - 62) 
Female, n (%) 10 (66%) 
AVM location, n 
Frontal  3  
Parietal 2  
Occipital 4  
Temporal 3  
Basal ganglia  2  
Post fossa 1  
Lateralisation, % Right 53% Left 47% 
Presentation, n (%) 
Intracranial bleed 10 (66%) 
Seizures 2 (14%) 







< 3 cm 71% 
3 - 6 cm 22% 













5.3.2 Triple-MRA imaging protocol 
Triple-MRA was acquired using a 32-channel Achieva 3.0 T MRI system (Philips 
Healthcare Systems, Best, The Netherlands).  The protocol included ASL-MRA, 
CE-MRA and post-contrast HD-TOF and the scanning parameters are provided in 
Table 5.2. Triple-MRA was non-stereotactic (without a stereotactic frame) and 
performed before GKR. The median time between triple-MRA and GKR was 10 
days (range, 2 – 87 days); it was more than 30 days in four patients. 
ASL-MRA uses the same principle as ASL perfusion imaging: arterial blood 
water is magnetically labelled with a radiofrequency pulse proximal to the brain 
and it is used as an intrinsic contrast agent and flow tracer (Petersen et al, 2006). 
This is achieved by inverting the longitudinal magnetization of arterial water spins 
which changes the contrast properties of inflowing blood with respect to the 
surrounding tissue (Golay et al, 2005). The subtraction of an image with inverted 
blood spins (label) and without inversion (control) results in images of the 
inflowing blood only (Lindner et al, 2015). Under normal conditions, most 
labelled water is extracted at the capillary level into the tissue, giving rise to the 
parenchymal perfusion signal intensity for which ASL is better known (Petersen 
et al, 2006; Xu et al, 2010). The same principle, with an earlier acquisition -before 
the labelled water leaves the vasculature- and with a much higher resolution can 
be applied to obtain angiographic images with near zero background and inflow 
dynamics similar to DSA (Nakamura et al, 2012). ASL angiography with Echo 
Planar Imaging (EPI) enables fast dynamic acquisition of multiple phases per 
second with reasonable scanning times (Suzuki et al, 2017). This offers a high 
degree of flexibility in terms of temporal resolution which was exploited in our 
study for individualised timing of ASL-MRA (Figure 5.2). An ASL survey with 
EPI acceleration was used to characterise the filling velocity of the AVM in each 
individual case. The three time points best suited to show the arterial phase of the 
AVM nidus were then acquired with ASL-MRA which had less dynamic time 
points, better spatial resolution and pulsation artefact robustness (non-EPI).  By 
reducing the number of dynamic points the labelled blood is less saturated during 
acquisition which prolongs the labelling effect and improves the SNR (Jensen-
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Kondering et al, 2015). The ASL survey encompassed 8 dynamic phases with a 
temporal resolution of 200 ms. A 300 mm Signal Targeting with Alternating 
Radiofrequency (STAR) labelling slab was positioned below the imaging plane. A 
small (10 mm) axial slab including part of the AVM nidus was scanned in 54 
seconds (Table 5.2). The size and position of the labelling slab used for the ASL 
survey remained unchanged for ASL-MRA acquisition to ensure the same transit 
time between the labelling slab and the AVM nidus.  There was a significant 
degree of variability between patients in terms of optimal label delay which 
ranged from 200 - 800 ms (mean: 470 ms; SD: 212 ms) and phase interval, or 
time between dynamic frames, which ranged from 200 to 300 ms (mean: 236 ms). 
For this reason, ASL-MRA scanning time varied among patients from 5:58 to 
12:24 min (mean: 8:46 min). 
CE-MRA included 24 dynamic time points and was acquired using a 3D, T1 
weighted, fast-field echo (FFE) sequence. A reference scan was acquired before 
contrast injection for subtraction of the stationary tissue and dynamic sampling 
was started at the same time as the injection. A manual IV bolus injection of 
0.2mL/kg of Gadobenic acid 0.5M (MultiHance, Milan, Italy) was performed 
over an estimated time of 4 seconds followed by a saline flush of 20 ml. The fast 
dynamic acquisition used contrast-enhanced robust-timing angiography 
(CENTRA) and the keyhole method with 20% of the k-space collected per 
keyhole frame (Willinek et al, 2008). Sensitivity encoding (SENSE) was also used 
with a reduction factor of 4 in the phase-encoding direction and 2 in the slice-
encoding direction resulting in a temporal resolution of 608 ms/phase. HD-TOF 
acquisition was started approximately 10 minutes after injection of gadolinium. It 
was based on a 3D-FFE acquisition with flow compensation and tilt-optimized 
non-saturated excitation (TONE) across the slab (Wrede et al, 2014). Four slabs 
covering 50mm in the cranio-caudal direction were obtained with parallel 
imaging, SENSE factor of 2. A 3D post-contrast T1 weighted MRI scan which is 
part of standard GKR planning was acquired alongside triple-MRA -to avoid 
double injection of contrast agent- using the following parameters: T1 FFE; 
acquisition matrix: 256 x 256; slice thickness: 1.5 mm, no overlap; voxel size: 





Figure 5.2. Representative example of the ASL survey developed to individualise 
timing of ASL-MRA. The ASL survey (left panel; temporal resolution: 200 ms; axial 
slab: 10 mm, acquisition time: 54 sec) enabled rapid characterisation of AVM filling 
velocity and the selection of three time points (500, 700 and 900 ms) in which the filling 
of the nidus is adequately visualised. The ASL-MRA acquisition is then limited to the 
selected time points (middle panel, AP MIP). The right panel shows the AP projection of 















Table 5.2. Triple-MRA scanning parameters.  
Parameter ASL survey ASL-MRA CE-MRA HD-TOF 
MRA type Dynamic survey Dynamic Dynamic Single time point 
Scan duration (mins:sec) 0:54 5:58 - 12:24 3:19 08:54 
Contrast 
Scan mode 3D 3D 3D 3D 
Acquisition T1 TFEPI T1 TFE T1 FFE T1 FFE 
TR (ms) 12 4.5 3 25 
TE (ms) 5 2.5 1.1 3.45 
Flip Angle (°) 10 10 25 25 
Resolution 
FOV (RL x AP x CC, 
mm) 210 x 210 x 10 210 x 210 x 90 150 x 210 x 210 250 x 250 x 50 
Acquisition transversal transversal Sagittal transversal 
Slabs 1 1 1 4 
Acquisition matrix 172 x 167 x 8 172 x 172 x 70 50 x 248 x 248 832 x 568 x 50 
Acquired voxel size 
(mm) 1.22 x1.26 x1.3 1.22 x 1.22 x 1.3 3 x 0.85 x 0.85 0.3 x 0.44 x 1 
Reconstruction matrix 256 x 256 256 x 256 288 x 288 1936 x 1936 
Rec voxel size (mm) 0.82 x 0.82 x 0.65 0.82 x 0.82 x 0.65 1.5 x 0.73 x 0.73 0.13 x 0.13 x 0.5 
Number of slices 8 140 100 100 
SENSE factor 2.5 2.5 4/2 2 
Dynamic acquisition 
Dynamic imaging mode TFEPI TFE CENTRA keyhole - 
Number of phases 8 3 24 - 
Phase interval 
(temporal resolution) 200 200 - 300 ms 608 ms - 
Label delay 200 200 - 800 ms - - 





5.3.3 DSA protocol and stereotactic MRI for GKR planning 
The stereotactic method used at Queen Square Radiosurgery Centre has been 
described elsewhere (Rojas-Villabona et al, 2016a). Stereotactic DSA was 
performed under local anaesthesia using a biplane system (Artis zee Biplane, 
Siemens, Erlangen, Germany) and iodinated contrast agent (Iohexol 240 mg/ml, 
Omnipaque, GE Healthcare, Cork, Ireland). A femoral artery approach was used 
for selective contrast injection of one or several vessels known to supply the 
AVM. DSA was performed at a rate of 3-7 frames/second in standard orthogonal 
anteroposterior (AP) and lateral projections; oblique projections were acquired 
when deemed necessary. For GKR planning a thorough review of the DSA series 
by the interventional neuro-radiologist performing the procedure results in the 
selection of one or a few time points in the early arterial phase where the AVM 
nidus is optimally pictured. The AP and lateral X Ray projections of the selected 
time points are then imported into Leksell GammaPlan 10.1 (Elekta Instrument 
AB, Stockholm, Sweden) and defined into the stereotactic coordinates system, 
together with stereotactic T1 and T2 weighted MRI, for radiosurgery targeting.  
Stereotactic 3D T1 and T2 weighted MRI were obtained on the day of GKR using 
a Magnetom Avanto 1.5 T MRI system (Siemens AG, Erlangen, Germany) with 
the following parameters. T1 weighted: FLASH; T2 weighted: CISS; acquisition 
matrix: 448 x 448; slice thickness: 1.5 mm, no overlap; FOV: 210 x 210 mm; 
voxel size: 0.47 x 0.47 x 1 mm. Stereotactic 3D T1 weighted MRI was obtained 
post-contrast in four cases in which triple-MRA had been performed more than 30 
days before GKR. In the remaining cases, the T1 post-contrast scan acquired on 
the day of triple-MRA was used for planning of GKR by co-registering it to the 
non-contrast stereotactic scans obtained on the same day of GKR, using the co-
registration tool in Leksell GammaPlan 10.1. TOF angiography is routinely used 
as a complementary imaging modality to DSA in many GKR centres around the 
world (Potts et al, 2014; Seymour et al, 2016). For this reason, HD-TOF was also 
co-registered with the stereotactic scans performed on the day of GKR and it was 
available to the radiosurgery team for target delineation alongside DSA. In 
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stereotactic DSA, stereotactic T2 weighted and post-contrast T1 weighted MRI 
and HD-TOF (Figure 5.3).  
The early arterial phase of the AVM nidus was delineated in consensus by the 
practising consultant neurosurgeon, the interventional neuroradiologist who 
performed the DSA procedure and a medical physicist using the delineation tool 
in Leksell GammaPlan 10.1. The resultant volume (DSA volume) was then used 
to develop a radiosurgery treatment plan which was then delivered with a Leksell 
Gamma Knife Perfexion (Elekta Instrument AB).  
5.3.4 AVM target definition on triple-MRA  
ASL-MRA, CE-MRA and HD-TOF data were transferred to the Brainlab 
Elements platform (Brainlab AG, Munich, Germany) for post-processing and 
triple-MRA target delineation. The volumetric datasets of all three ASL-MRA 
time points were individually co-registered with HD-TOF using Brainlab Merge 
Element (Brainlab AG). The quality of co-registration was validated using 
intracranial arteries as landmarks, namely, branches of the middle cerebral artery 
bilaterally, the pericallosal and marginal arteries superiorly and the basilar artery 
bifurcation. The overlap of these blood vessels in the individual pairs of datasets 
undergoing co-registration was visually assessed in all three orthogonal planes 
and co-registration ROIs were defined to improve the quality of co-registration 
where necessary. This applied to all co-registration steps performed in this study. 
Dynamic CE-MRA datasets were visually inspected (ARV) to select two time 
points that best depicted the AVM nidus, in a similar manner as DSA dynamic 
datasets are routinely reviewed to select a few DSA images that are incorporated 
into GKR planning.  Volumetric datasets of selected CE-MRA time points were 
co-registered to HD-TOF and 360 degree of rotation Maximum Intensity 
Projections (MIPs) were generated for all three MRA sequences. In order to 
simulate the clinical scenario in which angiography is used alongside structural 
MRI for radiosurgery planning, the T1 post-contrast and T2 weighted MRI data 
were also imported into the Brainlab platform, co-registered to HD-TOF and used 




Figure 5.3. Imaging used for AVM delineation with the standard DSA based method 
and triple-MRA. Stereotactic DSA(D-F) together with standard volumetric MRI (top 
row) is the current reference standard for target delineation in AVM radiosurgery. The 
limits (blue lines) of an AVM ROI delineated on 2D DSA images (blue contour) are 
projected into volumetric MRI defining an area within which the AVM is contained. A 
3D volume is then drawn within this area on volumetric scans (DSA volume, orange).  
Definition of an AVM volume on triple-MRA (bottom three rows) is based on co-
registered MRA sequences: ASL MRA (K-L), CE-MRA (J) and HD-TOF (I) together 
with routine volumetric MRI. A 3D volume is drawn including areas shown to be part of 
the AVM nidus on all co-registered multimodality images and the resultant triple-MRA 




Triple-MRA based volumes were delineated using the semi-automatic drawing 
tool SmartBrush Element (Brainlab AG) by including areas shown to be part of 
the AVM nidus on ASL-MRA, CE-MRA, HD-TOF, post-contrast T1 and T2 
weighted MRI scans, excluding draining veins. This was done by an 
interventional neuroradiologist and a consultant neurosurgeon (TS and JG), both 
with more than 15 years of experience, who are radiosurgery practitioners at 
Queen Square and had not been involved with treatment planning of the patients 
recruited, except in two cases in which the consultant neurosurgeon (JG) was 
involved in delineation of both the DSA as well as the triple-MRA volumes. 
The quality of triple-MRA was evaluated with regards to artefacts that could 
potentially affect the quality of AVM delineation. Vessel visualization was 
assessed for each MRA sequence using a five-point categorical scale (poor, fair, 
good, very good, excellent). Characterisation of AVMs on triple-MRA included 
Spetzler-Martin grading and identification of feeding arteries, abnormalities of the 
draining veins and associated aneurysms. The observer’s level of confidence on 
their estimation of AVM nidus on triple-MRA was assessed using a three-point 
categorical scale (not entirely confident, confident, highly confident) by asking 
them how confident they would feel about delivering GKR based on triple-MRA 
volume. 
5.3.5 Data analysis 
Difference in size, degree of inclusion and concordance between DSA and triple-
MRA volumes were calculated (Duan et al, 2014). Triple-MRA volumes were 
imported into Leksell GammaPlan 10.1 on format DICOM-RT structure using the 
HD-TOF dataset which was co-registered into the stereotactic system. This 
enabled both triple-MRA and DSA volumes to be defined in the same stereotactic 
space, and on common MRI datasets, for comparison. The percentage difference 
between DSA and triple-MRA volumes is reported. One-sample t-test was used to 
determine if the percentage difference between DSA and triple-MRA volumes 
was significantly different from 0. The percentage difference between DSA and 
triple-MRA volumes was further analysed using a Bland-Altman plot. 
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Comparison of volumes in terms of inclusion and concordance was performed 
off-line using MATLAB 9.2 (The MathWorks Inc, Natick, Massachusetts, USA). 
The DICOM-RT structures of both DSA and triple-MRA volumes were exported 
from GammaPlan and used to create separate masks on HD-TOF for computation. 
Degree of inclusion (DI) is the percentage of DSA volume (DSAv) included in 
triple-MRA volume (tMRAv) calculated using the equation below, where Ç is the 
intersection between two volumes: 
DI	 DSAv	in	tMRAv = 	 DSAv	 ∩ 	tMRAv	DSAv 	×	100 
The percentage of triple-MRA volume not included in DSA volume, termed 
degree of non-inclusion (DnI), is: 
DnI	 tMRAv	not	in	DSAv = 1 − DSAv	 ∩ 		tMRAv	tMRAv ×100	 
The Concordance Index (CcI) of DSA and triple-MRA volumes is the ratio of the 
intersection to the union (È) of the two volumes, as described by Jaccard. The 
maximum value of CcI is 1 if the two volumes are identical, and the minimum 
value is 0 if the volumes are completely non-overlapping (Jaccard, 1912).  
CcI	 = DSAv	 ∩ 	tMRAvDSAv	 ∪ 	tMRAv 
Correlation between CcI and age, AVM volume, Spetzler-Martin grade and ASL-
MRA phase interval were assessed with Spearman's rank correlation coefficient 
(rho). The effect of categorical variables (gender, previous bleeds, previous 
treatments, laterality, location, eloquence of the surrounding brain, drainage 
pattern and AVM density assessed on DSA as diffuse vs compact) on CcI was 
assessed using the non-parametric Mann-Whitney U test. Statistical analyses were 
performed using the Statistical Package for the Social Sciences (SPSS Statistics, 






All fifteen participants successfully underwent triple-MRA before the day of 
GKR. They also had stereotactic DSA for planning of radiosurgery, except one 
patient who declined GKR after triple-MRA had been acquired. This case was 
excluded and final statistical analysis includes 14 subjects. Total triple-MRA 
scanning time ranged from 19:05 to 25:33 min (mean: 21:53 min). It varied 
among patients due to individualised timing of ASL-MRA.  
AVM target volumes obtained using the standard DSA method and triple-MRA 
are presented in Table 5.3. The mean DSA volume, drawn by the neurosurgical 
team for delivery of GKR using 2D projections of DSA into structural MRI, was 
3.89 ml (95%CI: 1.95 - 5.82 ml; SD: 3.35 ml; median: 3.35 ml; range: 0.1 - 10.77 
ml). AVM volumes delineated on triple-MRA were significantly smaller (p = 
0.003). The mean triple-MRA volume was 3.49 ml (95%CI: 1.77 – 5.2 ml; SD: 
2.97 ml; median: 2.88 ml; range: 0.09 - 9.89 ml) and was smaller than the DSA 
volume in all but one case (Figure 5.4). The relative difference between DSA and 
triple-MRA volumes was on average 9.8% (95%CI: 5.6 - 13.9%; SD:7.14%; 
median: 10.5%; range: -7.3 - 18.7%). 
DI of DSA volume in triple-MRA volume was on average 73.5% (95%CI: 71.2 - 
76%; SD: 4.1%; median: 73%; range: 65 - 80%). It was above 70% in all subjects 
except for case 9, in which a small difference between the volumes represented a 
high percentage discrepancy due to the very small size of the target (0.103 ml, 
Figure 5.5). The mean percentage of triple-MRA volume not included on DSA 
(DnI) was 18% (95%CI: 14.7 - 21.3%; SD: 5.7%; median: 18.4%; range: 7 - 
30%). It was 20% or less in all subjects except for two cases (Table 5.3). One of 
these was case 9 (30%) for the same reason as stated above (Figure 5.5). The 
other case (26%) was the only subject in which triple-MRA volume (2.27 ml) was 
larger than DSA volume (2.10 ml). This was due to the inclusion on triple-MRA 
volume of an area in the medial aspect of the AVM nidus which appeared 
abnormal on triple-MRA, T1 post-gad and T2 but only slight and diffuse 




Table 5.3. AVM target volumes obtained using the standard DSA method and 
triple-MRA. DSA volume is the radiosurgical target drawn by the clinical team for 
delivery of GKR using 2D projections of DSA into volumetric structural MRI. Triple-
MRA volume includes all areas shown to be part of the AVM nidus on ASL-MRA, CE-
MRA, HD-TOF and volumetric structural MRI. DI is the percentage of DSA volume 
included in triple-MRA volume. DnI is the percentage of triple-MRA volume not 









difference (%) DI (%) DnI (%) CcI 
1 3.03 2.48 (-)18.3 76 7 0.72 
2 8.73 7.21 (-)17.5 71 14 0.63 
3 4.96 4.96 (-)0.05 79 20 0.65 
4 0.56 0.51 (-)10.7 71 20 0.60 
5 3.69 3.29 (-)10.4 71 20 0.60 
6 5.87 5.14 (-)13.2 72 17 0.63 
7 10.77 9.89 (-)8.2 78 15 0.69 
8 1.32 1.07 (-)18.7 71 12 0.65 
9 0.10 0.09 (-)8.1 65 30 0.51 
10 2.10 2.27 7.3 80 26 0.62 
11 0.23 0.21 (-)9.8 74 18 0.64 
12 1.29 1.13 (-)12.7 71 19 0.61 
13 4.20 4.00 (-)4.4 75 20 0.63 







































Figure 5.4. Bland-Altman plot of the difference between DSA and triple-MRA 
volumes.  
 
The mean CcI was 0.63 (95%CI: 60.4 - 66.2; SD: 0.05; median: 0.63; range: 0.51-
0.72). CcI was above 0.6 in all other cases but one in which the discrepancies 
described above also had a considerable effect on CcI (0.52, case 9). There was a 
weak correlation between CcI and AVM volume (rho = 0.54; p = 0.047). This 
was driven mainly by case 9 which was the smallest AVM and also had the lowest 
CcI in the group. Hence, the correlation was not seen if case 9 was excluded 
(rho=0.42; p = 0.15). There was no correlation between CcI and age (p = 0.83), 
Spetzler-Martin grade (p = 0.89) or ASL-MRA phase interval, the latter of which 
can be considered a surrogate for AVM filling velocity (p = 0.61). There was no 
difference on CcI between groups of gender (p = 0.45), previous bleeds (p = 0.45) 
or treatments (p = 0.09), laterality (p = 0.7), AVM location (p = 0.18), 
surrounding brain eloquence (p = 0.36), venous drainage pattern (p = 0.75) and 




The AVM nidus was clearly identified on all three MRA techniques in all but two 
cases.  In one case, the lesion was not seen on ASL-MRA due to the very 
superficial location in the posterior fossa, with the ASL labelled blood losing its 
tagging before reaching the AVM (case 12).  In the other case, shown in Figure 
5.3, it was not possible to visualize the AVM in CE-MRA because the acquisition 
did not include the arrival of gadolinium bolus due to accidental mistiming of the 
injection with respect to the dynamic acquisition. However, both lesions were 
well depicted by the other two MRA sequences, their results in terms of CcI were 
no different to the rest of the cases (p = 0.1) and this was thought to be of no 
consequence for drawing of triple-MRA volumes. Triple-MRA enabled Spetzler-
Martin grading in all subjects. The main arterial feeder was identified with triple-
MRA in all cases but one (case 9) due to the small size of the lesion and the 
overlapping of multiple small vessels on MIP of CE-MRA and ASL-MRA 
(volume: 0.103 ml; maximum diameter: 4 mm; Figure 5.5). Abnormalities of the 
draining veins including varicose dilatation or stenosis were identified in 6 
subjects and intra-nidal aneurysms were seen in 3 cases. Both members of the 
triple-MRA planning team indicated they would feel highly confident delivering 
GKR based on triple-MRA volumes in 43% of the cases. The interventional 
neuroradiologist felt confident in the remaining 57% of the cases while the 
consultant neurosurgeon was confident in 43% and not entirely confident in 14% 
of them (two cases). One of these was the case in which ASL-MRA did not show 
the AVM nidus (case 12). The other was a large AVM (case 14) in which the 
nidus was not clearly visualized on ASL-MRA due to a number of greatly dilated 
veins being embedded in the nidus. Differences between DSA and triple-MRA 
volumes in these two cases were not significantly higher than the rest of the 





Figure 5.5. DSA and triple-MRA volumes in the case with the lowest DI and CcI. 
The DSA volume (orange) and triple-MRA volume (green) at five representative axial 
levels of the AVM in case 9 are shown on HD-TOF, T1 post-gad and T2 weighted MRI 
(first three columns from the left, respectively). The two volumes are also displayed on 
the lateral and AP projections of DSA (last two columns on the right).  Triple-MRA 
volume seems to be more conformal than DSA volume with the AVM ROI delineated on 
2D DSA images (blue contour). During a standard GKR planning session the limits of the 
AVM ROI delineated on 2D DSA are projected into volumetric MRI scans to define an 









Figure 5.6. Case 10, in which triple-MRA volume was larger than DSA volume. The 
top two rows show representative axial levels of the area in the medial aspect of the 
AVM nidus which appeared abnormal (red arrows) on HD-TOF, T1 post-gad and T2 and 
therefore was included on triple-MRA volume (green). Only very slight and diffuse 
vasculature is noted in this area on DSA (third row) and this resulted on DSA volume 
(orange) being smaller than triple-MRA volume in this case. In the bottom row, triple-






This study aimed to prospectively evaluate whether the combination of three 
MRA sequences, namely ASL-MRA, CE-MRA and HD-TOF, could be used as 
an alternative to DSA for visualisation and delineation of brain AVMs for GKR 
targeting. In a group of 14 patients undergoing GKR, the AVM nidus was 
delineated on triple-MRA and compared to the AVM target defined for GKR 
using the current planning paradigm, which is stereotactic intra-arterial DSA and 
volumetric MRI scans on the day of treatment (DSA volume). The use of DSA for 
AVM radiosurgery planning could be abandoned without reservations, if no 
difference whatsoever would have been detected between triple-MRA and DSA 
volumes. That was, however, not the outcome of the study. Triple-MRA volumes 
were on average 10% smaller than DSA volumes. The size difference between 
DSA and triple-MRA volumes was statistically significant and only in one case 
was triple-MRA volume larger than DSA volume (Figure 5.6). On average, 73.5% 
of DSA volume was included in triple-MRA volume and the mean CcI, which is 
the ratio of the intersection and the union of the two volumes, was 0.63.   
The differences observed between triple-MRA and DSA volumes in terms of size 
and concordance could be the result of three elements of the evaluation process. 
First, the use of a different set of images for target delineation, i.e. true volumetric 
triple-MRA instead of projection based DSA, which is the subject of our study. 
Second, the degree of variability inherent to AVM radiosurgery planning, in 
particular inter-observer variability. This is most likely to affect estimates of 
concordance between the volume contours rather than systematically providing 
smaller volumes with one of the methods. However, this defines the best results 
that can be achieved within our study design, in terms of concordance between the 
two volumes, considering that DSA and triple-MRA volumes were delineated by 
two different radiosurgical teams. Third, the uncertainty or error of the co-
registration procedures used to relay information from non-stereotactic images 
(triple-MRA) into the stereotactic GKR system.  
The use of triple-MRA instead of DSA is likely to be the main contributor to the 
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finding of smaller target volumes when delineation is performed on triple-MRA. 
DSA provides only 2-dimensional projections of the AVM nidus and spatial 
information is lost because of dimensional reduction (Colombo et al, 2003). 
Volumes rendered from data with reduced dimensions are likely to be 
overestimated due to superimposition of feeding arteries and draining veins and 
difficulties in determining complex 3D variations on nidus geometry (Huang et al, 
2017). Triple-MRA sequences, on the other hand, are all volumetric acquisitions 
which are thought to enable more refined delineation of complex 3D objects such 
as AVMs (Bednarz et al, 2000). Additionally, the dynamic information provided 
by triple-MRA is likely to improve target delineation by better differentiation of 
AVM components, particularly the distinction between nidus and draining veins 
(Taschner et al, 2007). This is not possible using TOF and standard structural 
MRI only and previous studies have reported that the lack of dynamic information 
in these techniques results in overestimation of the nidus (Buis et al, 2007; Huang 
et al, 2017). The combination of dynamic MR angiography with HD-TOF and 
structural MRI can overcome this issue by showing haemodynamic abnormalities 
specific to the nidus. ASL-MRA, for instance, can be used to reliably identify AV 
shunting which is an unequivocal and defining element of the AVM nidus. 
Because AVMs lack a capillary bed for water extraction to take place, and the 
labelled spins are shunted directly into the venous circulation with minimal transit 
time, signal intensity which is specific to an AV shunt and early draining veins 
can be obtained using ASL (Jang et al, 2014). This can effectively help exclude 
areas that do not have the characteristic flow abnormalities of the AVM nidus and 
therefore should not be included in the target volume, such as draining veins, 
hematoma, stagnated blood or neo-vascularisation tissue (Bednarz et al, 2000). 
ASL-MRA is also a very flexible technique that enables personalised image 
acquisition based on the individual characteristics of each patient. This is a well-
recognised concept in DSA where different frame rates (3 to 7 time points/sec) are 
used depending on the filling velocity of the abnormality. To our knowledge, this 
is the first time individualised timing of MRA acquisition was used for imaging of 
brain AVMs (Figure 5.2). This has enabled us to account for differences in heart 
rate, blood flow and AVM filling velocity between patients which contributed to 
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better discrimination of the AVM nidus and the smaller target volumes found with 
triple-MRA.  
In this study, triple-MRA volume was defined as areas shown to be part of the 
AVM nidus on ASL-MRA, CE-MRA, HD-TOF, post-contrast T1 and T2 
weighted MRI scans, excluding draining veins. This means that only areas that 
were convincingly part of the nidus in all sequences were included. Under these 
conditions triple-MRA does not only pool the strengths of each MRA sequence 
but it also works as a multi-level evaluation system that results in the exclusion of 
areas which do not appear to be consistently part of the nidus. Therefore, decision 
making is not based on a single imaging modality but on several complementing 
sequences, which are individually better suited for assessment of specific aspects 
of an AVM. CE-MRA, for example, is the best sequence for the evaluation of 
draining veins. Figure 5.7 shows how CE-MRA can show the early filling of 
draining veins with a degree of detail that is not far from DSA. This is of great 
importance for planning of GKR of AVMs because radiosurgical targets can be 
overestimated by failing to identify and exclude the draining veins (Buis et al, 
2007). As part of triple-MRA, this specific strength of CE-MRA complements the 
other MRA sequences, i.e., ASL-MRA and TOF. The former has adequate 
temporal resolution to enable depiction of the feeding arteries (Figure 5.8) and the 
latter has a higher spatial resolution but lacks the possibility to discriminate 
between arterial and venous vessels. Therefore, the more refined delineation of 
AVMs on triple-MRA results in smaller volumes compared to the traditional 
planning method based on DSA. 
There is extensive evidence demonstrating that larger AVM volumes result in 
higher rates of both symptomatic and radiological ARE (Cohen-Inbar et al, 2015; 
Kano et al, 2017; Yen et al, 2013). The volume of tissue receiving 12 Gy or more 
is the factor that best correlates with the development of ARE (Flickinger et al, 
2000). Therefore, tighter and more precise delineation of AVM radiosurgical 
targets is a desirable improvement for GKR (Guo et al, 1993; Moosa et al, 2014). 
In terms of obliteration rates, it is not possible to tell from our study if the 10% 
reduction in target size accomplished by using triple-MRA for delineation would 
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affect clinical outcomes. This is because triple-MRA volume in our study was 
obtained for comparison purposes only and GKR was delivered based on the 
standard planning method, i.e. DSA volume. The relatively similar response rate 
reported by GKR centres with different target delineation methods and levels of 
expertise suggests that small differences in target size are unlikely to result in 
reduced response rate (Kano et al, 2012b; Koltz et al, 2013; Starke et al, 2017). 
For instance, before CT and MRI were introduced, treatment planning for AVMs 
was based on DSA only and 3D delineation of radiosurgical targets was not used 
at all (Kemeny et al, 1989; Lunsford et al, 1991). However, their reported two-
years obliteration rates of 70 - 80% were not different from modern GKR 
outcomes. Recent reports of patients treated with GKR using MRI only without 
DSA have showed no difference in obliteration rate (Amponsah et al, 2012) and 
contemporary groups that still do not delineate a radiosurgical target on their 
planning imaging also achieve similar results in terms of obliteration (Levrier et 
al, 2001). Differences in ARE have been noted between these groups, but 
response rates appear to be comparable between them. The improvement of GKR 
planning methods that took place over the last few decades with the introduction 
of CT and/or MRI for planning -alongside DSA- and the technical development of 
planning software, did not increase obliteration rates either. This strongly suggests 
that the 10% reduction in volume target that results from using triple-MRA 







Figure 5.7. CE-MRA and DSA in a study subject with brain AVM. CE-MRA (right) 
has a temporal resolution of 600 ms and it can show the early filling of draining veins 























Figure 5.8. ASL-MRA and DSA in a patient with a brain AVM. The ASL-MRA (left) 
shows the arterial inflow phase with depiction of the AVM nidus and draining veins 
















The differences between DSA and triple-MRA volumes in our study were not 
limited to size, however. There was also a degree of discrepancy between the 
contours which was quantified using DI (73.5%; range: 65 - 80%), DnI (18%; 
range: 7 - 30%) and CcI (0.63; range: 0.51 - 0.72). The fact that triple-MRA 
volumes are smaller than DSA volumes directly affects these parameters but this 
is more likely to be the result of the inter-observer variability inherent to AVM 
radiosurgery planning. In our study triple-MRA and DSA volumes were 
delineated by two different teams to avoid recall bias and it is not possible to 
quantify the degree of uncertainty that this could have added to the results. Inter-
observer variability, which is a well-recognised issue in AVM radiosurgery and 
has been quantified elsewhere (Al-Shahi et al, 2002b; Buis et al, 2005; Sandstrom 
et al, 2014), is important for our study because it defines the best results that can 
be possibly achieved within our study design. Buis et al evaluated the extent of 
inter-observer variation in contouring AVMs on DSA in 31 patients who had 
undergone stereotactic radiosurgery. Six clinicians including two neuro-
radiologists, two neurosurgeons and two radiation oncologists independently 
contoured the nidus on DSA. The reported ratio between the volumes of 
agreement and the corresponding encompassing volumes (CcI) for all possible 
pairs of observers was 0.45 ± 0.18 and it was below 0.6 in 76% of the cases.  It 
dropped to 0.19 ± 0.14 when calculated for all six volumes together (Buis et al, 
2005). In our study, concordance was considerably better and even our worst case, 
which is the only one with CcI below 0.6, did not show as poor a CcI as their 
average estimate. The estimates of inter-observer variability reported by the study 
above are based on AVM target volumes delineated by active radiosurgery 
practitioners and they reflect a degree of uncertainty which is already present in 
standard GKR practice. Sandstrom et al also studied the inter-observer variability 
of AVM delineation for GKR. The case of a 39-year-old male with a lateral 
frontal AVM was delineated by 14 observers including neurosurgeons, radiation 
oncologists and physicists from several GKR centres around the world 
(Sandstrom et al, 2014). Imaging provided for delineation included DSA, TOF, 
T1 post-contrast and T2 weighted MRI. The AVM target volumes produced by 
each observer were compared to a calculated average target (11.86 ml) which was 
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assumed to resemble the true target. They found that only 1.36 ml were common 
to all volumes and their union was as much as 27.2 ml. This resulted in a mean 
CcI of 0.63 (range: 0.24 to 0.81) for all pairs of observations. A mean DI of 78% 
(range: 11 - 93%) can also be inferred from their results. Although the minimum 
CcI and DI observed in our study (0.51 and 65%, respectively) are not as low as 
the ones reported by Sandstrom et al (0.24 and 11%, respectively), their average 
estimates are very similar to ours. It could, therefore, be argued that the 
discrepancies between DSA and triple-MRA volumes noted in our study are in 
effect the expected inter-observer variability rather than unsatisfactory 
performance of triple-MRA for AVM target delineation. Yet, delineation of 
AVMs on triple-MRA resulted in consistently smaller AVM volumes (10%) and 
this is directly reflected by estimates of inclusion and concordance. However, the 
differences in size between DSA and triple-MRA in our study volumes were 
nowhere as large as volume differences described by Sandstrom et al (3.48 – 
21.05 ml) and even with this extra uncertainty, the contour discrepancy between 
DSA and triple-MRA volumes in our study was not bigger than the expected 
degree of inter-observer variability. If anything, concordance between triple-MRA 
and DSA volumes is better than the inter-observer variability reported by Buis et 
al using DSA. 
Satisfactory delineation of AVM target volumes without the use of DSA has been 
previously suggested for selected AVM cases (Buis et al, 2007; Taschner et al, 
2007; Yu et al, 2004). Yu et al assessed the feasibility of AVM delineation on 
MRI only for GKR and concluded that it was adequate for cases with non-diffuse 
and large non-embolised AVMs (Yu et al, 2004). Buis et al concluded that TOF 
angiography might be used as the sole imaging modality for radiosurgical 
treatment of AVMs  < 3 ml if they were located in non-eloquent areas (Buis et al, 
2007). Most GKR practitioners probably also remember cases of small, compact 
and non-eloquent AVMs which they felt could be accurately delineated and 
treated using MRI/MRA without a DSA. In our study, we did not identify any 
convincing variable affecting the quality of target delineation on triple-MRA. The 
case with the poorest concordance between triple-MRA and DSA volumes in our 
series was also the smallest and this resulted in a weak correlation between AVM 
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volume and CcI. We do not believe that triple-MRA volume in this case was 
inferior in quality compared to DSA volume and if anything, triple-MRA volume 
seemed to be more conformal with the AVM ROI delineated on 2D DSA images 
(Figure 5.5). The correlation between AVM volume and CcI in fact disappeared if 
that case was excluded from the analysis. A review of the case with the second 
most significant discrepancy between DSA and triple-MRA volumes also failed to 
reveal a specific factor to explain the differences (case 10). In this case triple-
MRA volume was 0.17 ml larger than DSA volume (2.27 vs 2.10 ml) due to the 
inclusion of an area in the medial aspect of the AVM nidus which appeared 
abnormal on triple-MRA, T1 post-gad and T2 but only slight and diffuse 
abnormal vasculature is noted on DSA (Figure5.6). In this case, 80% of DSA 
volume was included on triple-MRA and CcI was still above 62%. Exactly what 
constitutes the AVM nidus in this case is open to interpretation but it is not 
unreasonable to say that these two volumes will most likely result in similar 
clinical outcomes.   
Some of the studies mentioned above have also looked at the effect that AVM 
delineation without DSA has on treatment dosimetry (Bednarz et al, 2000; Buis et 
al, 2007). The original treatment plans developed using DSA were used as a 
reference for comparison and for this reason the results of these analyses mostly 
reflected the volumetric differences of the targets in question. The use of triple-
MRA instead of DSA will still follow the current planning philosophy of 
delineating the margin of the vascular lesion and then working on conformal 
coverage. As a result, dosimetric variations should be proportional to volumetric 
differences. We are aware, however, that adequate treatment conformity (i.e., 
coverage, selectivity and conformity indices) can be more challenging to achieve 
if the target outline is less smooth, which can be the case of AVM volumes 
delineated using triple-MRA. 
The use of triple-MRA as an alternative to DSA for AVM radiosurgery planning 
relies on the development of tools and software capable of integrating 
multimodality 4D data into the planning procedure.  This is still to be 
accomplished and currently available software could be greatly improved by 
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implementing co-registration of dynamic sequences and by enabling the 
visualisation of delineated targets on 4D datasets such as CE-MRA and ASL-
MRA. In our study, we relied on a series of co-registrations of the individual time 
points of the dynamic sequences, which is a potential source of uncertainty 
affecting the comparability of triple-MRA and DSA volumes. To minimise 
uncertainty, all co-registrations were validated using intracranial arteries as 
landmarks by assessing their overlap in all three orthogonal planes. Also, HD-
TOF was used as a common dataset in all co-registration pairs, so that it worked 
as a central link between all sequences avoiding a chain of co-registrations with 
cumulative and transferable co-registration errors.  Two critical co-registration 
procedures were performed. First, the co-registration between triple-MRA 
sequences to enable their combined use for delineation of triple-MRA volume. 
This was accomplished with Brainlab elements merging tool (multimodal rigid 
image registration with cranial distortion correction). The accuracy of co-
registration quoted by the manufacturer is below 1 mm within the intracranial 
cavity for typical multimodality registrations (Brainlab, 2011; 2017). Second, the 
co-registration between non-stereotactic HD-TOF and stereotactic MRI which 
was performed to transfer triple-MRA volume to the stereotactic system. The use 
of triple-MRA for radiosurgery planning with currently available technology is 
based on this co-registration step which we performed using GammaPlan. Co-
registration of non-stereotactic MRI or CT imaging has long been integrated into 
GKR planning. Diagnostic MRI taken prior to GKR is frequently used for 
treatment pre-planning and on the treatment day dose planning is completed by 
co-registering them with the stereotactic MRI or CT (with the frame). The 
geometrical accuracy of this procedure has been independently demonstrated in 
both phantom and clinical studies, using multi-modality co-registration, and the 
mean error of coordinates between images were consistently < 1 mm (Cernica et 
al, 2006; Nakazawa et al, 2014c). We selected HD-TOF to transfer triple-MRA 
into the GKR planning software because it has the best spatial resolution; 
however, it was co-registered to a different sequence dataset, i.e., a structural T1 
weighted MRI scan. The quality of co-registration is known to improve if two 
datasets of the same kind are used (Nakazawa et al, 2014c). Therefore, if triple-
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MRA is to be used in clinical practice two post-contrast T1 weighted MRI scans 
with the same spatial resolution (preferably submillimetre) should be used for this 
co-registration step. This was not possible in our study because of the ethical 
considerations of giving a second injection of gadolinium for research purposes 
within such a short period of time.  
The use of triple-MRA for AVM radiosurgery adds freedom to the planning 
procedure by enabling the analysis of the AVM architecture in advance. This 
removes time constraints and team pressure that result from the frame being fitted 
to the patient while the treatment plan is developed using the traditional DSA 
based method. This also gives the opportunity to make arrangements for DSA in 
case triple-MRA images are deemed not optimal for targeting by the radiosurgical 
team. ASL-MRA and CE-MRA sequences have not yet been assessed and 
optimised for acquisition with the stereotactic Leksell frame G and distortion 
issues have been described with 3 T acquisitions using the stereotactic frame 
(Nakazawa et al, 2014d). For this reason, triple-MRA was performed before the 
day of GKR. We see as an advantage the opportunity to plan the treatment in 
advance; however, some radiosurgery planners may not be comfortable delivering 
GKR based on angiographic images not acquired on the same day of treatment. 
There is no reason why triple-MRA could not be performed on the same day, 
apart from limited time for triple-MRA post-processing and co-registration, but 
also structural remodelling of AVMs which is known to be a slow process is 
unlikely to significantly alter AVM structure over short periods of time (da Costa 
et al, 2009). We arbitrarily suggest that triple-MRA should be acquired within 
days, one week maximum before GKR unless the patient presents with symptoms 
suggestive of intracranial bleed in which case triple-MRA should be repeated. 
In terms of aspects of the study that could be improved, the analysis of a larger 
number of subjects may have identified subgroups of patients, or AVM features, 
with extremes of concordance between DSA and triple-MRA volumes. This 
would have been useful for case selection in future phases of clinical 
implementation. For instance, previous embolization has been repeatedly 
described as a confounder on AVM target delineation but in our study 
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concordance between DSA and triple-MRA volumes in previously embolised 
patients was not significantly different from previously untreated cases. Our 
group, however, included only three patients with history of embolization and the 
performance of triple-MRA for planning of cases with previous embolization may 
need further attention. The quantification of accuracy of co-registration could 
have helped to establish how much of the observed discrepancy between triple-
MRA and DSA volumes was caused by the use of different imaging techniques, 
as opposed to other technical factors. Inter-observer variability could have also 
been removed from our study design if both triple-MRA and DSA volumes were 
delineated by the same radiosurgical team. This, however, would have resulted in 
the introduction of recall bias which is more difficult to quantify and could have 
undermined the validity of the results. Potential improvements of the MRA 
sequences include the use of vessel selective acquisition of ASL-MRA which 
could help to avoid vessel superposition issues on MIP and improve 
characterisation of feeding patterns (Chng et al, 2008; Fujima et al, 2016; Lindner 
et al, 2015). The improved spatial resolution of HD-TOF in our study was 
achieved through a compromise between coverage and acquisition time and to this 
end FOV was reduced to 50 mm in the cranio-caudal direction. This may require 
altering for planning of large AVMs that are not fully covered by this tight FOV. 
The arrival of contrast agent was not detected by CE-MRA in one of the patients 
due to accidental mistiming of the manual gadolinium injection with respect to the 
dynamic acquisition. This could be improved by the use of an automatic injection 
pump which results in more consistent boluses and more reproducible injection 
rates. Future phases of clinical implementation should include thorough and long-
term follow-up in order to ascertain if planning of GKR using triple-MRA instead 
of DSA affects treatment outcomes, i.e. obliteration rates and ARE.   
The development of GKR as a treatment for brain AVMs was historically 
accomplished using DSA and the radiosurgical community have a very high level 
of confidence in DSA, which is still considered the reference standard method for 
treatment planning. This has contributed to the limited and hesitant use of MRA 
as an alternative to DSA in radiosurgery. For that reason, the members of the 
multidisciplinary team drawing AVM volumes on triple-MRA were asked how 
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confident they would feel about delivering GKR based on triple-MRA volume. 
Reassuringly, they stated that they would feel highly confident or confident 
delivering GKR based on triple-MRA volume in 100 and 86% of the cases 
(interventional radiologist and consultant neurosurgeon, respectively). This is an 
encouraging finding which can help promote the use of less invasive imaging 
methods for AVM patients.  
5.6 Conclusions 
The technical feasibility of using triple-MRA, instead of DSA, for visualisation 
and delineation of brain AVMs for GKR targeting has been demonstrated. Target 
volumes obtained using triple-MRA are on average 10% smaller than AVM 
targets obtained with the standard DSA planning method which can potentially 
reduce the risk of ARE. More than 70% of the volume identified as AVM nidus 
with the standard DSA planning method was also included in the triple-MRA 
volume. The discrepancies between triple-MRA and DSA volumes are less than 
the inter-observer variability observed when an AVM target is delineated by 
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6.1 Abstract 
Introduction: DSA is the reference standard for confirmation of obliteration 
following GKR of brain AVMs, due to suboptimal diagnostic accuracy of 
standard MR angiography. However, DSA is invasive and it carries a potential 
risk of complications. This study aims to evaluate whether a combination of three 
MRA sequences, referred to as triple-MRA, can be used as an alternative to DSA 
to confirm AVM obliteration following GKR and to characterise residual AVMs 
in case of incomplete response. 
Methods: Thirty patients undergoing DSA for confirmation of obliteration 
following GKR for AVMs also underwent triple-MRA including ASL-MRA, HD-
TOF and CE-MRA. The DSA and triple-MRA were independently and blindly 
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evaluated by two observers regarding the presence/absence of a residual AVM. 
The Spetzler-Martin grading system was used to grade residual lesions on both 
imaging modalities. Sensitivity, specificity, negative and positive predictive value 
of triple-MRA for confirmation of AVM obliteration are reported. Diagnostic 
accuracy of triple-MRA was evaluated using ROC curve analysis and kappa (k) 
coefficient was used to measure agreement between DSA and triple-MRA.  
Results: Mean time between GKR and follow-up DSA/triple-MRA was 53 
months (95%CI: 42 - 64; range: 22 - 168). One patient was excluded due to 
suboptimal imaging quality. Total triple-MRA scanning time was 18:11min. 
Triple-MRA demonstrated AVM obliteration in 20 patients and a residual AVM 
was detected in 9 subjects by both observers (obliteration rate: 69%). This was in 
complete agreement with the interpretation of DSA. Triple-MRA showed 
complete sensitivity and specificity for confirmation of obliteration with 
maximum positive and negative predictive value (100%). ROC analysis 
confirmed complete diagnostic accuracy with an area under the curve of 1 (p < 
0.001) and kappa agreement between DSA and triple-MRA was 1 for both 
observers (p < 0.001). 
All nine residual AVMs were identified by both observers on at least two MRA 
sequences. CE-MRA failed to show the residual lesion in two cases and ASL-
MRA in one (false positive rate: 11% and 5%, respectively). There was complete 
agreement on size and drainage scores between triple-MRA and DSA for both 
observers in all residual lesions (kappa = 1; p < 0.003). Poor agreement was 
observed between eloquence scores on DSA and triple-MRA due to the 
limitations of DSA (2D) in terms of anatomical localization. 
Conclusion: Triple-MRA consistently demonstrated/ruled out residual AVMs in 
patients who had undergone GKR for brain AVMs. It provides optimal sensitivity 
and specificity for confirmation of obliteration following GKR compared to DSA 
and it can also be reliably used for characterisation of residual AVMs. 
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6.2 Introduction  
AVMs are congenital vascular abnormalities characterised by anomalous 
connections between arteries and veins leading to arteriovenous shunting through 
a network of coiled and tortuous vessels, the so-called nidus (Hernesniemi et al, 
2008). Brain AVMs most commonly present with spontaneous intracranial 
haemorrhages and they are a potential source of neurological morbidity and 
mortality due to the life-long risk of bleeding if left untreated (1.5 - 4.0% per 
year) (da Costa et al, 2009; Stapf et al, 2006). GKR is a well-established 
minimally invasive treatment for selected patients with brain AVMs (Mohr et al, 
2013; van Beijnum et al, 2011).  It produces a detectable decrease in blood flow 
through the AVM nidus a few months after treatment which gradually progresses 
so that by two to three years approximately 75% of the AVMs are completely 
obliterated (Koltz et al, 2013). The risk of intracranial bleed persists until 
complete obliteration of the nidus is achieved and for this reason it is imperative 
to confirm AVM cure after treatment (Kano et al, 2013).  
Intra-arterial DSA has been traditionally used for confirmation of obliteration 
following GKR and it is currently considered the reference standard for detection 
and characterization of AVMs, due to the limited spatial and temporal resolution 
of other vascular imaging techniques (Giesel et al, 2010; Khandanpour et al, 
2013; Lee et al, 2015; Soize et al, 2014). Most GKR centres around the world use 
regular MRI and MRA for follow-up (every 6 or 12 months) but patients still 
undergo DSA to confirm cure a few years after treatment; usually once 
obliteration is suggested by MRI/MRA (Pollock et al, 2016; Starke et al, 2017). 
Although widely used, DSA conveys some risk of complications (Bendszus et al, 
1999). Kaufmann et al reported the complication data of 19826 consecutive 
patients undergoing DSA from 1981 to 2003 and reported neurological 
complications in 522 examinations (2.63%). Twenty-seven of these (0.14%) were 
strokes with permanent disability, twelve deaths occurred (0.06%) and access site 
hematoma (4.2%) was the most common complication overall (Kaufmann et al, 
2007). DSA also exposes both patients and medical staff to ionizing radiation and 
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it carries a risk associated with injection of iodinated contrast agents. 
Furthermore, it is an unpleasant experience for patients due to pain, invasiveness 
and prolonged bed rest after the procedure (Fifi et al, 2009). Finally, the cost 
associated with DSA examinations can also be significant. 
The potential to improve follow-up procedures after GKR by using less invasive 
imaging methods has been described elsewhere and important attempts have been 
made using MRA as an alternative to DSA (Buis et al, 2012; Lee et al, 2015; Lim 
et al, 2012; Soize et al, 2014). Lee et al retrospectively reviewed the MRI and 
TOF MRA of 136 patients who had undergone GKR and reported a sensitivity of 
76-85% and specificity of 89-95% compared to DSA (Lee et al, 2015). Similarly, 
poor results in terms of sensitivity had been previously published by Buis et al 
using 3D TOF only (Buis et al, 2012).  Lim et al reported good sensitivity for 
confirmation of AVM obliteration (above 90%) using contrast-enhanced (CE) 
time-resolved MRA but the specificity fell short of 80% which was prospectively 
replicated by Soize et al (Lim et al, 2012; Soize et al, 2014). The studies above 
concluded that individually, TOF and CE-MRA have good diagnostic accuracy 
and their inclusion on standard follow-up protocols was supported; however, due 
to the suboptimal sensitivity and specificity they recommended that DSA should 
still be performed to confirm AVM obliteration. 
MR vascular imaging has continued to develop with the optimisation of MRA 
sequences at higher field strengths and the combination of parallel imaging with 
intelligent sampling of the k-space, which has resulted in higher spatial resolution 
and sub-second temporal resolution (Chang et al, 2015; Hadizadeh et al, 2011). 
Also, the introduction of ASL based angiography has allowed the acquisition of 
time-resolved cerebral angiography with temporal resolution comparable to that 
of DSA (100 - 200 ms), without the administration of contrast agents (Lindner et 
al, 2015; Suzuki et al, 2017; Wu et al, 2013). ASL-MRA has already proved to be 
useful for non-invasive assessment of cerebral AVMs, providing dynamic 
information of flow and angio-architecture which had not been previously 
obtained with MRA (Fujima et al, 2016; Iryo et al, 2016). 
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None of currently available angiography sequences has been shown to reliably 
confirm/rule out the presence of residual AVMs in patients treated with GKR. 
They differ in terms of spatial and temporal resolution and rely on different 
contrast mechanisms to depict the unpredictable and heterogeneous structure and 
flow observed in AVMs. We hypothesise that the combined use of TOF, CE and 
ASL MRA results in optimal sensitivity and specificity for detection of residual 
AVMs. This study aims to evaluate whether the combination of these three MRA 
sequences, referred to as triple-MRA, can be reliably used as an alternative to 
DSA for confirmation of AVM obliteration after GKR and to characterise residual 
AVMs in cases with incomplete response.  
6.3 Methods  
6.3.1 Patients 
Thirty consecutive adult patients undergoing DSA for confirmation of obliteration 
following GKR of brain AVMs at University Hospital of Verona between 
November 2014 and December 2016 were prospectively recruited. The decision 
to perform a follow-up DSA had been independently made by the clinical 
multidisciplinary team before recruitment and all participants gave written 
consent for a triple-MRA to be performed on the same day of DSA. The study 
was approved by London Queen Square Research Ethics Committee (UK) and 
Verona and Rovigo Ethics Committee for Clinical Research (Italy) (Appendix 4). 
Patients unable to tolerate MR imaging without sedation/anaesthesia and those 
with altered renal function (eGFR > 30 ml/min) were excluded. Inability to 
consent, pregnancy, history of allergic reaction to gadolinium based contrast 
agents and contraindication to MRI (i.e., pacemakers, metallic implants, etc.) 
were also exclusion criteria. 
Table 6.1 shows the demographic details and AVM characteristics of the study 
subjects. The mean age was 37y (range: 18 - 69) and 66% of participants were 
female. The mean AVM volume at the time of GKR was 7.01 ml (range: 0.07 - 
50.54; SD: 9.8) and the AVMs were well distributed across the head anatomy 
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with nine AVMs being located in the temporal lobe, six in the frontal lobe, six 
parietal and three occipital. Four were deep seated (basal ganglia or brainstem) 
and two were located in the posterior fossa. Ten patients (33.3%) had undergone 
glue embolization and 3 (10%) microsurgical resection before GKR. One of them 
had received GKR twice for the same AVM. No patients presented with 
intracranial bleeds or received further treatments after GKR. 
 
Table 6.1. Demographic details and AVM characteristics of the study subjects.  
Age mean (min - max) 37 y (18 - 69) 
Female, % 66% 
AVM location, n 
(%) 
Temporal 9 (30%) 
Frontal 6 (20%) 
Parietal 6 (20%) 
Occipital 3 (10%) 
Basal 
ganglia/brainstem 4 (13%) 




AVM volume mean (min - max) 7.01 ml (0.07 - 50.54) 
GKR,  
mean (min - max) 
Dose 17 Gy (11 - 22) 
Percentage isodose 50% 
Mean time post-GKR (min - max) 53 mo (22 - 168) 
 
6.3.2 MRA imaging 
Triple-MRA included 4D ASL-MRA, HD-TOF and CE-MRA. They were 
acquired using an 8-channel head-coil on an Achieva 3.0 T MRI system (Philips 
Healthcare Systems, Best, The Netherlands) and the scanning parameters are 
shown in Table 6.2. Total triple-MRA scanning time was 18:11min. 
ASL-MRA labelling was performed with the STAR method and a labelling slab 
of 300 mm positioned 20 mm below the imaging plane (Nakamura et al, 2012). 
The echo-planar imaging (EPI) acceleration method (Suzuki et al, 2017) enabled 
the acquisition of 8 dynamic phases with a temporal resolution of 200 ms and six 
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minutes’ acquisition time. HD-TOF was based on a 3D T1 fast-field echo (FFE) 
acquisition (RF-spoiled, gradient echo) with flow compensation and TONE across 
the slab (Wrede et al, 2014). Four slabs covering 50 mm in the cranio-caudal 
direction were obtained with a parallel imaging SENSE factor of 2. CE-MRA 
included 24 dynamic sagittal acquisitions using a 3D, T1 weighted, FFE 
sequence. A reference scan was acquired before contrast injection for subtraction 
of the stationary tissue and dynamic sampling was started at the time as the 
injection. The fast dynamic acquisition used CENTRA and the keyhole method 
with 20% of the k-space collected per keyhole frame (Willinek et al, 2008). 
SENSE was employed with a reduction factor of 4 in the phase-encoding 
direction and 2 in the slice-encoding direction achieving a temporal resolution of 
608 ms/phase. An intravenous injection of 0.1 ml/kg of Gadobutrol 1.0 mmol 
(Gadovistâ; Bayer plc, UK) was given with an automated power injector at a 
flow rate of 3.5 ml/s and it was followed by 20 ml of normal saline flush injected 
at the same flow rate.  
MIPs of the individual MRA sequences were generated in the orthogonal planes 
(anteroposterior, lateral and cranio-caudal) and transferred to OsiriX DICOM 
viewer 8.4 (Pixmeo Sarl, Switzerland) for assessment.  
6.3.3 DSA imaging 
DSA was performed under local anaesthesia using a AlluraXper biplane 
angiography system (Philips Healthcare Systems, Best, The Netherlands) and 
iodinated contrast agent (Iohexol, Omnipaque, 240 mg/ml). A femoral artery 
approach was used for selective contrast injection of one or several vessels known 
to supply the previously treated AVM. DSA was performed at a rate of 3-7 





Table 6.2. Scanning parameters of triple-MRA sequences.  
Parameter ASL-MRA HD-TOF CE-MRA 
MRA type Dynamic Single time point Dynamic 
Scan duration (min:sec) 5:58  08:54 3:19 
Contrast 
Scan mode 3D 3D 3D 
Acquisition T1 TFEPI T1 FFE T1 FFE 
TR (ms) 12 25 3 
TE (ms) 5  3 1 
Flip Angle 10 20 25 
Resolution 
FOV (RL x AP x CC, mm) 210 x 210 x 90 250 x 250 x 50 150 x 210 x 210  
Acquisition transversal  transversal sagittal 
Slabs 1 4 1 
Acquisition matrix  172 x 172 x 70 832 x 568 x 50 50 x 248 x 248 
Acquired voxel size (mm) 1.22 x1.26 x 1.3 0.3 x 0.44 x 1 3 x 0.85 x 0.85  
Reconstruction matrix 256 x 256 1936 x 1936 288 x 288 
Rec voxel size (mm) 0.82 x 0.82 x 0.65 0.13 x 0.13 x 0.5 1.5 x 0.73 x 0.73  
Number of slices 140 100 100 
SENSE factor  2.5/1 2/1 4/2 
Dynamic acquisition 
Dynamic imaging mode TFEPI - CENTRA keyhole 
Number of phases 8 - 24 
Phase interval 
(temporal resolution) 200 ms - 608 ms 
Label delay 200 ms - - 
Contrast - - 
Gadovist 0.1ml/Kg                  









6.3.4 Data analysis 
DSA and triple-MRA were evaluated by two independent observers regarding the 
presence/absence of a residual AVM (Appendix 5). The observers were a 
neuroradiologist with 13 years of experience (FBP) and an interventional neuro-
radiologist with 15 years of clinical practice (TS). They were blinded to patient’s 
demographics, date of examination, previous clinical assessment and reports. The 
anonymized DSA and triple-MRA examinations were randomly numbered and 
reviewed in different sessions to prevent reporting bias. In order to simulate the 
clinical scenario in which assessment of cerebral angiographies is aided by pre-
existing knowledge of size and location of treated AVMs, the observers had 
access to anonymized images of the stereotactic DSA and post-contrast T1 MRI -
performed on the day of GKR- for comparison with follow-up DSA and triple-
MRA, respectively. Figure 6.1 shows a representative example of the datasets 
available to the observers for evaluation. The observers also reported which of the 
MRA sequences showed the lesion in cases with residual AVMs and this enabled 
the calculation of specificity and false positive rate for individual MRA 
sequences. 
AVM obliteration was defined as the complete absence of a nidus and 
arteriovenous shunt (early-filling draining veins). The Spetzler-Martin grading 
system (size: < 3 cm, 3 - 6 cm and > 6 cm; venous drainage: deep vs superficial 
only; eloquence of adjacent brain: eloquent vs. non-eloquent) was used to grade 
residual lesions on both imaging modalities (Spetzler & Martin, 1986). Further 
characterisation of residual AVMs included the identification of feeding arteries 
and draining veins. The quality of triple-MRA was evaluated in regards to 
artefacts that could have affected the quality of radiological assessment. Vessel 
visualization was assessed for each MRA sequence using a five-point categorical 
scale (poor, fair, good, very good, excellent).  The observer’s level of confidence 
on their assessment of the absence/presence of a residual AVM on DSA and 
triple-MRA was reported using a three-point categorical scale (not entirely 






Figure 6.1. Representative example of DSA and triple-MRA datasets presented to 
the independent observers for review in a case with complete AVM obliteration. 
DSA (top row) and triple-MRA series (C-E) were reviewed in different sessions. The 
stereotactic DSA performed on the day of GKR (A, note fiducial crosses) was available 
to the observers and it served as an aid for the assessment of follow-up DSA (B). 
Similarly, the stereotactic T1 MRI with contrast (C, note stereotactic fiducial markers) 
was used as a guide for the evaluation of triple-MRA, which included HD-TOF (D), CE-











The sensitivity, specificity, negative predictive value (NPV) and positive 
predictive value (PPV) of triple-MRA for detection of AVM obliteration were 
calculated. Sensitivity was defined as the probability of confirming obliteration on 
triple-MRA among those cases demonstrating complete obliteration on DSA. 
Specificity was the probability of finding a residual AVM among those with a 
residual on DSA. PPV was the percentage of cases with complete obliteration on 
triple-MRA and in whom this was confirmed on DSA. NPV was the percentage of 
patients found to have a residual AVM on triple-MRA and in whom this was 
confirmed on DSA. Additionally, the diagnostic performance or accuracy of 
triple-MRA, as well as individual MRA sequences, to discriminate between 
patients with residual AVMs and complete obliteration was evaluated using 
Receiver Operating Characteristic (ROC) curve analysis (Metz, 2008). For 
interpretation of ROC analysis 1 is complete agreement while 0 denotes no 
agreement other than what would be expected by chance. Weighed Cohen’s kappa 
(k) coefficient was calculated to measure agreement between DSA and triple-
MRA for obliteration and Spetzler-Martin grade for each observer (Chng et al, 
2008). k was interpreted as follows: k ≤ 0.20 = poor; k = 0.21-0.40, fair; k = 0.41-
0.60, moderate; k = 0.61 – 0.80, good; k = 0.81 – 0.90, very good; and k ≥ 0.91, 
excellent (Machet et al, 2012). Statistical significance was defined as a p value of 
< 0.05 and analyses were performed using the Statistical Package for the Social 
Sciences (SPSS Statistics, Version 23. IBM Corp).   
6.4 Results 
6.4.1 Confirmation of AVM obliteration 
The mean time between GKR and follow-up DSA/triple-MRA was 53 months 
(95%CI: 42-64; range: 22-168). In one case the AVM region of interest was not 
included in the HD-TOF field of view and arrival of contrast agent was not 
detected by CE-MRA due to mistiming of the gadolinium injection with respect to 
the dynamic acquisition. This case was excluded and final statistical analysis 
included 29 patients. 
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Triple-MRA demonstrated AVM obliteration in 20 patients and a residual AVM 
was detected in 9 subjects by both observers, which resulted in an obliteration rate 
of 69%. This was in complete agreement with both their own interpretation of 
DSA as well as the clinical reports produced by the interventional radiologist who 
performed the DSA procedure. Triple-MRA showed 100% sensitivity and 
specificity for confirmation of obliteration of brain AVMs with maximum 
positive and negative predictive value. ROC analysis demonstrated complete 
diagnostic accuracy of triple-MRA for confirmation of obliteration, with an area 
under the curve of 1, p < 0.001(Figure 6.2). The weighted Cohen’s kappa 
coefficient for obliteration status between DSA and triple-MRA was 1 (p < 0.001) 
for both observers.  
 
 
Figure 6.2. Diagnostic accuracy (ROC curve) of triple-MRA and individual MRA 
sequences for confirmation of AVM obliteration following GKR.  





Table 6.3 shows the interpretation of individual MRA sequences including their 
specificity, PPV and false positive rate. This is based on whether residual AVMs 
were visualised on individual MRA sequences during triple-MRA assessment 
rather than an entirely independent evaluation of each sequence. All residual 
AVMs were detected by both observers on HD-TOF which had the best 
specificity of all three MRA sequences. In two cases the residual lesion was 
detected on ASL-MRA and HD-TOF but not on CE-MRA due to the very small 
size of the residual lesion in one (6 mm, Figure 6.3) and the diffuse nature of the 
residual AVM nidus in the second case. In one patient, the residual AVM was 
identified in all three MRA sequences by one observer but it was reported as not 
detectable on CE-MRA by the other. This resulted on a 11-17% false positive rate 
for CE-MRA which also showed the lowest specificity of all three MRA 
sequences (67-78%). ASL-MRA failed to show the residual AVM in the case 
presented in Figure 6.4g. The ROC area under the curve for the MRA sequences, 
i.e., HD-TOF, ASL-MRA and CE-MRA, was 1, 0.94 and 0.83-0.89, respectively. 
 
Table 6.3. Confirmation of obliteration with triple-MRA and DSA following 










Observer 1 and 2c 1 and 2c 1 and 2c 1 2 
Obliterated 20 20 (+1)a 20 18 (+5)b 17 (+5)b 
Residual 9 8 9 6 7 
Response rate 69% 71% 69% 75% 71% 
Specificity - 89% 100% 67% 78% 
PPV - 95% 100% 83% 89% 
False positives  
n (rate) - 1 (5%) 0	 (3) 17% (2) 11% 
 
a ASL-MRA was not available in one patient in whom DSA showed complete 
obliteration.  
b Arrival of contrast on CE-MRA was not depicted in 5 subjects, in whom DSA 
demonstrated complete obliteration, due to accidental mistiming of the gadolinium 
injection with respect to the dynamic acquisition. 
c Same results obtained by both observers. 
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6.4.2 Characterisation of residual AVMs in cases of incomplete 
response 
Table 6.4 shows the interpretation of DSA and triple-MRA regarding Spetzler-
Martin grading of residual AVMs by both observers. The kappa coefficient -of 
agreement- between DSA and triple-MRA for Spetzler-Martin grade was 0.85 (p 
< 0.001) for the first observer and 0.55 (p = 0.004) for the second due to 
disagreements on the eloquence part of the grading system. There was complete 
agreement on size and drainage scores between triple-MRA and DSA for both 
observers in all nine residual lesions (kappa = 1; p < 0.003). Different eloquence 
scores on DSA and triple-MRA were noted in one case for the first observer 
(kappa = 0.78; p < 0.016) and in three cases for the second observer (kappa = 
0.31; p = 0.34). This was the result of limited anatomical localization on DSA 
images (2D) compared to triple-MRA as follows. In the first case a residual AVM 
located on the left cerebellar peduncle was incorrectly considered as non-eloquent 
on DSA by the first observer. Observer 2 considered the left frontal residual AVM 
shown in Figure 6.3 and a residual lesion located in the right temporo-parietal 
lobe to be in eloquent areas on DSA but their assessment on triple-MRA 
demonstrated non-eloquent location. Also, a temporo-parietal residual AVM was 
considered to be non-eloquent on DSA by the second observer but triple-MRA 
demonstrated its eloquence (Wernicke’s area). There was no difference on the 
assessment of eloquence of the affected brain using triple-MRA between the two 
observers in all cases. 
Observer 1 identified a total of 14 feeding arteries and 13 draining veins both on 
DSA and triple-MRA. Observer two identified 17 feeding arteries and 15 draining 
veins on DSA but only 15 and 12 on triple-MRA, respectively (Table 6.4). The 
same blood vessel was identified by both observers as the main feeding artery on 
DSA and triple-MRA for eight out of nine residual AVMs. In one case, observer 1 
named the superior cerebellar artery as the only feeder on DSA and the posterior 
cerebral artery on triple-MRA, while observer 2 named the same feeding vessels 
but in the opposite set of investigations, i.e. superior cerebellar artery on triple-





Figure 6.3. Representative case of confirmation of AVM obliteration using triple-
MRA. The pre GKR DSA (A) and MRI (B) showed two AVM nidi (blue arrows) at the 
time of GKR in a patient with previous partial surgical excision of a ruptured AVM. The 
most lateral nidus is not identified in post GKR imaging; however, a residual of the most 
medial nidus (red arrow heads) is identified in post GKR HD-TOF (D) and ASL-MRA 
(E). These findings are confirmed by post GKR DSA (C). The small size of the lesion 














The characterisation of residual AVMs in terms of size, location and 
feeding/draining vessels relied on the combined use of all three MRA sequences. 
Figure 6.4 demonstrates how each of the sequences provided relevant details of 
the angio-architecture and flow dynamics of the nidus and enabled complete 
characterisation of the AVM in two representative cases. The location and size of 
the AVM nidus in the first case (right occipital residual AVM, 4A-D) are 
demonstrated on HD-TOF, while the dynamic MRA sequences confirmed blood 
supply from the middle meningeal artery (ASL-MRA) and venous drainage 
through the superficial system only (CE-MRA).  The combination of three MRA 
sequences was also important in cases where one of them failed to show the 
residual AVM as shown in the second case in Figure 6.4e-h.  
 
Table 6.4. Characterisation of residual AVMs using triple-MRA compared to 
DSA. 
 
Observer 1 Observer 2 
DSA t-MRA DSA t-MRA 
SMS 
Size 
< 3 cm 7 7 7 7 
3-6 cm 2 2 2 2 
> 6 cm - - - - 
Drainage 
Superficial only 5 5 5 5 
Deep 4 4 4 4 
Eloquence 
Non-eloquent 5 4 3 4 
Eloquent 4 5 6 5 
Feeding arteries 14 14 17 15 








6.4.3 Image quality and reporting level of confidence 
The most common issue affecting image quality was failure to depict the arrival 
of contrast agent on CE-MRA due to mistiming of the gadolinium injection with 
respect to the dynamic acquisition. This occurred in six cases but was found to 
significantly affect the quality of the radiological assessment only in one patient 
(excluded) in whom HD-TOF was also unsatisfactory due to the AVM region of 
interest not being included in the acquired volume. In the remaining five cases, 
the other two MRA sequences were optimal in terms of acquisition and image 
quality and they provided a good degree of confidence for confirmation of 
obliteration. ASL-MRA was not available in one patient due to a temporary 
failure of the scanner software. All cases with incomplete triple-MRA datasets 
(i.e. missing ASL-MRA or CE-MRA) were subjects in whom complete 
obliteration was demonstrated on DSA. A blood vessel doubling or “ghosting” 
artefact was observed on the ASL-MRA sequence in the majority of cases. This 
affected mainly the larger vessels of the circle of Willis and was more evident in 
the AP direction. This artefact was thought to be of no consequence for the quality 
of the radiological assessment. Minor motion artefacts were observed in two 
patients, affecting mainly the CE-MRA acquisition.  
Vessel visualization on HD-TOF was reported as very good or excellent in 96 and 
90% of the cases by observer 1 and 2, respectively. They also considered vessel 
visualisation to be good or very good in more than 90% of the patients for ASL-
MRA and 80% for CE-MRA. There was no difference in the observer’s level of 
confidence on the assessment of triple-MRA and DSA regarding the 






Figure 6.4. Combined use of three MRA sequences for identification and 
characterisation of residual AVMs in two representative cases.  The DSA (A) and 
HD-TOF (B) of the first case demonstrates a residual < 3 cm in diameter AVM nidus 
(yellow arrow) located on the right occipital lobe. ASL-MRA (C) depicts the middle 
meningeal artery (blue arrow) feeding the AVM nidus while the superficial venous 
drainage (red arrowhead) is visualized on CE-MRA (D). In the second case (E-H), the 
identification of a small nidus (yellow arrow) on HD-TOF (F) and CE-MRA (H) provides 
convincing evidence of the presence of a residual AVM, despite this not being visible on 












Figure 6.5. Observer’s level of confidence on the assessment of triple-MRA and DSA 
regarding the absence/presence of a residual AVM. 
6.5 Discussion  
This work presents a detailed evaluation of triple-MRA for confirmation of 
obliteration of brain AVMs following GKR in comparison to DSA. The triple-
MRA and DSA of 30 patients who attended follow-up imaging to confirm 
obliteration of brain AVMs following GKR, were blindly assessed by two 
independent observers. The combined use of ASL-MRA, CE-MRA and HD-TOF 
was shown to be a reliable method to confirm/rule out the presence of residual 
AVMs after radiosurgery. Triple-MRA showed maximal sensitivity and 
specificity, which makes this the first study demonstrating satisfactory diagnostic 
accuracy of MRA for confirmation of obliteration following GKR of brain AVMs 
compared to DSA. This study supports the use of triple-MRA as a first line 
modality for confirmation of obliteration following GKR which is of high clinical 
relevance, because triple-MRA can not only avoid unnecessary DSA 
examinations for patients with cured AVMs (69% in our study group) but it can 
also help rationalize its use in patients with residual AVMs, who may need further 
DSAs for embolization or repeated GKR.  













spatial resolution, which are necessary to appreciate the dynamic characteristics of 
AVMs (Khandanpour et al, 2013). AVMs exhibit a high degree of heterogeneity 
in terms of angio-architecture and flow dynamics and even within the same lesion 
there may be dramatic and unpredictable differences in terms of vessel 
configuration and blood flow (Stapf et al, 2006). For this reason, AVMs are very 
difficult to characterise fully using a single MRA sequence. Previous studies have 
used individual MRA sequences, either TOF or CE-MRA along with structural 
MRI, in an attempt to image residual AVMs (Buis et al, 2012; Lee et al, 2015; 
Lim et al, 2012; Soize et al, 2014). These sequences, however, rely on contrast 
mechanisms which cannot by themselves account for all the possible variations in 
flow and velocity to optimally portray abnormal blood vessels in AVMs. If used 
independently they tend not to capture all the complexity and heterogeneity of 
shapes, sizes and velocities seen on AVMs.  However, as it has been 
demonstrated in this study, in combination as triple-MRA they form a robust 
method to detect/rule out the presence of residual AVMs after GKR by reducing 
the chances of false positives and false negatives and by providing both structural 
and dynamic information of residual lesions to allow their characterization. 
The use of multiple sequences for diagnostic purpose is common place in 
radiology and it is well accepted that information from multiple sources such as 
T1, T2 and contrast enhanced imaging may be required to achieve full diagnosis. 
The combination of several sequences or imaging techniques has proved to be 
even more valuable in vascular imaging where for instance a number of 
physiological parameters such as cerebral blood volume, cerebral blood flow and 
mean transit time are measured to understand the abnormalities of cerebral 
perfusion (Karonen et al, 2000; Kennan & Jäger, 2003). Dynamic contrast 
enhanced and dynamic susceptibility contrast MR perfusion imaging are also 
frequently used in combination to obtain these parameters which cannot be 
obtained using a single acquisition (Shin et al, 2014). CE-MRA and TOF 
angiography have been used in combination for follow-up of intracranial 
aneurysms treated by flow diverter and a combination of ASL-perfusion and CE-
MRA is a promising strategy for non-invasive assessment of cerebral AVMs, 
providing functional information that so far has been gained only with DSA 
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(Kukuk et al, 2010; Shin et al, 2014).  
We have demonstrated that triple-MRA is comparable to DSA for confirmation of 
obliteration following GKR, but of course this does not provide any evidence that 
triple-MRA is equivalent to DSA for other uses. In this study, the observers were 
aided by a very high index of suspicion because they were aware of the location 
of AVMs at treatment and therefore knew where to look for residual lesions. 
Triple-MRA assessment was designed to replicate the clinical scenario in which 
DSA examinations are reviewed specifically to confirm obliteration. Results 
might have been different if the observers had no indication of the potential 
findings or location.  
A completely independent review of each MRA sequence to assess their ability to 
individually confirm AVM obliteration was not part of our study design. The 
observers simultaneously viewed all three MRA sequences but indicated 
subsequently which of them showed the residual AVMs (Appendix 5). Although 
HD-TOF (but not the other MRA sequences) was found to demonstrate the 
residual nidi in all DSA positive cases (specificity: 100%; NPV: 100%; no false 
positives), we cannot conclude that this would have been the case if HD-TOF had 
been the only MRA modality available. It might be tempting to argue that HD-
TOF on its own is as good as DSA, or triple-MRA, due to the result of ROC area 
under the curve of 1. However, the combined assessment of all three MRA 
sequences is highly likely to have resulted in a degree of crossed reinforcement or 
reassurance of findings between the individual sequences. In fact, less than 
optimal sensitivity and specificity of TOF have been repeatedly demonstrated in 
previous studies (Buis et al, 2012; Lee et al, 2015) and this motivated the 
development of triple-MRA by combining multiple MRA sequences. Lee et al, for 
instance, studied a group of 136 patients who had undergone GKR and 
retrospectively reviewed their MRI and TOF. They reported that in 5-10% of the 
cases TOF showed apparent obliteration, although a residual AVM was found on 
DSA (false positives) (Lee et al, 2015). This is a recognised weakness of TOF and 
convincing explanations have been proposed for it. During a TOF acquisition, the 
static tissue is repeatedly excited with RF pulses reducing the steady-state 
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magnetization signal (signal saturation). Unsaturated blood flowing into the 
excited volume gives considerably more MR signal than the background tissue 
creating the blood-to-background contrast known as TOF (Bosmans et al, 1995). 
As a consequence, a slow flowing residual AVM -or parts of it- can pass 
undetected on TOF if blood passage through the nidus is not fast enough to give 
more signal than the background tissue. This is likely to be the case at late stages 
of blood vessel stenosis which occurs for AVM obliteration following 
radiosurgery (Schneider et al, 1997). The TOF effect is known to improve at 
higher magnetic field strength due to increase in the T1 of static tissue which 
improves its saturation as well as the inherent increase in bulk magnetization 
(MacDonald & Frayne, 2015). Also, it has also been previously demonstrated that 
stronger magnetic fields result in visualisation of more and smaller blood vessels 
(Kang et al, 2009). Therefore, the use of a stronger magnetic field (3 T) in our 
study could partly explain the apparent improved performance of HD-TOF 
compared to previous studies which used 1.5 T magnets (Buis et al, 2012; Lee et 
al, 2015).  
The limitations of TOF are not restricted to overestimation of the true obliteration 
rate. Buis et al retrospectively reviewed the TOF (1.5 T) and T2 weighted MRI of 
120 patients after GKR to assess their ability to correctly determine nidus 
obliteration compared to DSA (Buis et al, 2012). They found that obliteration was 
demonstrated on DSA in 48% of the cases in which the AVM appeared to be 
patent on TOF (false negatives) and this resulted in very low sensitivity (0.52) and 
NPV (0.55-0.62). During a TOF acquisition, tissues with very short T1s, such as 
hematoma or stagnated blood, might produce hyper-intense signal similar in 
appearance to residual AVMs which is likely to explain the reported rate of false 
negatives (Bednarz et al, 2000). Buis et al also found that a nidus size < 10 mm 
was a major limiting factor for reliable assessment of obliteration using TOF and 
a similar size threshold had been previously described with magnitude contrast 
MR angiography (Buis et al, 2012; Mukherji et al, 1995). This was not the case in 
our study where lesions as small as 6 mm (Figure 6.3d) and 8 mm (Figure 6.4f) 
were visualized adequately on HD-TOF. The higher spatial resolution of HD-TOF 
in our study (0.3 x 0.44 x 1 mm acquired voxels), directly resulting from the use 
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of higher field strength, is likely to have contributed to the improved AVM 
detection rate in our study. Although, some methodological issues in those studies 
could have also contributed to their poorer results. For instance, in the studies 
discussed above MRA and DSA were not acquired on the same day and a time 
interval of up to six months was noted between DSA and MRA in one of them 
(Buis et al, 2012). Also, we did not include in the assessment of obliteration a 
contrast enhanced T1 sequence which is known to cause underestimation of nidus 
obliteration due to contrast enhancement of scar tissue and post-radiosurgical 
changes (Lee et al, 2015; Warren et al, 2001). There are reasons to believe that 
our HD-TOF did provide better accuracy than the sequences used in previous 
studies but TOF angiography still lacks temporal information which is a major 
limitation that renders it inherently inadequate for the evaluation of dynamic 
abnormalities such as AVMs. It relies exclusively on visualisation of the AVM 
nidus for identification of AVMs, as opposed to dynamic MRA sequences 
which can demonstrate arteriovenous shunting (Figure 6.6), and by itself it is 
not suitable for characterisation of residual AVMs. Therefore, it is convenient to 
combine multiple MRA sequences including dynamic acquisitions such as CE and 







Figure 6.6. Identification of residual AV shunt using ASL-MRA and CE-MRA in 
two cases with residual AVMs after GKR. In the top row case, a residual AV shunt is 
demonstrated with ASL-MRA (B) by visualising an early filling draining vein (red arrow 
heads) which is also depicted by DSA (A). The CE-MRA of the second case (bottom 
row) shows the early filling of the straight sinus (blue arrows) confirming the presence of 
residual arteriovenous shunting (C).  
 
Four-dimensional CE-MRA, also referred to as TRICKS, TWIST or TRAK, has 
been shown to have good accuracy for AVM detection and optimal agreement 
with DSA on nidus size and type of venous drainage (Machet et al, 2012). The 
main strength of CE-MRA for AVMs assessment after radiosurgery is the fact 
that it can depict AV shunting (Figure 6.6), which is relevant not only for the 
evaluation of AVM obliteration but also for characterisation of residual lesions. In 
our study, CE-MRA not only contributed to the cumulative evidence of triple-
MRA for assessment of obliteration but it was also very important in the case in 






demonstrates how the three sequences complement each other and the use of 
multiple acquisition methods increases the chances of AVM detection. 
Furthermore, although CE-MRA cannot depict all residual AVMs, it is very 
useful in cases with residual AV shunt/nidus because it enables the 
characterisation of residual lesions in terms of feeding arteries and draining veins. 
This was also the conclusion of previous studies that compared CE-MRA with 
DSA for confirmation of obliteration after radiosurgery (Lim et al, 2012; Soize et 
al, 2014). These studies reported diagnostic accuracy for detection of residual 
AVMs as opposed to confirmation of obliteration which was the objective of our 
study and the TOF papers mentioned above. This posed some difficulties for 
comparison between papers given that a positive result on CE-MRA studies 
(residual AVM present) was considered a negative result for us (no obliteration 
achieved). For this reason, the results by Soize et al and Lim et al have been re-
termed to facilitate comparison. 
Soize et al used SENSE in combination with Half-Fourier imaging, CENTRA and 
keyhole k-space filling to achieve a temporal resolution of 1.4 seconds per volume 
(Soize et al, 2014). They found that all the cases with no residual AVM on DSA 
also appeared to show complete obliteration on CE-MRA, i.e. no false negative 
cases, 100% sensitivity for obliteration and negative predictive value 100%. 
However, they also found a 15% false positives rate which was the result of 
residual AVMs visualized on DSA not showing up on CE-MRA (specificity: 
73.7% and PPV: 78.3%). In our study group, at least two residual AVMs that 
were detected on DSA, HD-TOF and ASL-MRA were not visible on CE-MRA. 
The resultant false positive rate (11-17%), specificity (67-78%) and PPV (83-
89%) are comparable to the estimates by Soize at al. Similar findings were 
reported by Lim et al who prospectively examined 35 patients with CE-MRA and 
found that in 13-15% of the cases in which CE-MRA demonstrated complete 
obliteration, there was actually a residual on DSA (false positive). The unseen 
nidi in previous studies were very small and they proposed that suboptimal spatial 
resolution was to account for this, along with heterogeneity of the nidus such as in 
cases with previous embolization. However, our false positives (residual AVMs 
not detected on CE-MRA) were not significantly smaller than the rest of the 
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lesions and two of them were actually above 1 cm in maximum diameter. This 
supports the hypothesis that heterogeneity of the nidus has an important role on 
detectability of AVMs on CE-MRA -and almost certainly other MRA sequences 
too. Our results and previous studies demonstrate that CE-MRA is useful for 
characterisation of residual AVMs and it is more reliable when a residual AVM is 
visualized (good negative predictive value and high sensitivity). This appears to 
complement TOF which lacks temporal resolution, and is therefore inadequate for 
characterisation of residual AVMs, but can more reliable confirm obliteration 
(very good positive predictive value and high specificity) (Buis et al, 2012; Lee et 
al, 2015). This again supports the combined use of more than one MRA sequence 
to detect and characterise residual AVMs.  
In our study, the arrival of contrast agent was not detected by CE-MRA in an 
important number of cases (5) due to mistiming of the gadolinium injection with 
respect to the dynamic acquisition. Also, in a few cases the first dynamic phase 
showing arrival of gadolinium happened to show the bolus just before it reached 
the AVM nidus so that 600 ms later when the next phase was acquired, the 
contrast had already filled the nidus and it had shunted into the venous side with 
the arterial phase of the nidus not being depicted on its own. These issues 
demonstrate that CE-MRA on its own cannot consistently provide all the dynamic 
information required for complete characterisation of AVMs and an additional 
dynamic MRA sequence, such as ASL-MRA, is required if results comparable to 
DSA are to be obtained.  
There are to date no studies using ASL-MRA for confirmation of obliteration 
after radiosurgery. A number of studies have used ASL-MRA and ASL perfusion 
for assessment of AVMs with promising results but its value compared to DSA is 
still to be fully established (Fujima et al, 2016; Iryo et al, 2016; Yu et al, 2012). 
ASL-MRA uses the same principles of ASL perfusion to acquire images of the 
vasculature. The arterial blood water is magnetically labelled with a 
radiofrequency pulse proximal to the brain and it is used as an intrinsic contrast 
agent and flow tracer (Petersen et al, 2014). This is achieved by inverting the 
longitudinal magnetization of arterial water spins which changes the contrast 
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properties of inflowing blood with respect to the surrounding tissue (Golay et al, 
2005). The subtraction of an image with inverted blood spins (label) and without 
inversion (control) results in images of the inflowing blood only (Lindner et al, 
2015). Under normal conditions, most labelled water is extracted at the capillary 
level into the tissue, giving rise to the parenchymal perfusion signal intensity for 
which ASL is better known (Petersen et al, 2006; Xu et al, 2010). The same 
principle, with an early acquisition -before the tagged water leaves the 
vasculature- is applied to obtain angiographic images with near zero background 
and inflow dynamics similar to DSA (Suzuki et al, 2017). The T1 recovery of 
labelled spins is shorter than capillary transit time and for this reason signal 
intensity is not normally seen within intracranial veins in ASL angiography 
(Kukuk et al, 2010). AVMs, however, lack a capillary bed for water extraction to 
take place, and the labelled spins are shunted into the venous circulation with 
minimal transit time, giving rise to a high signal intensity in the AVM draining 
veins on ASL (Jang et al, 2014). This makes of ASL-MRA an appealing 
technique for confirmation of obliteration because -by definition- any depicted 
venous signal is the result of AV shunting, which is an unequivocal and defining 
element of AVMs (Figure 6.6).  
In our study ASL-MRA showed the AVM shunt or nidus in 89% of the cases with 
a residual AVM. It proved critical to the assessment of obliteration in two cases 
where CE-MRA failed to demonstrate the residual lesion (Figure 6.3) and 
provided important information on nidus size and number of feeding arteries. 
Fujima et al compared ASL-MRA with TOF and DSA of 12 AVM patients and 
also concluded that ASL-MRA was useful for the detection of feeding arteries and 
characterisation of the nidus structure (Fujima et al, 2016). ASL-MRA has a great 
potential in terms of temporal resolution and acquisitions as fast as less than 100 
ms per frame have been described (Lindner et al, 2015). We used a temporal 
resolution of 200 ms per frame, which is very close to the maximum resolution 
used in DSA (133 ms). We found that at this resolution the filling of the nidus can 
be optimally depicted, with unequivocal identification of the shunt and feeding 
arteries (Figure 6.6). Nonetheless, as other individual MRA sequences, ASL-
MRA is by itself unable to capture all the possible scenarios of size, flow and 
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velocity to reliably detect residual AVMs. This is evidenced by the occurrence of 
false positives in which ASL-MRA fails to show the residual nidus (Figure 6.4g). 
If used on its own, ASL-MRA would then overestimated response rate. Early 
studies using ASL-MRA on AVM patients have already observed that despite 
offering hemodynamic information with very good temporal resolution (50 – 100 
ms) it is better used as a complement to existing angiography methods (Yu et al, 
2012). Nonetheless, ASL-MRA is a rapidly evolving technique. It has been shown 
to be suitable for imaging of selective vascular territories (Dai et al, 2010; 
Hendrikse et al, 2004; Robson et al, 2010) and it is being applied to several 
cerebrovascular diseases (Jensen-Kondering et al, 2015). Furthermore, the timing 
of dynamic acquisition in ASL-MRA can be personalised for the individual 
characteristics of lesion of interest. This can be achieved by using a short ASL 
vascular survey to characterise AVM filling velocity so that time resolution in the 
final acquisition is tailored according to the flow patterns in each individual case 
(Rojas-Villabona et al, 2017). 
The main limitation of our study is the relatively small sample size. The 
assessment of a larger number of patients could have improved the study power 
and external validity of the results. Further optimisation of HD-TOF can be 
achieved by acquiring it after contrast injection (Bosmans et al, 1995). 
Gadolinium based contrast agents reduce the T1 of blood which enhances blood 
magnetisation recovery and improves the contrast between flowing blood and 
background tissues in this inherently T1 weighted acquisition (Yang et al, 2002). 
This was not part of our scanning protocol but it should be considered in future 
applications of triple-MRA. There is also a great potential for improvement of 
triple-MRA by post-processing the individual datasets to generate a single product 
that incorporates the information provided by all three sequences. This ranges 
from simple co-registration and superposition of the dynamic sequences on HD- 
TOF to complex algorithms that look at signal in each sequence and weigh it or 
model it to correct for flow artefacts and compensate for the reduced spatial 
resolution of the dynamic sequences (McGee et al, 2006). This is still to be 
accomplished and developers should aim for more sophisticated 4D visualisation 
maps which enhance the visual experience and facilitate interpretation. In our 
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study, the aim was to demonstrate the principle that using three MRA sequences 
in combination is as good as DSA for confirmation of obliteration. Therefore, 
extended image post-processing which could have become a confounding factor 
was avoided. 
Finally, it is important to observe that the development of GKR as a treatment for 
brain AVMs was historically accomplished using DSA and radiosurgery 
practitioners still rely on post-treatment DSAs to assess obliteration and to advise 
patients on their cure or need for further treatment. The radiosurgical community 
have, therefore, a very high level of confidence on DSA as the reference standard 
method for confirmation of obliteration. This has contributed to the limited and 
hesitant use of MRA as an alternative to DSA in radiosurgery. For that reason, we 
asked the observers how confident they were of their assessment of obliteration 
both on triple-MRA and DSA. Surprisingly, there was no difference on the level 
of confidence reported when making assessment on triple-MRA compared to 
DSA and this is an encouraging finding which should help promote the use of less 
invasive imaging methods for AVM patients. 
6.6 Conclusions 
Triple-MRA consistently demonstrated/ruled out residual AVMs in patients who 
had undergone GKR for brain AVMs compared to DSA. The combination of 
three MRA sequences provides optimal sensitivity and specificity for 
confirmation of obliteration following GKR and it can also be reliably used for 





7. Conclusions and future work 
The work presented in this dissertation is the response to a series of technical and 
clinical challenges encountered during the first four years of operations in the 
Gamma Knife Centre at Queen Square. These challenges, which are common to 
most contemporary Gamma Knife centres, were prospectively addressed and 
practical solutions were developed for the questions they posed.  
 The study in chapter 3 demonstrated that inhomogeneity correction with the 
convolution algorithm results in a considerable but consistent dose shift compared 
to the TMR 10 algorithm traditionally used for GKR. No significant difference in 
relative dose distribution was noted and it was concluded that a reduction of the 
prescription dose is necessary to obtain the same absolute dosimetric effect with 
the convolution algorithm. This specific recommendation is of good practical 
value for radiosurgery practitioners because it enables informed selection of the 
dosimetry algorithm for treatment. The clinical use of the convolution algorithm 
has not yet been reported on peer-reviewed publications and future research work 
should result in the delivery of convolution-planned GKR treatments. We have 
provided appropriate guidance on dose adjustments that are required if this is to 
be done. We have also recommended that special attention be given to cases with 
major CT artefacts around the target, where the convolution algorithm may not 
optimally simulate dose distributions. This is important for case selection in future 
implementation phases.  
 The stability of the Leksell frame G in GKR was reported in chapter 4. A 
comprehensive study design involving repeated measurements of landmarks by 
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two observers was developed to exploit imaging data that was primarily acquired 
for the convolution algorithm study. It is likely that this is the first time a group of 
40 non-selected patients underwent stereotactic imaging at both the beginning and 
the end of a GKR procedure and, therefore, it was important to assess the stability 
of the frame in this group of patients. The study provided reliable and realistic 
evidence of submillimetre stability of the stereotactic frame throughout the 
treatment procedure which is important for evaluation and development of new 
frameless radiosurgery systems. The stability of patient fixation in GKR has 
recently gained importance with the introduction of the Leksell Gamma Knife 
Icon (Elekta AB), which enables frameless radiosurgery with the Gamma Knife 
by using a new frameless Patient Positioning System (PPS) along with a Cone-
Beam CT (CBCT) system and an Intra Fraction Motion Management (IFMM) 
system (Zeverino et al, 2017). The clinical accuracy of the new Icon Gamma 
Knife needs to be independently assessed and the data provided by this study will 
be a useful reference for comparison.  
The combination of multiple MRA sequences as triple-MRA is an innovative 
strategy which was developed to reduce the invasiveness of GKR of brain AVMs 
by optimising the treatment planning method, traditionally based on DSA 
(Chapter 5). The technical feasibility of using triple-MRA, instead of DSA, for 
visualisation and delineation of brain AVMs for GKR targeting has been 
demonstrated. Target volumes obtained using triple-MRA are on average 10% 
smaller than AVM targets obtained with the standard DSA planning method and 
this can potentially reduce the risk of AREs. The discrepancies between triple-
MRA and DSA volumes were less than the inter-observer variability observed 
when an AVM target is delineated by different radiosurgical teams. The treatment 
planning method described here has laid the way for changing clinical practice in 
favour of the less invasive approach. Two opportunities are potentially available 
for further clinical implementation of this research work. First, a randomised 
clinical trial to assess blindly whether planning of GKR using triple-MRA instead 
of DSA affects treatment outcomes, i.e., obliteration rates and ARE.  Second, a 
staged implementation of the new planning method by continuing to trial it 
initially on selected low risk cases (small, compact and non-eloquent AVMs) and, 
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subject to results, more complex cases at a later stage. The second option may be 
more convenient because it provides further insight into the technical suitability of 
triple-MRA for radiosurgery planning and gives more opportunity for continued 
development and optimisation.  Either way, future phases of clinical 
implementation should include thorough and long-term follow-up of patients 
treated with GKR using triple-MRA only; this will help to ascertain the impact of 
the planning method on clinical outcomes.   
 The same principle of less invasive AVM imaging by combining several MRA 
sequences was used at the post-GKR stage, when a DSA is routinely performed to 
confirm AVM obliteration (chapter 6). Triple-MRA was found consistently to 
confirm or rule out residual AVMs in patients who have undergone GKR for brain 
AVMs, compared to DSA. Triple-MRA provides optimal sensitivity and 
specificity for confirmation of obliteration following GKR and it can also be 
reliably used for characterisation of residual AVMs after radiosurgery. The 
widespread use of triple-MRA as a first line for the assessment of obliteration 
after GKR (instead of DSA) can positively impact radiosurgery practice by 
avoiding unnecessary DSA examinations for patients with cured AVMs but also 
through rationalising its use in patients with residual AVMs, who may need 
further treatments. The subjects studied in this project were all recruited and 
scanned at the University Hospital of Verona and future efforts should focus on 
extending this work to other radiosurgery centres, including Queen Square, to be 
able to study a larger group of patients. Optimisation of the imaging protocol on 
other scanning systems (i.e., Siemens and GE) will also allow for a larger 
population of patients to be studied. 
GKR is a rapidly evolving and changing discipline and accelerated progress has 
historically been triggered by technical developments such as the introduction of 
CT and MR imaging in the 1980s or, more recently, the incorporation of 
frameless radiosurgery in the new Gamma Knife model. This context is necessary 
to understand the relevance of the research presented in this thesis but most 
importantly in helping to guide future research activities. This thesis has explored 
the dosimetric differences between the new convolution algorithm and the 
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standard TMR 10, demonstrated the stability of the rigid stereotactic Leksell 
frame and described the use of triple-MRA for planning and follow-up of GKR of 
brain AVMs. Future work should, therefore, aim to make GKR more accurate and 
less invasive by deploying the convolution algorithm, comparing new frameless 
systems with traditional rigid fixation and by replacing DSA with triple-MRA for 
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Appendix 2. Ethical considerations of the convolution project. 
As submitted to the Queen Square Ethics Committee on 29th July 2013. 
This study will be conducted in full conformance with principles of the 
“Declaration of Helsinki”, Good Clinical Practice (GCP) and the UK regulations 
for research in humans. The research protocol will not modify the treatment that 
patients should receive by any means. Apart from the potential benefit for the 
patient to have a more accurate dose calculation method for future GKR, there is 
not any other direct benefit from participation in the study. The results of this 
study are very likely to positively impact the quality of dose calculation method 
for future patients receiving treatment in the QSRC. 
The main risk associated with participation in this study is the radiation exposure 
by an additional CT scan. The radiation received by an adult from a CT scan of 
the head has been estimated to be 2 mSv (95%CI: 0.9-3.0mSv)(Wall & Hart, 
1997). This was confirmed in 2003 by a review of patient doses from CT 
examinations in over a quarter of all UK scanners (Shrimpton et al, 2006). For 
comparison, it is several orders of magnitude less than the patients will be 
receiving from their GKR. In addition, all of us receive about 3 mSv of radiation 
exposure to natural background radiation every year (UN, 2000). The dose 
involved in a head CT scan is considered to be a relatively small dose and the 
risks associated to it are minimal and too small to allow epidemiological 
detection. Estimates of risk from x-ray exposure have a broad range of statistical 
uncertainty, and there is controversy regarding the effects from very low doses 
like the one used in CT scans. The most important of these risks is a 0.01% higher 
mortality by radiation induced cancer (Brenner & Hall, 2007). The risk of 
heritable mutations leading to genetically associated diseases in offspring is 
thought to be very small to observe for radiation doses of the magnitude that are 
associated with CT procedures(Dauer et al, 2010).   
A CT scan of the head is a procedure considered clinically safe and acceptable. It 
is not an indispensable part of pre-treatment imaging for GKR in the UK; 
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however, many centres around the world have included stereotactic CT scan of 
the head as routine for all patients undergoing GKR. Also, it is the imaging 
technique used on patients unable to undergo MRI scanning (Attia et al, 2012). 
Handling of this ethical issue is of paramount importance for the research team. 
Therefore, the scanning sequence has been set up to minimize the radiation 
received by the patient and the acquisition includes the use of the CARE Dose 4D 
Automatic exposure Control system, which allows acquisition of images with the 
required quality giving the lowest possible radiation.  
Patients will be counselled on radiation exposure risks, including information 
about larger radiation-induced cancer mortality and heritable mutations risks, they 
will be given time to think and discuss about the risk involved by participation. 
Subjects will be entirely free to decide their involvement in research and they will 
be able to withdraw at any time without giving any reason. 
Personal identifiable information will be adequately handled to minimize the risks 
of confidentiality aggression. Photographs obtained as part of the research 
participation will be immediately transferred to the Gamma Knife registry 
workstation where they will be stored and used only for research purposes. They 
will be safely stored in the Gamma Knife premises together with the project 
master file and no third party will have access to these records. Only anonymised 
information will be removed from the Gamma Knife premises for analysis. 
Written consent will be taken to use anonymised images or information of 
treatment plans in scientific conferences or paired reviewed scientific journals.  
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NRES Committee London - Queen Square 
HRA NRES Centre Manchester 
Barlow House 
3rd Floor 




Telephone: 0161 625 7816 
 Fax: 0161 625 7299 
 
 
20 January 2015 
 
Dr Rolf Jager 
8-11 Queen Square   
London, UK 




Dear Dr Jager  
 
Study title: Optimization of magnetic resonance vascular imaging 
for planning and follow up of Gamma Knife 
Radiosurgery for brain arteriovenous malformations 
REC reference: 15/LO/0033 
Protocol number: v 1.1 - 23/10/2014 
IRAS project ID: 155348 
 
The Research Ethics Committee reviewed the above application at the meeting held on 15 
January 2015.   The Committee thank Dr Villabona for attending the meeting to discuss the 
application.  
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this favourable opinion letter.  The expectation is that this information will be 
published for all studies that receive an ethical opinion but should you wish to provide a 
substitute contact point, wish to make a request to defer, or require further information, 
please contact the REC Manager Miss Rachel Heron, nrescommittee.london-
queensquare@nhs.net. Under very limited circumstances (e.g. for student research which 
has received an unfavourable opinion), it may be possible to grant an exemption to the 




The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation, subject to the conditions specified below.  
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Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study.   
 
1) Participant Information: 
a) The study was a feasibility study. This should be made clear on the 
participant information.  
b) Contact details for the student should be added. 
2) Consent forms: in Section 9 of the consent form for follow-up patients, the 
phrase ‘do I have to have gamma knife surgery?’ is redundant as patients 
would have already had surgery. This should be removed.  
 
You should notify the REC in writing once all conditions have been met (except for 
site approvals from host organisations) and provide copies of any revised 
documentation with updated version numbers.  The REC will acknowledge receipt and 
provide a final list of the approved documentation for the study, which can be made 
available to host organisations to facilitate their permission for the study. Failure to 
provide the final versions to the REC may cause delay in obtaining permissions. 
 
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned.   
 
Management permission (“R&D approval”) should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk.  
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites (“participant identification centre”), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.  
 
Sponsors are not required to notify the Committee of approvals from host organisations. 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database. This should be before the first participant is 
recruited but no later than 6 weeks after recruitment of the first participant. 
  
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment.  We will audit the registration details as 
part of the annual progress reporting process. 
  
To ensure transparency in research, we strongly recommend that all research is registered 
but for non-clinical trials this is not currently mandatory. 
  
If a sponsor wishes to request a deferral for study registration within the required timeframe, 
they should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials 
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permissible with prior agreement from NRES. Guidance on where to register is provided on 
the HRA website.  
 
It is the responsibility of the sponsor to ensure that all the conditions are complied 
with before the start of the study or its initiation at a particular site (as applicable). 
 




The favourable opinion applies to all NHS sites taking part in the study taking part in the 
study, subject to management permission being obtained from the NHS/HSC R&D office 
prior to the start of the study (see “Conditions of the favourable opinion” below).  
 
Non NHS sites 
 
The Committee has not yet completed any site-specific assessment(s) (SSA) for the non-
NHS research site(s) taking part in this study.  The favourable opinion does not therefore 
apply to any non-NHS site at present.  I will write to you again as soon as an SSA 
application(s) has been reviewed.  In the meantime no study procedures should be initiated 
at non-NHS sites.  
 
Summary of discussion at the meeting 
 
Social or scientific value; scientific design and conduct of the study 
 
The Committee agreed that the study had scientific value. The design was difficult to follow 
due to the technical language used throughout the application. It was not clear whether the 
comparison between conventional angio and MRA was qualitative or quantitative.  
 
Dr Villabona elaborated that the team would look at the MRA and MRI scans and use a 
software tool to draw around the tumour (AVM) on a computer screen, looking at the volume 
and location. Following treatment as normal, they would again draw the lesion. They would 
then evaluate the treatment, and a score would be given for residual lesion. 
 
The Committee enquired if the MRA results would be used for surgical planning.  
 
Dr Villabona confirmed that this would not happen during the trial.  
 
Favourable risk benefit ratio; anticipated benefit/risks for research participants 
(present and future) 
 
There were no direct benefits to participants in the study.  
 
The Committee noted that the care pathway was altered to prevent the need to administer 
the contrast agent more than once. The MRI was usually carried out on the day of the 
surgery, but here was being carried out before the surgery, with a possible gap of 1 month 
between MRI and surgery. The Committee asked if there would be a need to administer an 
additional dose of contrast agent to any patient.  
 
Dr Villabona advised that this would only happen if the treatment had to be delayed, and this 
would be extremely unlikely. He advised that the MRI could be carried out up to a month in 
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The Committee asked if patients in the follow-up part of the study would be asked to have an 
extra MRI as this was not part of routine care at follow up.  
 
Dr Villabona advised that patients would have an MRI every 6 months at follow-up, and at 2 
year the patient could be recalled for an angiogram. The researchers would then try to use 
the scan which had already been done.  
 
The Committee asked if it would be possible for a patient to go through the study twice. Dr 
Villabona advised that this would be ideal, but not possible within the timescale of the study. 
 
Informed consent process and the adequacy and completeness of participant 
information 
 
The Committee asked for a clarification of the consent process.  
 
Dr Villabona advised that patients would receive a telephone call from the research team at 
the time of the decision to give the treatment. Consent for the research would not be given 
on the day of the blood test, which was the day patients consented to the treatment, but at a 
later date. Patients would have a week to decide whether to participate.  
 
The Committee approved these arrangements. 
 
The Committee noted that the Patient Information Sheet had contact details for the Chief 
Investigator but not the student, and should include both.  
 
The Committee advised Dr Villabona that minor points relating to the consent form and 




The documents reviewed at the meeting were: 
 
Document   Version   Date   
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [140791 Insurance Confirmation Letter 04.12.14  ]  
04/12/2014  04 December 2014  
IRAS Checklist XML [Checklist_11122014]    11 December 2014  
Other [UCL 2014-15 Insurance Certificate  ]  2014-15  14 July 2014  
Other [Academic_supervisor_letter_04122014  ]  04122014  04 December 2014  
Participant consent form [Consent_form_CCA_for_GK_planning  ]  v1.1  04 December 2014  
Participant consent form [ 
Consent_form_CCA_for_response_evaluation_after_GKR  ]  
v2.1  04 December 2014  
Participant information sheet (PIS) [PIS_CCA_for_GK_planning  ]  v2.1  04 December 2014  
Participant information sheet (PIS) 
[PIS_CCA_for_response_evaluation_after_GKR    ]  
v3.1  04 December 2014  
REC Application Form [REC_Form_11122014]    11 December 2014  
REC Application Form [REC_Form_11122014]    11 December 2014  
Referee's report or other scientific critique report 
[peer_review_verona_01_11_14  ]  
01/11/2014  01 November 2014  
Research protocol or project proposal 
[optimization_MRA_for_GK_of_brain_AVM_Research_protocol_]  
v1.2  09 December 2014  
Summary CV for Chief Investigator (CI)  v1.1  01 January 2013  
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Summary, synopsis or diagram (flowchart) of protocol in non-
technical language 
[Research_flowchart_MRA_for_GK_v.1.1_04122014]  
v 1.1  23 October 2014  
 
Membership of the Committee 
 
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet. 
 
Mrs Claire Reynolds declared that she had worked with the researchers on this study as she 
used to be employed in the same department; however she was not involved with this 
particular study. The Committee was happy for her to take part in the discussion.  
 




The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
• Notifying substantial amendments 
• Adding new sites and investigators 
• Notification of serious breaches of the protocol 
• Progress and safety reports 
• Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light of 




The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please use the 





We are pleased to welcome researchers and R&D staff at our training days – see details at 
http://www.hra.nhs.uk/hra-training/  
 
 15/LO/0033  Please quote this number on all correspondence 
 





Signed on behalf of 
Dr Yogi Amin 
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Enclosures:          List of names and professions of members who were present at the 
meeting and those who submitted written comments 
 
“After ethical review – guidance for researchers”   
  
Copy to: Mrs Tabitha/TK Kavoi 
 
Dr Alvaro Villabona  
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Confirmation of obliteration after GKR 
 
Research case number:                                                     Evaluator:   
                                      
Institution: London/Verona                                              Review date:  
  
B. CONVENTIONAL CATHETER ANGIOGRAPHY  
 
For the second part of the assessment, please answer the questions based in the information from the 
DSA ONLY.  
 
Examination date: _ _ / _ _/ _ _ _ _ 
 
 
1. Can you detect a vascular abnormality in the DSA?   
                                          Yes                       No  
      If “No”, please go to question 11 and do not answer questions 2- 10.  
 









4. Regarding the Spetzler-Martin Grade for the AVM, please complete the table below: 
 
 Parameter Score 
Approximate lesion volume Assume the lesion is ellipsoid  (a x b x c /2)  
Size of AVM 
(nidus max diameter) 
Small < 3 cm 1 
Medium 3 - 6 cm 2 
Large > 6 cm 3 
Eloquence of adjacent brain 
(brainstem, thalamus, hypothalamus, cerebellar 
peduncles, sensorimotor, language, and primary 
visual cortices) 
Non eloquent 0 
Eloquent 1 
Pattern of venous drainage 














5. How many feeding arteries can you identify? (please give a number)     
 
a. Cortical: …….              b. Deep/perforating: …….             C. Infratentorial: ……. 
 
6. What is the main arterial feeder?  
 
       ………………………………………………………………………………………… 
 
7. How many draining veins can you identify? (please give a number) 
 
a. Deep: …….                   b. Superficial: …….                   
 
8. Can you detect any abnormality of the draining veins?  
 
a. Stenosis                           b. Varices                                 C. Dilated              D.None 
 
9. Can you detect any aneurism associated to this abnormality?  
 
         No                             Pre-nidal                            nidal                           post-nidal  
  
10. Can you observe an extra-nidal arterial-venous fistula in this DSA examination? 
 
                                              Yes                               No                         
 
11. How confident are you of this assessment?  
 























Confirmation of obliteration after GKR 
 
Research case number:                                                     Evaluator:   
                                      
Institution: London/Verona                                              Review date:  
  
 
A. MR ANGIOGRAPHY  
Please review the MR angiography examinations ONLY and answer the following questions:  
Examination date: _ _ / _ _/ _ _ _ _ 
Sequences available: …………………………………………………………………………………… 
1. Is there any kind of artefact in the images that would affect the quality of your radiological 
assessment?  
                                                    Yes                     No 
2. What do you think about the quality of the vessels’ representation in the examinations below?  
 
 Poor Fair Good Very good Excellent 
TOF      
4D ASL angio      
CE angio      
 
3. Can you detect a vascular abnormality in these scans?   
                                          Yes                       No  
      If “No”, please go to question 15 and do not answer questions 4- 14.  
 








6. What MRA sequences DO show the abnormality?  
 
      …………………………………………………………………………………………….. 
 












8. Regarding the size and Spetzler-Martin Grade for this AVM, please complete the table below: 
 
 Parameter Score 
Approximate lesion volume Assume the lesion is ellipsoid  (a x b x c /2)  
Size of AVM 
(nidus max diameter) 
Small < 3 cm 1 
Medium 3 - 6 cm 2 
Large > 6 cm 3 
Eloquence of adjacent brain 
(brainstem, thalamus, hypothalamus, cerebellar 
peduncles, sensorimotor, language, and primary 
visual cortices) 
Non eloquent 0 
Eloquent 1 
Pattern of venous drainage 





9. How many feeding arteries can you identify? (please give a number)     
 
a. Cortical: …….              b. Deep/perforating: …….             C. Infratentorial: ……. 
 
10. What is the main arterial feeder?  
 
       ………………………………………………………………………………………… 
 
11. How many draining veins can you identify? (please give a number) 
 
a. Deep: …….                   b. Superficial: …….                    
 
12. Can you detect any abnormality of the draining veins?  
 
a. Stenosis                           b. Varices                                 C. Dilatation          D.None 
 
13. Can you detect any aneurism associated to this abnormality?  
 
         No                             Pre-nidal                            nidal                           post-nidal  
  
14. Can you observe an extra-nidal arterial-venous fistula in this MR examination? 
 
                                              Yes                               No                         
 
15. How confident are you of this assessment?  
 
      Not entirely confident                          Confident                             Highly confident  
		
 
